C000001	AA_DNA_MUTATION_SIGNATURE
C000002	AA_SIGNATURE_NON_NORMALIZED
C000003	AA_SIGNATURE_NORMALIZED
C000004	ABDOMINAL_DISTENSION
C000005	ABDOMINAL_MASS_WEEKS
C000006	ABDOMINAL_PAIN_WEEKS
C000007	ABERRANT_CELL_FRACTION
C000008	ABI_ENZA_EXPOSURE_STATUS
C000009	ABLATION_EMBOLIZATION_TX_ADJUVANT
C000010	ABNORMAL_LYMPHOCYTE_PERCENT
C000011	ABSOLUTE_CANCER_DNA_FRACTION
C000012	ABSOLUTE_EXTRACT_PLOIDY
C000013	ABSOLUTE_EXTRACT_PURITY
C000014	ABSOLUTE_GENOME_DOUBLINGS
C000015	ABS_NEUTROPHIL_VALUE
C000016	ACCESSION_OUT
C000017	ACGH_DATA
C000018	ACGH_TUMOR_TYPE
C000019	ACHIEVED_RESECTION
C000020	ACTIONABLE_ALTERATIONS
C000021	ACTIONABLE_ALT_LEVEL
C000022	ADDITIONAL_NOTES
C000023	ADDITIONAL_RX_TX
C000024	ADDITIONAL_SAMPLE
C000025	ADDITIONAL_SURGERY_FOR_NEW_TUMOR_EVENT
C000026	ADDITIONAL_TREATMENT_FOR_NEW_TUMOR_EVENT_PHARMACEUTICAL
C000027	ADDITIONAL_TREATMENT_FOR_NEW_TUMOR_EVENT_RADIATION
C000028	ADIPOSE_TISSUE_PERCENTAGE
C000029	ADJUVANT_CHEMO
C000030	ADJUVANT_CT
C000031	ADJUVANT_FOLFOX_METACHRONOUS_METS
C000032	ADJUVANT_HAIP
C000033	ADJUVANT_HORMONE_THERAPY
C000034	ADJUVANT_NEOADJ_IMATINIB
C000035	ADJUVANT_TX
C000036	ADJ_RT_AFTER_FIRST_SURGERY
C000037	ADJ_TX_AFTER_FIRST_SURGERY
C000038	ADJ_XRT
C000039	ADMINISTRATION_OF_DRUG_WEEKS
C000040	AE1
C000041	AE1_AE3_STAIN
C000042	AFB1_SIGNATURE_NON_NORMALIZED
C000043	AFB1_SIGNATURE_NORMALIZED
C000044	AFP_AT_PROCUREMENT
C000045	AFP_NORM_RANGE_LOWER
C000046	AFP_NORM_RANGE_UPPER
C000047	AGE
C000048	AGENT
C000049	AGE_AT_BIRTH_OF_FIRST_CHILD
C000050	AGE_AT_BMI_MEASUREMENT
C000051	AGE_AT_DEATH
C000052	AGE_AT_DIAGNOSIS
C000053	AGE_AT_DIAGNOSIS_GROUP
C000054	AGE_AT_INITIAL_DIAGNOSIS
C000055	AGE_AT_INITIAL_PATHOLOGIC_DIAGNOSIS
C000056	AGE_AT_LAST_FOLLOWUP
C000057	AGE_AT_PROCEDURE
C000058	AGE_AT_PROCUREMENT
C000059	AGE_AT_RELAPSE
C000060	AGE_AT_SEQ_REPORT
C000061	AGE_AT_SURGERY
C000062	AGE_CELL_LINE_YEAR
C000063	AGE_CLASS
C000064	AGE_CURRENT
C000065	AGE_FUDR_START
C000066	AGE_GROUP
C000067	AGE_IN_DAYS
C000068	AGE_REGISTRATION
C000069	AGE_TESTING_YEARS
C000070	AJCC_CLINICAL_TUMOR_STAGE
C000071	AJCC_INCIDENTAL_PROSTATE_CANCER
C000072	AJCC_METASTASIS_CLINICAL_CM
C000073	AJCC_METASTASIS_PATHOLOGIC_PM
C000074	AJCC_NODES_CLINICAL_CN
C000075	AJCC_NODES_CLINICAL_CT
C000076	AJCC_NODES_PATHOLOGIC_PN
C000077	AJCC_PATHOLOGIC_TUMOR_STAGE
C000078	AJCC_STAGING_EDITION
C000079	AJCC_TUMOR_CLINICAL_CT
C000080	AJCC_TUMOR_PATHOLOGIC_PT
C000081	AKT1_E17K_MUTATION_STATUS
C000082	AKT1_MUTATION
C000083	ALB_G_DL
C000084	ALCOHOL
C000085	ALCOHOL_CONSUMPTION_FREQUENCY
C000086	ALCOHOL_EXPOSURE_INTENSITY
C000087	ALCOHOL_HISTORY_DOCUMENTED
C000088	ALC_COUNT
C000089	ALIAS
C000090	ALK_ANALYSIS_TYPE
C000091	ALK_TRANSLOCATION_STATUS
C000092	ALK_TRANSLOCATION_VARIANT
C000093	ALLELE_FREQUENCY_CELLULARITY
C000094	ALLERGIES
C000095	ALPHA_FETOPROTIEN_AT_PROCUREMENT
C000096	ALPHA_FETOPROTIEN_NORMAL_RANGE_LOWER
C000097	ALPHA_FETOPROTIEN_NORMAL_RANGE_UPPER
C000098	ALP_U_L
C000099	ALTERATIONS
C000100	ALTERNATE_THERAPY
C000101	ALTERNATE_THERAPY_OTHER
C000102	ALT_COUNT
C000103	ALT_FREQUENCY
C000104	AML_DIAGNOSIS
C000105	AML_IN_SKIN_PERCENTAGE
C000106	AMOUNT
C000107	AMPLIFICATION_1P
C000108	AMPLIFICATION_1Q
C000109	AMPLIFICATION_STATUS
C000110	AMP_12Q15_CDK4
C000111	AMP_12Q15_DDIT3
C000112	AMP_12Q15_FRS2
C000113	AMP_12Q15_HMGA2
C000114	AMP_12Q15_MDM2
C000115	AMP_FEATURE
C000116	ANALYSIS_COHORT
C000117	ANALYSIS_COHORT_CA
C000118	ANALYSIS_COHORT_HA
C000119	ANALYSIS_ID
C000120	ANALYSIS_TYPE
C000121	ANAPLASTIC_PERCENTAGE
C000122	ANATOMICAL_SUBTYPE
C000123	ANATOMIC_REGION
C000124	ANC_COUNT
C000125	ANDROGEN_DEPRIVATION_THERAPY
C000126	ANEUPLOIDY_SCORE
C000127	ANGIOLYMPHATIC_INVASION
C000128	ANIMAL_INSECT_ALLERGY_AGE
C000129	ANIMAL_INSECT_ALLERGY_HIST
C000130	ANIMAL_INSECT_ALLERGY_TYPES
C000131	ANTIREFLUX_TREATMENT
C000132	ANTIREFLUX_TREATMENT_TYPE
C000133	ANTIRETROVIRAL_THERAPY_AT_DIAGNOSIS
C000134	ANTI_O_VIVERRINI_IGG
C000135	ANY_THERAPY_2YRS
C000136	ANY_THERAPY_XRC_RESPONSE
C000137	APC_INTRON
C000138	ARCHER
C000139	ARHGAP26_ARHGAP6_CLDN18_REARRANGEMENT
C000140	ARHGAP35_MUTATION_STATUS
C000141	ARID1A_MUTATION
C000142	ARID1A_PROTEIN_CODING
C000143	ARID5B_MUTATION_STATUS
C000144	ARMDRIVER_CN
C000145	ARM_SCNA_CLUSTER
C000146	ARNT_SOMATIC
C000147	AR_EXPRESSION
C000148	AR_HIGH
C000149	AR_MRNA
C000150	AR_PROTEIN
C000151	AR_SCORE
C000152	AR_STATUS
C000153	AR_V7_PRESENCE
C000154	AR_V7_RATIO
C000155	AR_V7_READS
C000156	AR_VALUE
C000157	ASBESTOS_EXPOSURE_AGE
C000158	ASBESTOS_EXPOSURE_AGE_LAST
C000159	ASBESTOS_EXPOSURE_SOURCE
C000160	ASBESTOS_EXPOSURE_TYPE
C000161	ASBESTOS_EXPOSURE_YEARS
C000162	ASG_5ME
C000163	ASSOCIATED_ADENOMA
C000164	ASSOCIATED_BORDERLINE_OVARIAN_TUMOR
C000165	ASSOCIATED_GENETIC_METABOLIC_DISEASE
C000166	ASTHMA_ECZEMA_ALLERGY_FIRST_DIAGNOSIS
C000167	ASTHMA_HISTORY
C000168	ASYMPTOMATIC_WEEKS
C000169	ATM_MUT
C000170	ATM_MUTATION_STATUS
C000171	ATRA_EXPOSURE
C000172	ATRX_DELETION
C000173	ATRX_SOMATIC
C000174	ATRX_STATUS
C000175	ATR_MUTATION_STATUS
C000176	ATYPICAL_MITOTIC_FIGURES
C000177	AT_PROCUREMENT_PROTHROMBIN_TIME_INR
C000178	AURKA_FISH
C000179	AVERAGE_SAMPLE_ALLELE_FREQUENCY
C000180	AVE_DNA_PURITY
C000181	AVE_PLOIDY
C000182	AVE_RNA_PURITY
C000183	AVG_CN_12Q13_15
C000184	A_C
C000185	A_G
C000186	A_T
C000187	BAIT_VERSION
C000188	BAP1_LOSS
C000189	BARRETTS_ESOPHAGUS
C000190	BASELINE_BIOPSY_SITE
C000191	BASELINE_CNS_DISEASE
C000192	BASELINE_EXTRAMEDULLARY_DISEASE
C000193	BASOPHILS_COUNT
C000194	BATCH_NUMBER
C000195	BCFI_MONTHS
C000196	BCFI_STATUS
C000197	BCL2_BA
C000198	BCL2_REAR
C000199	BCL6_BA
C000200	BCL6_REAR
C000201	BCL6_STATUS
C000202	BCLC_STAGE
C000203	BCR_ABL1_STATUS
C000204	BCR_ABL_P190_NEGATIVE
C000205	BCR_ABL_P190_POSITIVE
C000206	BCR_ABL_P210_NEGATIVE
C000207	BCR_ABL_P210_POSITIVE
C000208	BCR_FOLLOWUP_BARCODE
C000209	BCR_FOLLOWUP_UUID
C000210	BCR_FREE_MONTHS
C000211	BCR_PATIENT_BARCODE
C000212	BCR_PATIENT_UUID
C000213	BCR_SAMPLE_UUID
C000214	BCR_STATUS
C000215	BCR_TREATMENT_BARCODE
C000216	BEST_ORR
C000217	BEST_RANO_RESPONSE
C000218	BEST_RESPONSE_TO_ALKYLATING_AGENT
C000219	BEST_RESPONSE_TO_EVEROLIMUS
C000220	BEST_RESPONSE_TO_PLATINUM
C000221	BEST_RESPONSE_TO_SUNITINIB
C000222	BEST_RESPONSE_TO_THERAPY
C000223	BETA_HCG_LEVELS
C000224	BIC_FILE_SAMPLE_ID
C000225	BIC_PATIENT_ID
C000226	BILATERAL
C000227	BILATERAL_DIAGNOSIS_TIMING_TYPE
C000228	BILIRUBIN_TOTAL
C000229	BILIRUBIN_TOTAL_NORMAL_RANGE_LOWER
C000230	BILIRUBIN_TOTAL_NORMAL_RANGE_UPPER
C000231	BILIRUBIN_TOTAL_NORM_RANGE_LOWER
C000232	BILIRUBIN_TOTAL_NORM_RANGE_UPPER
C000233	BIND
C000234	BIOCHEMICAL_RECURRENCE_INDICATOR
C000235	BIOCHEMICAL_TESTING
C000236	BIOPSY_AT_PROGRESSION
C000237	BIOPSY_FROM_IRRADIATED_SITE
C000238	BIOPSY_GLEASON_SCORE
C000239	BIOPSY_GLEASON_SCORE_1
C000240	BIOPSY_GLEASON_SCORE_2
C000241	BIOPSY_OBTAINED
C000242	BIOPSY_PRE_OR_POST_IPI
C000243	BIOPSY_PROCEDURE
C000244	BIOPSY_TIME
C000245	BIRTH_COUNTRY
C000246	BIRTH_YEAR
C000247	BKM120_DOSAGE
C000248	BLADDER_GROUP_GRADE
C000249	BLADDER_GROUP_METASTASIS_STAGE
C000250	BLADDER_GROUP_NODE_STAGE
C000251	BLADDER_GROUP_STAGE
C000252	BLADDER_MIBC_CHEMO_TYPE
C000253	BLADDER_MIBC_NO_CHEMO_PROGRESSIVE
C000254	BLADDER_MIBC_NO_CHEMO_PROGRESSIVEPRIOR_BCG
C000255	BLADDER_MIBC_OR_NON_MIBC
C000256	BLADDER_MIBC_PRIOR_INTRAVESICAL_CHEMOTHERAPY
C000257	BLADDER_MIBC_PROGRESSIVE
C000258	BLADDER_MIBC_SPECIMEN_CHEMOTHERAPY_STATUS
C000259	BLADDER_NECK_INVASION
C000260	BLADDER_NMIBC_ADJUVANT_BCG
C000261	BLADDER_NMIBC_ADJUVANT_MITOMYCIN
C000262	BLADDER_NMIBC_CIS
C000263	BLADDER_NMIBC_CYSTO_FUPTIME
C000264	BLADDER_NMIBC_ESTIMATED_TUMOR_SIZE
C000265	BLADDER_NMIBC_GROUP
C000266	BLADDER_NMIBC_HIGH_GRADE_NED_AT_24_MONTHS
C000267	BLADDER_NMIBC_HIGH_GRADE_RECURRENCE
C000268	BLADDER_NMIBC_HIGH_GRADE_RECURR_TIME
C000269	BLADDER_NMIBC_NED_AT_24_MONTHS
C000270	BLADDER_NMIBC_RECURRENCE
C000271	BLADDER_NMIBC_TCGA_SMOKING_CATEGORY
C000272	BLADDER_NMIBC_TIME_TO_RECURRENCE
C000273	BLADDER_NMIBC_TUMOR_NUMBER
C000274	BLAST_COUNT
C000275	BLAST_PERCENT_CBC
C000276	BLEEDING_WEEKS
C000277	BLOCK
C000278	BLOCK_ACCESSION
C000279	BLOCK_ID
C000280	BLOOD_COLLECTION
C000281	BMI
C000282	BMI_CATEGORY
C000283	BM_BLAST_PERCENTAGE
C000284	BM_DAY_15
C000285	BM_DAY_29
C000286	BM_DAY_43
C000287	BM_DAY_8
C000288	BONE_MARROW_BIOPSY_PERFORMED
C000289	BONE_MARROW_INVOLVEMENT
C000290	BONE_MARROW_LEUKEMIC_BLAST_PERCENTAGE
C000291	BONE_MARROW_SAMPLE_HISTOLOGY
C000292	BONE_MARROW_SITE_OF_RELAPSE
C000293	BONE_SCAN_RESULT
C000294	BORBORYGMI_WEEKS
C000295	BORR
C000296	BORRMANN_CLASSIFICATION
C000297	BOWEL_HABITS_CHANGE_WEEKS
C000298	BRAC2_GERMLINE
C000299	BRACHYTHERAPY_TOTAL_DOSE_POINT_A
C000300	BRACHYTHERAPY_TYPE
C000301	BRACHYTHERAPY_TYPE_OTHER
C000302	BRAFV600E_RAF_CLASS
C000303	BRAFV600E_RAF_SCORE
C000304	BRAFV600E_RAS
C000305	BRAF_FUSION
C000306	BRAF_GENE_ANALYSIS_INDICATOR
C000307	BRAF_GENE_ANALYSIS_RESULT
C000308	BRAF_KIAA1549_FUSION
C000309	BRAF_MUTATION
C000310	BRAF_SOMATIC
C000311	BRAF_STATUS
C000312	BRAF_V600E_STATUS
C000313	BRAF_V600_LEVEL1
C000314	BRAIN_METS
C000315	BRCA1_CNA
C000316	BRCA1_GERMLINE
C000317	BRCA1_GERMLINE_MUT
C000318	BRCA1_HOMDEL
C000319	BRCA1_MUTATION
C000320	BRCA1_RESULT
C000321	BRCA2_CNA
C000322	BRCA2_GERMLINE_MUT
C000323	BRCA2_HOMDEL
C000324	BRCA2_MUTATION
C000325	BRCA2_RESULT
C000326	BRCA_GERMLINE_MUTATIONS
C000327	BRCA_TYPE
C000328	BRCA_VARIANT
C000329	BRC_RECEPTOR_SUBTYPE
C000330	BREAST_CANCER_RECEPTOR_STATUS
C000331	BREAST_CANCER_RECEPTOR_STATUS_DETAILED
C000332	BREAST_CANCER_RECEPTOR_STATUS_FINAL
C000333	BREAST_CANCER_RECEPTOR_STATUS_PRIMARY
C000334	BREAST_SURGERY
C000335	BRESLOW_DEPTH
C000336	BRONCHOSCOPY
C000337	BUBBLE_GROUP
C000338	BXCEP17_COPY
C000339	BXHER2_COPY
C000340	BXHER2_RATIO
C000341	BX_DCIS
C000342	BX_EPITHELIOID
C000343	BX_ER
C000344	BX_GRADE
C000345	BX_HER2FISH
C000346	BX_HER2IHC
C000347	BX_HER2OVERALL
C000348	BX_HISTOLOGY
C000349	BX_KI67
C000350	BX_LCIS
C000351	BX_LOCATION
C000352	BX_NOTES
C000353	BX_NUCLEAR_GRADE
C000354	BX_PERCENT_ER
C000355	BX_PERCENT_PR
C000356	BX_PR
C000357	BX_SIDEDNESS_BREAST
C000358	BX_SPINDLE_CELL
C000359	BX_TIME_DAYS
C000360	BX_TYPE
C000361	BX_VASOFORMATIVE
C000362	B_CELLS_MEMORY
C000363	B_CELLS_NAIVE
C000364	B_CELL_GENOTYPE_METHOD
C000365	CABAZI
C000366	CAISIS_AGE
C000367	CAISIS_AGENT
C000368	CAISIS_DFS_MONTHS
C000369	CAISIS_DFS_STATUS
C000370	CAISIS_DIAGNOSTIC_DATE
C000371	CAISIS_DIAGNOSTIC_NOTES
C000372	CAISIS_DIAGNOSTIC_TARGET
C000373	CAISIS_EVENT_TYPE
C000374	CAISIS_GENDER
C000375	CAISIS_MGMT_STATUS
C000376	CAISIS_NOTE
C000377	CAISIS_OS_MONTHS
C000378	CAISIS_OS_STATUS
C000379	CAISIS_RESULT
C000380	CAISIS_SAMPLE_HISTOLOGY
C000381	CAISIS_START_DATE
C000382	CAISIS_STATUS
C000383	CAISIS_STOP_DATE
C000384	CAISIS_SUBTYPE
C000385	CAISIS_TREATMENT_TYPE
C000386	CAISIS_WHO_GRADE
C000387	CALC_AGE_DX
C000388	CALC_DIFF_PRIMARY_DX_METS_DX_MONTHS
C000389	CALC_MET_SETTING
C000390	CALC_TIME_TO_METS_DX_DAYS
C000391	CALC_TIME_TO_METS_DX_MONTHS
C000392	CALC_TREATMENT_NAIVE
C000393	CAM_5_2
C000394	CANCER_DNA_FRACTION
C000395	CANCER_PROCUREMENT_STATE_PROVINCE
C000396	CANCER_TYPE
C000397	CANCER_TYPE_ACRONYM
C000398	CANCER_TYPE_DETAILED
C000399	CAPSULAR_INVASION
C000400	CAPTURE_BAIT_SET
C000401	CARBO
C000402	CARBON_MONOXIDE_DIFFUSION_DLCO
C000403	CATEGORY_SAMPLE
C000404	CAUSE_OF_DEATH_OTHER
C000405	CAUSE_OF_DEATH_SOURCE
C000406	CA_125
C000407	CA_19_9
C000408	CBEST_B_MEM
C000409	CBEST_B_NAIVE
C000410	CBEST_DENDRITIC_ACT
C000411	CBEST_DENDRITIC_REST
C000412	CBEST_EOSINOPHILS
C000413	CBEST_MACRO_M0
C000414	CBEST_MACRO_M1
C000415	CBEST_MACRO_M2
C000416	CBEST_MAST_ACT
C000417	CBEST_MAST_REST
C000418	CBEST_MONO
C000419	CBEST_NEUTROPHILS
C000420	CBEST_NK_ACT
C000421	CBEST_NK_REST
C000422	CBEST_PLASMA
C000423	CBEST_T_CD4_MEM_ACT
C000424	CBEST_T_CD4_MEM_REST
C000425	CBEST_T_CD4_NAIVE
C000426	CBEST_T_CD8
C000427	CBEST_T_FOLLI_HEL
C000428	CBEST_T_G_D
C000429	CBEST_T_REG
C000430	CBFT2A3_GLIS
C000431	CBIOPORTAL_UPLOAD_DATE
C000432	CBIO_PROJECT_NAME
C000433	CC_TT
C000434	CD10_STATUS
C000435	CD14_NEG_CD16_NEG_OUTOF_CD45POS
C000436	CD14_POS_CD16_POS_OUTOF_CD45POS
C000437	CD15_POS_CD16_POS_OUTOF_CD45POS
C000438	CD19_PERCENTAGE
C000439	CD19_POS_OUTOF_CD45POS
C000440	CD33_PERCENTAGE
C000441	CD38_PERCENTAGE
C000442	CD3_NEG_CD56_POS_CD16_NEG_OUTOF_CD45POS
C000443	CD3_NEG_CD56_POS_CD16_POS_OUTOF_CD45POS
C000444	CD3_POS_OUTOF_CD45POS
C000445	CD3_POS_WTT
C000446	CD45_NEGATIVE
C000447	CD45_POS_WTT
C000448	CD4_COUNTS_AT_DIAGNOSIS
C000449	CD56_POSITIVE
C000450	CD5_PERCENTAGE
C000451	CDC_HIV_RISK_GROUP
C000452	CDH1_STATUS
C000453	CDK12_CNA
C000454	CDK12_MUT
C000455	CDKN1B_CNA
C000456	CDKN1B_MUT
C000457	CDKN2A_DEL
C000458	CDKN2A_MET
C000459	CDKN2A_MUTATION
C000460	CDKN2A_SILENCING
C000461	CEA
C000462	CEA_RESULTS
C000463	CEBPA_MUTATION
C000464	CEBPA_NEGATIVE
C000465	CEBPA_POSITIVE
C000466	CELLULARITY
C000467	CELL_DIFFERENTIATION
C000468	CELL_LINE_INFORMATION
C000469	CELL_LINE_ORIGIN
C000470	CELL_LINE_SOURCE
C000471	CELL_NUM_PER_VIAL
C000472	CELL_OF_ORIGIN
C000473	CELL_TYPE
C000474	CENSORED
C000475	CENT17_COPY_NUMBER
C000476	CENTER
C000477	CENTRAL
C000478	CENTRAL_SCAR_FIBROSIS
C000479	CERVIX_SUV_RESULTS
C000480	CFDNA_INPUT_NG
C000481	CFDNA_PDX
C000482	CGA_IHC
C000483	CGH
C000484	CGH_ID
C000485	CGH_SAMPLE_ID
C000486	CG_1P
C000487	CHD1_CNA
C000488	CHD1_MUTATION
C000489	CHD4_MUTATION_STATUS
C000490	CHEMOTHERAPY
C000491	CHEMOTHERAPY_DETAILS
C000492	CHEMOTHERAPY_FIRST_LINE_PLATINUM_ETOPOSIDE
C000493	CHEMOTHERAPY_PRIOR_IMPACT
C000494	CHEMOTHERAPY_RESPONSE
C000495	CHEMO_CONCURRENT_COURSE
C000496	CHEMO_CONCURRENT_DOSE
C000497	CHEMO_CONCURRENT_FRACTIONS_TOTAL
C000498	CHEMO_CONCURRENT_REASON_NOT_GIVEN
C000499	CHEMO_CONCURRENT_REASON_NOT_OTHER
C000500	CHEMO_CONCURRENT_TYPE
C000501	CHEMO_CONCURRENT_TYPE_OTHER
C000502	CHEMO_CYCLES
C000503	CHEMO_DETAILS
C000504	CHEMO_END_REPORTING_PERIOD
C000505	CHEMO_EXPOSURE
C000506	CHEMO_EXP_SEQ_SPECIMEN
C000507	CHEMO_FIRST_LINE
C000508	CHEMO_FOURTH_LINE
C000509	CHEMO_PRE_PUMP
C000510	CHEMO_PRIOR_IMPACT
C000511	CHEMO_RECOMMENDED
C000512	CHEMO_REGIMEN_CATEGORY
C000513	CHEMO_RESISTANT
C000514	CHEMO_SECOND_LINE
C000515	CHEMO_SETTING_METASTATIC
C000516	CHEMO_THIRD_LINE
C000517	CHEST_PAIN_WEEKS
C000518	CHEST_XRAY
C000519	CHILD_PUGH_CLASSIFICATION
C000520	CHLOROMA
C000521	CHLOROMA_RELAPSE_SITE
C000522	CHR12_WCD
C000523	CHR18_WCD
C000524	CHR20_WCD
C000525	CHR2_FISH
C000526	CHR3_FISH
C000527	CHR7_WCD
C000528	CHROMOTRYPSIS_V2
C000529	CHRONIC_HEPATITIS_ANY_TYPE
C000530	CHRONIC_INFLAMATION
C000531	CHR_19_20_CO_GAIN
C000532	CHR_7_GAIN_CHR_10_LOSS
C000533	CIBERSORT_ABSOLUTE
C000534	CIBERSORT_CORRELATION
C000535	CIBERSORT_P
C000536	CIBERSORT_RMSE
C000537	CIMP_CATEGORY
C000538	CIRRHOSIS
C000539	CIS
C000540	CISPLATIN
C000541	CIS_PERCENTAGE
C000542	CITY_OF_PROCUREMENT
C000543	CK18_STAIN
C000544	CK7_STAIN
C000545	CKD_EPI
C000546	CKIT_EXON_17_MUTATION
C000547	CKIT_EXON_8_MUTATION
C000548	CKIT_EXON_MUTATION
C000549	CKIT_MUTATION
C000550	CLARK_LEVEL_AT_DIAGNOSIS
C000551	CLAUDIN_SUBTYPE
C000552	CLG_ID
C000553	CLINICAL_ASSESSMENT
C000554	CLINICAL_ASSOCIATION
C000555	CLINICAL_BENEFIT_TARGET_THERAPY
C000556	CLINICAL_DATA
C000557	CLINICAL_DIAGNOSIS_AND_HISTORY
C000558	CLINICAL_GLEASON
C000559	CLINICAL_GLEASON_CATEGORY
C000560	CLINICAL_GLEASON_SUM
C000561	CLINICAL_SPECIMEN_DEFINITION
C000562	CLINICAL_STAGE
C000563	CLINICAL_STATE
C000564	CLINICAL_STATE_AT_IMPACT_ORDER_DATE
C000565	CLINICAL_STATUS_AT_DIAGNOSIS
C000566	CLINICAL_STATUS_WITHIN_3_MTHS_SURGERY
C000567	CLINICAL_TRIAL
C000568	CLINICAL_TRIAL_1L
C000569	CLINICAL_TRIAL_2L
C000570	CLINICAL_TRIAL_3L
C000571	CLINICAL_TRIAL_DETAILS
C000572	CLINICAL_TRIAL_MT_IT
C000573	CLINICAL_VARIANT
C000574	CLINICAL_VARIANT_DETAILS
C000575	CLIN_AI
C000576	CLIN_IBD
C000577	CLIN_M_STAGE
C000578	CLIN_N_STAGE
C000579	CLIN_N_STAGE_CODE
C000580	CLIN_PSC
C000581	CLIN_T_STAGE
C000582	CLIN_T_STAGE_CODE
C000583	CLONALITY
C000584	CLONAL_LABEL
C000585	CLONET_PURITY
C000586	CLONET_STATUS
C000587	CMO_PATIENT_ID
C000588	CNA_CLUSTER_K4
C000589	CNA_DATA
C000590	CNE
C000591	CNS_DISEASE
C000592	CNS_DISEASE_EVER
C000593	CNS_SITE_OF_RELAPSE
C000594	CNS_STATUS
C000595	CNS_THERAPY_AGENT
C000596	CN_CLUSTER
C000597	CN_DATA
C000598	CN_INVOLVEMENT
C000599	COCA_CLUSTER
C000600	COHORT
C000601	COLLAB_ID
C000602	COLLOID
C000603	COLONOSCOPY
C000604	COLON_POLYPS_PRESENT
C000605	COLUMNAR_METAPLASIA_GOBLET_CELL_INDICATOR
C000606	COMBO_INV_TRIAL
C000607	COMMENTS
C000608	COMMERCIAL_AVAILABILITY
C000609	COMPLETE_DATA
C000610	COMPLETE_TCGA_ID
C000611	COMPLETE_TURBT
C000612	COMPLEXITY
C000613	CONCOMITANT_CIS
C000614	CONCURRENT_CHEMO
C000615	CONCURRENT_CHEMO_DETAILS
C000616	CONCURRENT_TREATMENT
C000617	CONDITIONING_REGIMEN
C000618	CONFIRMED_DRAW
C000619	CONGENITAL_ABNORMALITY
C000620	CONSENSUS_CLUSTER
C000621	CONSOLIDATION
C000622	CONSTIPATION_WEEKS
C000623	CONTEMPORARY_PATIENTS
C000624	CONTIGUOUS_ORGAN_INVADED
C000625	CONTIGUOUS_ORGAN_RESECTION
C000626	CONTIGUOUS_ORGAN_RESECTION_OTHER
C000627	CONTROL_SITE
C000628	CONVERTED_STAGE
C000629	COPY_NUMBER
C000630	COPY_NUMBER_CLUSTER
C000631	COPY_NUMBER_CLUSTER_EC
C000632	COPY_NUMBER_CLUSTER_GEA
C000633	COPY_NUMBER_CLUSTER_GEA_CIN
C000634	COPY_NUMBER_CLUSTER_SCC
C000635	CORPUS_INVOLVEMENT
C000636	CORRELATION
C000637	COUGH_WEEKS
C000638	COUNTRY
C000639	COUNTRY_OF_PROCUREMENT
C000640	COVERAGE
C000641	COVERAGE_GREATER_THAN_100X
C000642	COVERAGE_NORMAL
C000643	COVERAGE_TUMOR
C000644	COVERED_BASES
C000645	CQCF_COUNTRY
C000646	CQCF_DAYS_TO_SAMPLE_PROCUREMENT
C000647	CQCF_METHOD_OF_SAMPLE_PROCUREMEN
C000648	CRDB_ADJ_TXT
C000649	CRDB_BASIC_COMMENTS
C000650	CRDB_BRAINMET
C000651	CRDB_COMMENTS
C000652	CRDB_CONSENT_DATE_DAYS
C000653	CRDB_ECOG
C000654	CRDB_ENROLL_DX_GRADE
C000655	CRDB_ENROLL_DX_GRADE_DSCRP
C000656	CRDB_ENROLL_DX_HIST
C000657	CRDB_ENROLL_DX_M_STAGE
C000658	CRDB_ENROLL_DX_M_STAGE_DSCRP
C000659	CRDB_ENROLL_DX_N_STAGE
C000660	CRDB_ENROLL_DX_N_STAGE_DSCRP
C000661	CRDB_ENROLL_DX_SITE
C000662	CRDB_ENROLL_DX_STAGE
C000663	CRDB_ENROLL_DX_STAGE_DSCRP
C000664	CRDB_ENROLL_DX_STAGING_DSCRP
C000665	CRDB_ENROLL_DX_STATUS
C000666	CRDB_ENROLL_DX_STATUS_DAYS
C000667	CRDB_ENROLL_DX_STATUS_ID
C000668	CRDB_ENROLL_DX_SUB_HIST
C000669	CRDB_ENROLL_DX_SUB_SITE
C000670	CRDB_ENROLL_DX_SUB_SUB_HIST
C000671	CRDB_ENROLL_DX_SUB_SUB_SITE
C000672	CRDB_ENROLL_DX_SUB_SUB_SUB_HIST
C000673	CRDB_ENROLL_DX_T_STAGE
C000674	CRDB_ENROLL_DX_T_STAGE_DSCRP
C000675	CRDB_FIRST_METASTASIS_DAYS
C000676	CRDB_INITIAL_DX_DAYS
C000677	CRDB_INITIAL_SX_DAYS
C000678	CRDB_INIT_DX_GRADE
C000679	CRDB_INIT_DX_GRADE_DSCRP
C000680	CRDB_INIT_DX_HIST
C000681	CRDB_INIT_DX_M_STAGE
C000682	CRDB_INIT_DX_M_STAGE_DSCRP
C000683	CRDB_INIT_DX_N_STAGE
C000684	CRDB_INIT_DX_N_STAGE_DSCRP
C000685	CRDB_INIT_DX_SITE
C000686	CRDB_INIT_DX_STAGE
C000687	CRDB_INIT_DX_STAGE_DSCRP
C000688	CRDB_INIT_DX_STAGING_DSCRP
C000689	CRDB_INIT_DX_STATUS
C000690	CRDB_INIT_DX_STATUS_DAYS
C000691	CRDB_INIT_DX_STATUS_ID
C000692	CRDB_INIT_DX_SUB_HIST
C000693	CRDB_INIT_DX_SUB_SITE
C000694	CRDB_INIT_DX_SUB_SUB_HIST
C000695	CRDB_INIT_DX_SUB_SUB_SITE
C000696	CRDB_INIT_DX_SUB_SUB_SUB_HIST
C000697	CRDB_INIT_DX_T_STAGE
C000698	CRDB_INIT_DX_T_STAGE_DSCRP
C000699	CRDB_NOSYSTXT
C000700	CRDB_OFF_STUDY_DAYS
C000701	CRDB_PRIM_DISEASE_12245
C000702	CRDB_PRIOR_RX
C000703	CRDB_QS_DATE
C000704	CRDB_SURVEY_COMMENTS
C000705	CRDB_SURVIVAL_STATUS
C000706	CRDB_TREATMENT_END_DAYS
C000707	CREATININE
C000708	CREATININE_LEVEL_PRERESECTION
C000709	CREATININE_NORMAL_RANGE_LOWER
C000710	CREATININE_NORMAL_RANGE_UPPER
C000711	CREATININE_NORM_RANGE_LOWER
C000712	CREATININE_NORM_RANGE_UPPER
C000713	CREATININE_PRIOR_TX
C000714	CRITERIA
C000715	CRX
C000716	CR_STATUS_AT_END_OF_COURSE_1
C000717	CR_STATUS_AT_END_OF_COURSE_2
C000718	CSDE1_SOMATIC
C000719	CTCF_MUTATION_STATUS
C000720	CTNNB1_DELETION
C000721	CTNNB1_MUTATION
C000722	CT_ABDOMEN
C000723	CT_CAP
C000724	CT_CHEST
C000725	CT_SCAN_AB_PELVIS_INDICATOR
C000726	CT_SCAN_AB_PELVIS_RESULTS
C000727	CT_SCAN_PERFORMED
C000728	CT_SCAN_PREOP_RESULTS
C000729	CT_SLICE_SPACING
C000730	CUD_CATEGORY
C000731	CULTURE_PROPERTIES
C000732	CURATIVE
C000733	CURRENT_CLINICAL_STATUS
C000734	CURRENT_PDX_PASSAGE
C000735	CYSTECTOMY_N_STAGE
C000736	CYSTECTOMY_PRIMARY_HISTOLOGY
C000737	CYSTECTOMY_T_STAGE
C000738	CYSTECTOMY_VARIANT_HISTOLOGY
C000739	CYST_SIZE
C000740	CYTOGENETICS
C000741	CYTOGENETICS_CATEGORY
C000742	CYTOGENETIC_ABNORMALITY_TYPE
C000743	CYTOGENETIC_CODE_OTHER
C000744	RESCINDED_URI_PREVIOUSLY_USED_FOR_CYTOGENETIC_CODE_OTHER
C000745	CYTOGENETIC_COMPLEXITY
C000746	CYTOGENETIC_RELAPSE_SITE
C000747	CYTOLOGICAL_PHENOTYPE
C000748	CYTOLOGY
C000749	CYTOLYTIC_SCORE
C000750	CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT
C000751	CYTOREDUCTIVE_SURGERY
C000752	CYTOTOXIC_TREATMENT
C000753	C_A
C000754	C_G
C000755	C_N_STAGE
C000756	C_SAMP_METH_K3
C000757	C_SAMP_MIRNA_K4
C000758	C_SAMP_MIRNA_K6
C000759	C_SAMP_MRNA_K4
C000760	C_SAMP_SCNA_CLUSTER
C000761	C_T
C000762	DAILY_ALCOHOL
C000763	DARK
C000764	DARK_ZONE_STAT
C000765	DARWIN_AGE_AT_DIAGNOSIS
C000766	DARWIN_PATIENT_AGE
C000767	DARWIN_RACE
C000768	DARWIN_RELIGION
C000769	DARWIN_SEX
C000770	DARWIN_VITAL_STATUS
C000771	DATA
C000772	DATA_CORE_SAMPLE
C000773	DATA_FREEZE_STATUS
C000774	DATA_SOURCE
C000775	DATE_ADDED
C000776	DATE_ADDITIONAL_CLINICAL_DATA_ADDED
C000777	DATE_OF_BIOPSY
C000778	DATE_OF_BIOPSY_RELAPSE
C000779	DATE_OF_DIAGNOSIS
C000780	DAXX_STATUS
C000781	DAYS_FROM_SURGERY_TO_DEATH
C000782	DAYS_FROM_SURGERY_TO_LAST_FOLLOWUP
C000783	DAYS_FROM_SURGERY_TO_RECURRENCE
C000784	DAYS_LAST_FOLLOWUP
C000785	DAYS_METASTATIC
C000786	DAYS_TO_ADDITIONAL_SURGERY_METASTATIC_PROCEDURE
C000787	DAYS_TO_BILATERAL_TUMOR_DX
C000788	DAYS_TO_BIOCHEMICAL_RECURRENCE_FIRST
C000789	DAYS_TO_BIRTH
C000790	DAYS_TO_BONE_SCAN_PERFORMED
C000791	DAYS_TO_CELL_SURFACE_MARKER_TEST
C000792	DAYS_TO_COLLECTION
C000793	DAYS_TO_CT_SCAN_AB_PELVIS
C000794	DAYS_TO_DEATH
C000795	DAYS_TO_DEFINITIVE_SURGICAL_PROCEDURE_PERFORMED
C000796	DAYS_TO_DIAGNOSIS
C000797	DAYS_TO_DIAGNOSTIC_COMPUTED_TOMOGRAPHY_PERFORMED
C000798	DAYS_TO_DIAGNOSTIC_MRI_PERFORMED
C000799	DAYS_TO_EVENT
C000800	DAYS_TO_FDG_OR_CT_PET_PERFORMED
C000801	DAYS_TO_FIRST_BIOCHEMICAL_RECURRENCE
C000802	DAYS_TO_FIRST_SMN
C000803	DAYS_TO_HIV_DIAGNOSIS
C000804	DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS
C000805	DAYS_TO_INITIAL_SCORE_PERFOR
C000806	DAYS_TO_LABORATORY_PROCEDURE_TUMOR_MARKER_SQUAMOUS_CELL_CARCINOMA_ANTIGEN_RESULT
C000807	DAYS_TO_LAST_FOLLOWUP
C000808	DAYS_TO_LAST_KNOWN_ALIVE
C000809	DAYS_TO_MRI
C000810	DAYS_TO_NEW_TUMOR_EVENT
C000811	DAYS_TO_NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT
C000812	DAYS_TO_NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT_1
C000813	DAYS_TO_PATIENT_PROGRESSION_FREE
C000814	DAYS_TO_PERFORMANCE_STATUS_ASSESSMENT
C000815	DAYS_TO_POST_ORCHI_SERUM_TEST
C000816	DAYS_TO_PRE_ORCHI_SERUM_TEST
C000817	DAYS_TO_PSA
C000818	DAYS_TO_RESULTS
C000819	DAYS_TO_SPECIMEN_COLLECTION
C000820	DAYS_TO_TREATMENT_END
C000821	DAYS_TO_TREATMENT_START
C000822	DAYS_TO_TUMOR_PROGRESSION
C000823	DAY_TO_RELAPSE
C000824	DCIS_GRADE
C000825	DDR_MUTATION
C000826	DEATH_FROM_DISEASE
C000827	DECADRON_TREATMENT
C000828	DEFINITIVE_SURGERY
C000829	DEFINITIVE_SURGICAL_PROCEDURE
C000830	DEFINITIVE_TX_TYPE
C000831	DEL_11Q
C000832	DEL_12P13
C000833	DEL_13Q
C000834	DEL_13Q14
C000835	DEL_16Q
C000836	DEL_17Q13
C000837	DEL_1Q
C000838	DEL_20Q
C000839	DEL_4Q12
C000840	DEL_5Q
C000841	DEL_6Q
C000842	DEL_7
C000843	DEL_7Q
C000844	DEL_9Q
C000845	DEL_FEATURE
C000846	DEMIX_PURITY
C000847	DENDRITIC_CELLS_ACTIVATED
C000848	DENDRITIC_CELLS_RESTING
C000849	DERMAGRPHX_DES
C000850	DETAILED_METASTATIC_SITE
C000851	DETAILED_PRIMARY_SITE
C000852	DETAILED_SAMPLE_HISTOLOGY_CATEGORY
C000853	DETAILS_FIRST_LINE_COMMENTS
C000854	DE_NOVO_START_OUTOFFRAME
C000855	DFS_EVENT
C000856	DFS_MONTHS
C000857	DFS_STATUS
C000858	DIABETES_DIAGNOSIS_DAYS_TO
C000859	DIABETES_DIAGNOSIS_INDICATOR
C000860	DIABETES_STATUS
C000861	DIAGNOSIS
C000862	DIAGNOSTIC_CT_ABD_PELVIS_RESULT
C000863	DIAGNOSTIC_MRI_RESULT
C000864	DIAGNOSTIC_REFRACTORY_RELAPSE
C000865	DIAGNOSTIC_TYPE
C000866	DIAGNOSTIC_TYPE_DETAILED
C000867	DIAGNOSTIC_TYPE_SITE
C000868	DIFF
C000869	DIFFERENTIATION
C000870	DIFFERENTIATION_SCORE
C000871	DIFFUSE_ARCHITECTURE
C000872	DISCONTINUOUS_LESIONS_COUNT
C000873	DISEASE_AT_DIAGNOSIS
C000874	DISEASE_CLASSIFICATION
C000875	DISEASE_CODE
C000876	DISEASE_DETECTED_ON_SCREENING
C000877	DISEASE_EXTENT
C000878	DISEASE_MULTIFOCAL_INDICATOR
C000879	DISEASE_ONTOLOGY
C000880	DISEASE_RECURRENCE_OR_PERSISTENCE
C000881	DISEASE_SPECIFIC_FU
C000882	DISEASE_STAGE
C000883	DISEASE_STATE_TIME_OF_COLLECTION
C000884	DISEASE_STATUS
C000885	DISTANCE_FROM_ANAL_VERGE
C000886	DISTANT_METASTASIS_PATHOLOGIC_SPREAD
C000887	DISTANT_METS
C000888	DISTANT_MET_CHEMO_IMMUNO
C000889	DISTANT_RECURRENCE
C000890	DISTANT_RECURRENCE_NUM
C000891	DISTANT_RECURRENCE_SITE
C000892	DISTANT_RFS_MONTHS
C000893	DM_AT_PRESENTATION
C000894	DM_SITE_CODE
C000895	DNA_INDEX
C000896	DNA_INPUT
C000897	DNA_METHYLATION_CLUSTER_EC
C000898	DNA_METHYLATION_CLUSTER_GEA
C000899	DNA_METHYLATION_CLUSTER_GEA_CIN
C000900	DNA_METHYLATION_CLUSTER_SCC
C000901	DNA_REPAIR_STATUS
C000902	DOCE
C000903	DOD
C000904	DOMAIN
C000905	DONOR_SOURCE
C000906	DOPAMINE
C000907	DOSAGE
C000908	DOUBLING_TIME
C000909	DRFS_MONTHS
C000910	DRFS_STATUS
C000911	DRINKER
C000912	DRIVER_MUTATIONS
C000913	DRIVER_MUTATIONS_DETAILED
C000914	DSS_MONTHS
C000915	DSS_STATUS
C000916	DUPLICATION_NUM
C000917	DURABLE_CLINICAL_BENEFIT
C000918	DURATION
C000919	DURATION_OF_ADJUVANT_NEOADJUVANT_TX
C000920	DURATION_OF_IBD_AT_DIAGNOSIS
C000921	DURATION_OF_THERAPY_DAYS
C000922	DURATION_OF_THERAPY_WEEKS
C000923	DURLASTFU
C000924	DX_BIOPSY_LOCATION
C000925	DX_CEP17_COPY
C000926	DX_ER
C000927	DX_GRADE
C000928	DX_HER2FISH
C000929	DX_HER2IHC
C000930	DX_HER2OVERALL
C000931	DX_HER2_COPY
C000932	DX_HER2_RATIO
C000933	DX_HISTOLOGY
C000934	DX_LOCATION
C000935	DX_PERCENT_ER
C000936	DX_PERCENT_PR
C000937	DX_PR
C000938	DX_SIDEDNESS
C000939	DX_STAGE
C000940	DX_TO_IMPACT_EXTENT_MONTHS
C000941	DX_TYPE
C000942	DYSPLASIA
C000943	E2A_STATUS
C000944	EASTERN_CANCER_ONCOLOGY_GROUP
C000945	EBV_POSITIVE
C000946	EBV_POSITIVE_MALIGNANT_CELLS_PERCENT
C000947	EBV_PRESENT
C000948	EBV_STATUS
C000949	EBV_STATUS_MALIGNANT_CELLS_METHOD
C000950	EBV_TESTED
C000951	EC
C000952	ECE
C000953	ECE_BINARY
C000954	ECOG_AT_STAGE_4_DX
C000955	ECOG_SCORE
C000956	ECOG_STATUS
C000957	ECSMG
C000958	ECZEMA_HISTORY
C000959	EDMONDSON_GRADE
C000960	EFSCENS
C000961	EFS_EVENT_TYPE_ID
C000962	EFS_MONTHS
C000963	EFS_STATUS
C000964	EFS_TIME
C000965	EF_DAYS_DISEASE
C000966	EF_DAYS_METASTASIS
C000967	EGD
C000968	EGF1
C000969	EGF2
C000970	EGLN1_GERMLINE
C000971	ELN_GENETIC_RISK
C000972	EMBOLIZATION
C000973	EMT_SCORE
C000974	ENCAPSULATION
C000975	ENETS_STAGING
C000976	ENETS_T_STAGING
C000977	ENROLLMENT_ON_CLINICAL_TRIAL_BASED_ON_IMPACT
C000978	EOSINOPHILS
C000979	EPAS1_SOMATIC
C000980	EPIGENETIC
C000981	EPINEPHRINE
C000982	EPITHELIAL
C000983	EPITHELIOID_PERCENT_OF_TUMOR
C000984	ERBB_PATHWAY_MUTATION
C000985	ERG_EXPRESSION
C000986	ERG_FISH_RESULT
C000987	ERG_FUSION_ACGH
C000988	ERG_FUSION_GEX
C000989	ERG_FUSION_RNASEQ
C000990	ERG_FUSION_STATUS
C000991	ERG_IHC
C000992	ERG_NANOSTRING
C000993	ERG_STATUS
C000994	ERK_SCORE
C000995	ERROR_PERCENT
C000996	ERYTHROCYTE_SEDIMENTATION_RATE
C000997	ER_EXPR
C000998	ER_IHC
C000999	ER_POSITIVITY_METHOD
C001000	ER_POSITIVITY_SCALE_OTHER
C001001	ER_POSITIVITY_SCALE_USED
C001002	ER_PR_STATUS
C001003	ER_STATUS
C001004	ER_STATUS_BY_IHC
C001005	ER_STATUS_IHC_PERCENT_POSITIVE
C001006	ER_STATUS_METASTASIS
C001007	ER_STATUS_PRIMARY
C001008	ESOPHAGEAL_TUMOR_LOCATION_CENTERED
C001009	ESOPHAGEAL_TUMOR_LOCATION_EPC
C001010	ESOPHAGEAL_TUMOR_LOCATION_INVOLVED
C001011	ESOPH_COLUMNAR_METAPLASIA_INDICATOR
C001012	ESOPH_NON_CA_DEGREE_OF_DYSPLASIA
C001013	ESTIMATED_LEUKOCYTE_PERCENTAGE
C001014	ESTIMATE_COMBINED_SCORE
C001015	ESTIMATE_IMMUNE_SCORE
C001016	ESTIMATE_SCORE
C001017	ESTIMATE_STROMAL_SCORE
C001018	EST_TUMOR_CELLULARITY
C001019	ETE
C001020	ETE_STATUS
C001021	ETHNICITY
C001022	ETHNICITY_NAACCR
C001023	ETIOLOGY
C001024	ETOH
C001025	ETS
C001026	ETS_FUSION_SEQ
C001027	ETS_RAF_SPINK1_STATUS
C001028	ETV1_EXPRESSION
C001029	ETV1_FUSION
C001030	ETV1_STATUS
C001031	ETV4_EXPRESSION
C001032	ETV4_FUSION
C001033	ETV4_STATUS
C001034	ETV6_RUNX1_FUSION_STATUS
C001035	EVENT_DETAILS
C001036	EVENT_STATUS_FOR_DFS
C001037	EVENT_TYPE
C001038	EVENT_TYPE_DETAILED
C001039	EVER_METS_SITES
C001040	EVIDENCE_FOR_LOSS_OF_HER2
C001041	EXCESSIVE_FRAME_SHIFT_DELETIONS
C001042	EXOME
C001043	EXOME_CAPTURE
C001044	EXOME_SAMPLE_ID
C001045	EXOME_SEQ
C001046	EXOME_SEQUENCED_IN_BARBIERI_ET_AL_2012
C001047	EXON_IMBALANCE_SCORE
C001048	EXP
C001049	EXPOSURE
C001050	EXPRESSION_SUBTYPE
C001051	EXP_SAMPLE_ID
C001052	EXTENSION
C001053	EXTENSIVE_LOCAL_INVASION
C001054	EXTENT_OF_METS
C001055	EXTRACAPSULAR_EXTENSION
C001056	EXTRACAPSULAR_EXTENSION_PRESENT
C001057	EXTRACAPSULAR_SPREAD
C001058	EXTRACAPSULAR_SPREAD_PATHOLOGIC
C001059	EXTRAHEPATIC_DISEASE
C001060	EXTRAHEPATIC_DISEASE_PRE_PUMP
C001061	EXTRAHEPATIC_DISEASE_SITE
C001062	EXTRANOCULAR_NODULE_SIZE
C001063	EXTRANODAL_INVOLVEMENT
C001064	EXTRANODAL_INVOLVEMENT_SITE
C001065	EXTRANODAL_INVOLVMENT_OTHER
C001066	EXTRANODAL_LYMPHOMATOUS_INVOLVEMENT
C001067	EXTRAPROSTATIC_EXTENSION
C001068	EXTRASCLERAL_EXTENSION
C001069	EXTRATHYROIDAL_EXTENSION
C001070	EXTRAVASCULAR_MATRIX_PATTERNS
C001071	EXTRA_PANC_SPREAD
C001072	EXT_SLIDES_DES
C001073	EYE_COLOR
C001074	E_CIMP
C001075	FAB
C001076	FACETS
C001077	FACETS_PLOIDY
C001078	FACETS_PURITY
C001079	FAM175A_CNA
C001080	FAMILIAL_SYNDROME
C001081	FAMILY_HISTORY
C001082	FAMILY_HISTORY_CANCER_NUMBER_RELATIVES
C001083	FAMILY_HISTORY_CANCER_RELATIONSHIP
C001084	FAMILY_HISTORY_CANCER_TYPE
C001085	FAMILY_HISTORY_CANCER_TYPE_OTHER
C001086	FAMILY_HISTORY_ESOPH_GASTIC_CANCER
C001087	FAMILY_HISTORY_OF_CANCER
C001088	FAMILY_HISTORY_OF_PRIMARY_BRAIN_TUMOR
C001089	FAMILY_HISTORY_OF_RENAL_CELL_CARCINOMA
C001090	FAMILY_HISTORY_OF_STOMACH_CANCER
C001091	FAMILY_HISTORY_OF_THYROID_CANCER
C001092	FAMILY_HISTORY_OTHER_CANCER
C001093	FAMILY_HISTORY_PRAD
C001094	FAMILY_HISTORY_TESTICULAR_CANCER
C001095	FAMILY_HISTORY_THYROID_CANCER
C001096	FANCC_CNA
C001097	FANCC_MUT
C001098	FANCD2_CNA
C001099	FANCD2_MUT
C001100	FBXW7_MUTATION_STATUS
C001101	FEDPET_OR_CT_RESULTS
C001102	FEMALE_BREAST_FEEDING_OR_PREGNANCY_STATUS_INDICATOR
C001103	FEV1_FVC_RATIO_POSTBRONCHOLIATOR
C001104	FEV1_FVC_RATIO_PREBRONCHOLIATOR
C001105	FEV1_PERCENT_REF_POSTBRONCHOLIATOR
C001106	FEV1_PERCENT_REF_PREBRONCHOLIATOR
C001107	FGA
C001108	FGF1
C001109	FGF2
C001110	FGFR1_FISH
C001111	FGFR1_MUTATION
C001112	FGFR1_SOMATIC
C001113	FGFR2_MUTATION_STATUS
C001114	FGFR_ABNORMALITY
C001115	FIBER_PER_GM_IN_LUNG
C001116	FIGURE_1A
C001117	FIGURE_1B
C001118	FIGURE_2
C001119	FIGURE_3
C001120	FIGURE_4A
C001121	FIGURE_4B
C001122	FINAL_GRADE
C001123	FIRST_ADJUVANT_TX_TYPE
C001124	FIRST_CYCLE_XRT
C001125	FIRST_DIAGNOSIS_AGE_ASTH_ECZ
C001126	FIRST_DIAGNOSIS_AGE_OF_ANIMA
C001127	FIRST_DIAGNOSIS_AGE_OF_FOOD_ALLERGY
C001128	FIRST_DISTANT_RECURRENCE_SITE
C001129	FIRST_EVENT
C001130	FIRST_LINE_THERAPY
C001131	FIRST_MET_TX_TYPE
C001132	FIRST_PRESENTING_SYMPTOM
C001133	FIRST_PRESENTING_SYMPTOM_LON
C001134	FIRST_RECURRENCE_RESECTABLE_FOR_NED
C001135	FIRST_SITE_OF_METS
C001136	FIRST_SITE_OF_MET_DETAILED
C001137	FIRST_SURGICAL_PROCEDURE_OTHER
C001138	FIRST_SYMPTOM_LONGEST_DURATION
C001139	FIRST_SYSTEMIC_GIVEN_WITH_PUMP
C001140	FIRST_TREATMENT_SUCCESS
C001141	FISH_AR
C001142	FISH_TRANSLOCATION
C001143	FLI1_EXPRESSION
C001144	FLI1_STATUS
C001145	FLOWCELL_ANALYSIS
C001146	FLOW_ABNORMAL_BLAST
C001147	FLT3_ITD_ALLELIC_RATIO
C001148	FLT3_ITD_POSITIVE
C001149	FLT3_NEGATIVE
C001150	FLT3_PM
C001151	FLT3_POSITIVE
C001152	FMI_CASE_ID
C001153	FNCLCC_GRADE
C001154	FOCAL_DRIVER_CN
C001155	FOCAL_LESIONS_AT_RELAPSE
C001156	FOLLICULAR_COMPONENT_PERCENT
C001157	FOLLOWUP_LENGTH
C001158	FOLLOWUP_TIME_FROM_START_OF_CHEMO
C001159	FOLLOWUP_TREATMENT_SUCCESS
C001160	FOLLOWUP_YEARS
C001161	FOLLOW_UP_TIME_MONTHS
C001162	FOOD_ALLERGY_AGE
C001163	FOOD_ALLERGY_HISTORY
C001164	FOOD_ALLERGY_TYPES
C001165	FORM_COMPLETION_DATE
C001166	FOXA1_MUTATION
C001167	FPSA_PSA
C001168	FRACTION_CNA
C001169	FRACTION_GENOME_ALTERED
C001170	FRAMESHIFT_DELETION
C001171	FRAMESHIFT_INSERTION
C001172	FUHRMAN_GRADE
C001173	FUNCTIONAL
C001174	FUPTIME
C001175	FUPTIME_MONTHS
C001176	FUSED_EXONS
C001177	FUSION
C001178	FUSION_BY_RNA_PCR
C001179	FUSION_OTHER
C001180	FUSION_STATUS
C001181	GAIN_8Q
C001182	GALLBLADDER_STONES
C001183	GASTRECTOMY
C001184	GASTRIC_CLASSIFICATION
C001185	GCLID
C001186	GEA
C001187	GEACIN
C001188	GEACINSMG
C001189	GEAGEJ
C001190	GEASMG
C001191	GEA_CIN_INTEGRATED_CLUSTER_COCA
C001192	GEA_CIN_INTEGRATED_CLUSTER_CONSENSUS
C001193	GEA_CIN_INTEGRATED_CLUSTER_ICLUSTER
C001194	GEA_CIN_INTEGRATED_CLUSTER_MKL_KNN_4
C001195	GEA_CIN_INTEGRATED_CLUSTER_MKL_KNN_7
C001196	GEA_CIN_INTEGRATED_CLUSTER_SUPERCLUSTER
C001197	GEA_CIN_INTEGRATED_CLUSTER_VOTING
C001198	GEJ_CATEGORY
C001199	GEJ_CATEGORY_DICHOTOMIZED
C001200	GEJ_CATEGORY_DICHOTOMIZED_GEA_CIN_SAMPLES
C001201	GENDER
C001202	GENDER_CODE
C001203	GENE
C001204	GENETIC_ABNORMALITY_METHOD_OTHER
C001205	GENETIC_ABNORMALITY_RESULTS
C001206	GENETIC_ABNORMALITY_TESTED
C001207	GENETIC_ABNORMALITY_TESTED_OTHER
C001208	GENETIC_MODIFICATION
C001209	GENE_EXPRESSION_CLUSTER
C001210	GENE_EXPRESSION_CLUSTER_EC
C001211	GENE_EXPRESSION_CLUSTER_GEA
C001212	GENE_EXPRESSION_CLUSTER_GEA_CIN
C001213	GENE_EXPRESSION_CLUSTER_SCC
C001214	GENE_EXPRESSION_PROFILE
C001215	GENE_PANEL
C001216	GENIE_BIRTH_YEAR
C001217	GENOME_DOUBLED
C001218	GENOME_DOUBLINGS
C001219	GENOMIC_ALTERATIONS
C001220	GENOMIC_BIOPSY
C001221	GENOMIC_BURDEN
C001222	GENOTYPIC_ANALYSIS_DETECTED
C001223	GENOTYPIC_ANALYSIS_RESULTS_OTHER
C001224	GENOTYPING_RESULTS_GENE_MUTATION_NOT_REPORTED_REASON
C001225	GEOGRAPHIC_DISTRIBUTION
C001226	GERMLINE_CONTROL
C001227	GERMLINE_MUTKNOWN_BRCA1
C001228	GERMLINE_MUTKNOWN_BRCA2
C001229	GERMLINE_MUTKNOWN_OTHER
C001230	GERMLINE_MUTKNOWN_PALB2
C001231	GERMLINE_MUT_GENES_VARIANT
C001232	GERMLINE_TESTED
C001233	GERMLINE_TYPE
C001234	GLEASON_PATTERN_PRIMARY
C001235	GLEASON_PATTERN_SECONDARY
C001236	GLEASON_PATTERN_TERTIARY
C001237	GLEASON_SCORE
C001238	GLEASON_SCORE_1
C001239	GLEASON_SCORE_2
C001240	GLEASON_SCORE_PERCENT_4_AND_5
C001241	GLI2_AMPLIFICATION
C001242	GMED_OS_MONTHS
C001243	GORLIN_SPORADIC
C001244	GRADE
C001245	GRADE_TIER_SYSTEM
C001246	GREATER_THAN_3_SITES
C001247	GROUP
C001248	GROWTH_PATTERN
C001249	GTF2I_MUTATION_STATUS
C001250	GUAIAC_POSITIVE_STOOL_WEEKS
C001251	G_CIMP_METHYLATION
C001252	G_LOH
C001253	HAE
C001254	HARVEST_DATE
C001255	HAS_MATCHED_NORMAL
C001256	HAS_OTHER_CANCER
C001257	HAS_OTHER_KIDNEY_CONDITION
C001258	HAY_FEVER_HISTORY
C001259	HBV
C001260	HBV_CONSENSUS
C001261	HCV
C001262	HCV_CONSENSUS
C001263	HD_CHEMO_AUTO_SCT
C001264	HEADACHE_HISTORY
C001265	HEAD_VS_BODY_TAIL_PRIMARY_PANCREAS
C001266	HEAVY_CHAIN
C001267	HEIGHT
C001268	HEIGHT_M
C001269	HEMOGLOBIN_LEVEL
C001270	HEMORRHOIDS
C001271	HEPATIC_INFLAMMATION_ADJUVANT_TISSUE
C001272	HEPATIC_INFLAMMATION_ADJ_TISSUE
C001273	HEPATIC_VEIN_INVASION
C001274	HEPATITIS_B_POSITIVE_CUTOFF_RPM_POS_1_2
C001275	HEPATITIS_C_POSITIVE_CUTOFF_RPM_POS_1_2
C001276	HER2N
C001277	HER2NEU
C001278	HER2_AMPLIFICATION_STATUS
C001279	HER2_AND_CENT17_CELLS_COUNT
C001280	HER2_AND_CENT17_SCALE_OTHER
C001281	HER2_CENT17_COUNTED_CELLS_COUNT
C001282	HER2_CENT17_RATIO
C001283	HER2_COPY_NUMBER
C001284	HER2_DETAILS
C001285	HER2_DISCOVERY_BESTSAMPLE
C001286	HER2_DISCOVERY_PREORPOST
C001287	HER2_DISCOVERY_VALIDATION
C001288	HER2_EXPR
C001289	HER2_FISH
C001290	HER2_FISH_METHOD
C001291	HER2_FISH_METS
C001292	HER2_FISH_PRIMARY
C001293	HER2_FISH_RATIO_METS
C001294	HER2_FISH_RATIO_PRIMARY
C001295	HER2_FISH_STATUS
C001296	HER2_IHC_METS
C001297	HER2_IHC_OR_FISH
C001298	HER2_IHC_PERCENT_POSITIVE
C001299	HER2_IHC_PRIMARY
C001300	HER2_IHC_SCORE
C001301	HER2_IHC_VALUE_METS
C001302	HER2_IHC_VALUE_PRIMARY
C001303	HER2_IMPACT
C001304	HER2_IMPACT_LR
C001305	HER2_NOTES
C001306	HER2_POSITIVITY_METHOD_TEXT
C001307	HER2_POSITIVITY_SCALE_OTHER
C001308	HER2_RATIO
C001309	HER2_RESPONSE
C001310	HER2_SNP6
C001311	HER2_STATUS
C001312	HER2_STATUS_METASTASIS
C001313	HER2_STATUS_PRIMARY
C001314	HER2_STATUS_REPORTED
C001315	HER2_TTP_ON_1ST_LINE_MONTHS
C001316	HER2_TX_STATUS
C001317	HER2_VITAL_STATUS
C001318	HGB_G_DL
C001319	HGF1
C001320	HGF2
C001321	HHV_8_STATUS
C001322	HIGHEST_ACTIONABLE_LEVEL
C001323	HISPANIC
C001324	HISTOLOGICAL_COMPONENT_SEQUENCED
C001325	HISTOLOGICAL_DIAGNOSIS
C001326	HISTOLOGICAL_SUBTYPE
C001327	HISTOLOGICAL_TYPE
C001328	HISTOLOGICAL_TYPE_ESOPHAGUS
C001329	HISTOLOGICAL_TYPE_OTHER
C001330	HISTOLOGIC_DIAGNOSIS_PERCENT
C001331	HISTOLOGIC_RESPONSE
C001332	HISTOLOGY
C001333	HISTOLOGY_CLASSIFICATION_IN_PRIMARY_TUMOR
C001334	HISTOLOGY_EPC_2CLASS
C001335	HISTOLOGY_EPC_EMBRYONAL_CARCINOMA_NON_SEMINOMA
C001336	HISTOLOGY_EPC_MULTICLASS
C001337	HISTOLOGY_EPC_NON_SEMINOMA
C001338	HISTOLOGY_EPC_NON_SEMINOMA_CHORIOCARCINOMA
C001339	HISTOLOGY_EPC_NON_SEMINOMA_TERATOMA_IMMATURE
C001340	HISTOLOGY_EPC_NON_SEMINOMA_TERATOMA_MATURE
C001341	HISTOLOGY_EPC_NON_SEMINOMA_YOLK_SAC_TUMOR
C001342	HISTOLOGY_EPC_SEMINOMA
C001343	HISTOLOGY_FOR_CALC
C001344	HISTOLOGY_MULTIVARIATE_ANALYSIS
C001345	HISTOLOGY_OF_NEW_TUMOR_EVENT
C001346	HISTOLOGY_OF_PRIMARY_MSKCC
C001347	HISTOLOGY_OF_PRIMARY_TURIN
C001348	HISTONE_RELATED_GENES
C001349	HISTOPATHOLOGY
C001350	HISTORICAL_PATIENTS
C001351	HISTORY_ADRENAL_HORMONE_EXCESS
C001352	HISTORY_ASBESTOS_EXPOSURE
C001353	HISTORY_BARRETTS_ESOPHAGEAL_INDICATOR
C001354	HISTORY_BASIS_ADRENAL_HORMONE_DX
C001355	HISTORY_CHRONIC_PANCREATITIS
C001356	HISTORY_CHRONIC_PANCREATITIS_DAYS_TO
C001357	HISTORY_COLORECTAL_CANCER
C001358	HISTORY_FERTILITY
C001359	HISTORY_HEPATO_CARCINOMA_RISK_FACTORS
C001360	HISTORY_HORMONAL_CONTRACEPTIVES_USE
C001361	HISTORY_HYPOSPADIAS
C001362	HISTORY_IF_BARRETTS_GOBLET_CELL_INDICATOR
C001363	HISTORY_IMMUNOLOGICAL_DISEASE
C001364	HISTORY_IMMUNOLOGICAL_DISEASE_OTHER
C001365	HISTORY_IMMUNOSUPPRESIVE_DX
C001366	HISTORY_IMMUNOSUPPRESIVE_DX_OTHER
C001367	HISTORY_IMMUNOSUPPRESSIVE_DISEASE
C001368	HISTORY_IMMUNOSUPPRESSIVE_TX_OTHER
C001369	HISTORY_IONIZING_RT_TO_HEAD
C001370	HISTORY_LGG_DX_OF_BRAIN_TISSUE
C001371	HISTORY_MENOPAUSAL_HORMONE_THERAPY
C001372	HISTORY_NEOADJUVANT_MEDICATION
C001373	HISTORY_NEOADJUVANT_STEROID_TX
C001374	HISTORY_NEOADJUVANT_TRTYN
C001375	HISTORY_NEOADJUVANT_TX_TYPE
C001376	HISTORY_OF_CROHNS_DISEASE
C001377	HISTORY_OF_ULCERATIVE_COLITIS
C001378	HISTORY_OF_UNDESCENDED_TESTIS
C001379	HISTORY_OTHER
C001380	HISTORY_OTHER_MALIGNANCY
C001381	HISTORY_PHEO_OR_PARA_ANATOMIC_SITE
C001382	HISTORY_PHEO_OR_PARA_INCLUDE_BENIGN
C001383	HISTORY_RADIATION_EXPOSURE
C001384	HISTORY_REFLUX_DISEASE_TREATMENT
C001385	HISTORY_RELEVANT_INFECTIOUS_DX
C001386	HISTORY_TAMOXIFEN_USE
C001387	HISTORY_THYROID_DISEASE
C001388	HISTORY_THYROID_DISEASE_OTHER
C001389	HISTORY_UROTHELIAL_CARCINOMA
C001390	HISTO_ANY_DPM
C001391	HISTO_CC
C001392	HISTO_CLC
C001393	HISTO_DUCT
C001394	HISTO_DUCTULAR
C001395	HISTO_GEO_NECROSIS
C001396	HISTO_GT
C001397	HISTO_HEPATOID_CYTO
C001398	HISTO_HG_HG_DPM
C001399	HISTO_HG_SOLID
C001400	HISTO_IG_COMPACT_TUBULAR
C001401	HISTO_IG_COMPLEX
C001402	HISTO_INTERFACE
C001403	HISTO_INTERFACE_FIBROSIS
C001404	HISTO_INTRADUCTAL
C001405	HISTO_INTRADUCTAL_NEOPLASM
C001406	HISTO_LG_DPM
C001407	HISTO_LG_LARGE_DUCTS
C001408	HISTO_LG_TRABECULAR
C001409	HISTO_LG_TUBULAR
C001410	HISTO_LPN
C001411	HISTO_LYC
C001412	HISTO_MUCIN_EC
C001413	HISTO_MUCIN_IC
C001414	HISTO_PMNS
C001415	HISTO_SCAR
C001416	HISTO_SOLID_NESTED
C001417	HISTO_SR_DESMOPLASTIC
C001418	HISTO_SR_HYALIN
C001419	HISTO_STROMAPOOR
C001420	HISTO_TC
C001421	HISTO_TOTAL
C001422	HISTO_WORST_GRADE
C001423	HISTO_ZONES
C001424	HIV_RNA_LOAD_AT_DIAGNOSIS
C001425	HIV_STATUS
C001426	HLA_A
C001427	HLA_B
C001428	HLA_C
C001429	HLA_DPA1
C001430	HLA_DPB1
C001431	HLA_DQA1
C001432	HLA_DQB1
C001433	HLA_DRB1
C001434	HLA_I
C001435	HLA_II
C001436	HL_STATUS
C001437	HM27
C001438	HM450
C001439	HORMONE_RECEPTOR_STATUS
C001440	HORMONE_STATUS
C001441	HORMONE_THERAPY
C001442	HORMONE_THERAPY_DETAILS
C001443	HORMONE_THERAPY_YEARS
C001444	HOSPITAL_SITE
C001445	HPV_DETAILS
C001446	HPV_ISH
C001447	HPV_PATHSEQ
C001448	HPV_PCR
C001449	HPV_STATUS
C001450	HPV_STATUS_ISH
C001451	HPV_STATUS_P16
C001452	HPV_TYPES_OTHER
C001453	HPV_TYPES_POSITIVE
C001454	HPV_TYPING_METHOD
C001455	HPV_TYPING_METHOD_OTHER
C001456	HRAS_EXPRESSION
C001457	HRAS_HIGH
C001458	HRAS_MUTATION
C001459	HRAS_SOMATIC
C001460	HRD_LOH
C001461	HRT_HISTORY_YEARS
C001462	HSCT
C001463	HSCT_DAYS
C001464	HTN_STATUS
C001465	HYDRONEPHROSIS
C001466	HYPERCHOLESTEROLEMIA
C001467	HYPERDIPLOID
C001468	HYPERMETH_CLUSTER
C001469	HYPERMUTATED
C001470	HYPERMUTATED_COMBINED
C001471	HYPERTENSION_DIAGNOSIS
C001472	HYPODIPLOID
C001473	HYSTERECTOMY_AT_MSK
C001474	HYSTERECTOMY_TYPE
C001475	H_PYLORI
C001476	H_PYLORI_INFECTION
C001477	IBD
C001478	ICDO
C001479	ICDO_SNOMED_DESCRIPTION
C001480	ICD_0_3_T
C001481	ICD_10
C001482	ICD_O_3_HISTOLOGY
C001483	ICD_O_3_SITE
C001484	ICLUSTER
C001485	ICLUSTER_K3
C001486	IDFS_MONTHS
C001487	IDFS_STATUS
C001488	IDH1_MUTATION
C001489	IDH1_MUTATION_TESTED
C001490	IDH1_MUTATION_TEST_INDICATOR
C001491	IDH1_MUTATION_TEST_METHOD
C001492	IDH1_RESULT_SURGERY_1
C001493	IDH1_SOMATIC
C001494	IDH_1P19Q_SUBTYPE
C001495	IDH_CODEL_SUBTYPE
C001496	IDH_LEVEL
C001497	IDH_SPECIFIC_DNA_METHYLATION_CLUSTER
C001498	IDH_SPECIFIC_RNA_EXPRESSION_CLUSTER
C001499	IDH_STATUS
C001500	ID_SAMPLE_TYPE
C001501	IFN_TX_90_DAYS_PRIOR_TO_RESECTION
C001502	IF_AZA_NUMBER_PRIOR_CYCLES
C001503	IF_DECITABINE_PRIOR_CYCLES
C001504	IF_EXTRACAPSULAR_SPREAD_PRESENT
C001505	IF_INVESTIGATIONAL_TRIAL_IRB
C001506	IF_SARCOMA_SPECIFY
C001507	IGCCCG_STAGE
C001508	IGHV_GENE
C001509	IGHV_IDENTITY
C001510	IGHV_MUTATED
C001511	IGHV_UNMUTATED
C001512	IGH_GENE
C001513	IGH_GENOTYPE_RESULT
C001514	IGH_TRANSLOCATIONS
C001515	IGK_GENOTYPE_RESULT
C001516	IHC_AR
C001517	IHC_ARID1A
C001518	IHC_BAP1
C001519	IHC_BASAL
C001520	IHC_BCL6
C001521	IHC_B_TUBULIN
C001522	IHC_CD10
C001523	IHC_CDX2
C001524	IHC_CK20
C001525	IHC_CK5_6
C001526	IHC_CK7
C001527	IHC_EGFR
C001528	IHC_ER
C001529	IHC_HER2
C001530	IHC_IDH1
C001531	IHC_MSH6
C001532	IHC_MUM1
C001533	IHC_P16
C001534	IHC_P4EBP1
C001535	IHC_PAX8
C001536	IHC_PBRM1
C001537	IHC_PMS2
C001538	IHC_PR
C001539	IHC_PS6
C001540	IHC_PS6_235
C001541	IHC_PTEN
C001542	IHC_SCORE
C001543	IHC_SMAD4
C001544	IHC_SUBTYPE
C001545	IHC_TP53
C001546	IM
C001547	IMAGING
C001548	IMMUNE_SCORE
C001549	IMMUNE_STATUS
C001550	IMMUNE_TREATMENT
C001551	IMMUNOHISTOCHEMISTRY
C001552	IMMUNOPHENOTYPE
C001553	IMMUNOPHENOTYPIC_ANALYSIS_METHOD
C001554	IMMUNOPHENOTYPIC_ANALYSIS_RESULTS
C001555	IMMUNOPHENOTYPIC_ANALYSIS_TESTED
C001556	IMMUNOSUPPRESSION
C001557	IMMUNOTHERAPY_DURATION
C001558	IMMUNOTHERAPY_RESPONSE
C001559	IMPACT
C001560	IMPACT_1P19Q
C001561	IMPACT_DIRECTED_SOC_TX
C001562	IMPACT_GUIDED_MGMT_DETAILS
C001563	IMPACT_NOTES
C001564	IMPACT_PASSAGE
C001565	IMPACT_PATH_IN_SETTING_OF_TKI_REFRACTORY_DISEASE
C001566	IMPACT_PRE_KITI
C001567	IMPACT_PRE_POST
C001568	IMPACT_PRE_POST_TKI
C001569	IMPACT_PRE_RAFI
C001570	IMPACT_PRE_TKI
C001571	IMPACT_RESULT_GUIDED_MANAGEMENT
C001572	IMPACT_SAMPLE_NUMBER
C001573	INCIDENTAL_PROSTATE_CANCER
C001574	INCLUDE
C001575	INDEL
C001576	INDEL_SOMATIC_CODING
C001577	INDEL_SOMATIC_GENOMEWIDE
C001578	INDEX_LESION
C001579	INDUCTION
C001580	INFERRED_GENOMIC_REARRANGEMENT
C001581	INFERRED_MENOPAUSAL_STATE
C001582	INFLAMMATORY_STATUS
C001583	INFORMED_CONSENT_VERIFIED
C001584	INHERITED_GENETIC_SYNDROME_FOUND
C001585	INHERITED_GENETIC_SYNDROME_INDICATOR
C001586	INHERITED_GENETIC_SYNDROME_RESULT
C001587	INHERITED_GENETIC_SYNDROME_SPECIFIED
C001588	INITIALLY_UNRESECTABLE
C001589	INITIAL_CA_125
C001590	INITIAL_DEFINITIVE_TREATMENT_DETAILS
C001591	INITIAL_DIAGNOSIS_ESOPHAGEAL_CA_TYPE
C001592	INITIAL_GRADE
C001593	INITIAL_LN_STATUS
C001594	INITIAL_MET_DISEASE
C001595	INITIAL_PATHOLOGIC_DIAGNOSIS_METHOD
C001596	INITIAL_PATHOLOGIC_DX_YEAR
C001597	INITIAL_RX
C001598	INITIAL_STAGE
C001599	INITIAL_SX_YEAR
C001600	INITIAL_TNM_STAGE
C001601	INITIAL_TREATMENT
C001602	INITIAL_TX_RESPONSE
C001603	INITIAL_WEIGHT
C001604	INIT_PATHOLOGY_DX_METHOD_OTHER
C001605	INSERTION_NUM
C001606	INSS_STAGE
C001607	INSTITUTE
C001608	INSULIN_STATUS
C001609	INSULIN_USE
C001610	INTCLUST
C001611	INTEGRATED_CLUSTERS_NO_EXP
C001612	INTEGRATED_CLUSTERS_UNSUP_EXP
C001613	INTEGRATED_CLUSTERS_WITH_PAM50
C001614	INTERVAL_FROM_INDEX_LESION_TO_PRESENT_LESION
C001615	INTERVAL_FROM_LAST_LESION_TO_STUDY
C001616	INTERVAL_FROM_PRIMARY_TO_MBC_DX_YEARS
C001617	INTERVAL_TO_METS
C001618	INTESTINAL_PERCENTAGE
C001619	INTESTINAL_TYPE_SUBCLASS
C001620	INTRANSIT_DESC
C001621	INTRATUBULAR_GERM_CELL_NEOPLASM
C001622	INTRA_TUMORAL_HETEROGENEITY
C001623	INT_ID
C001624	INVADED_STRUCTURES
C001625	INVADE_BONE
C001626	INVADE_LARGER_THAN_SUBCUTANEOUS_TISSUE
C001627	INVADE_PAROTID
C001628	INVADE_SKULL_BASE
C001629	INVASION_DEPTH
C001630	INVASIVE
C001631	INVASIVE_ADENOCARCINOMA_INDICATOR
C001632	INVASIVE_TUMOR_PERCENTAGE
C001633	INVESTIGATOR_PATIENT_ID
C001634	INVESTIGATOR_SAMPLE_ID
C001635	INV_16
C001636	INV_3
C001637	IN_FRAME_DELETION
C001638	IN_FRAME_INSERTION
C001639	IN_TRANSIT
C001640	IO_EBV_TESTED
C001641	IO_EGC_SURVIVAL_OS_MONTHS_START_OF_IO_TO_DATE_OF_DEATH_LAST_FOLLOW_UP
C001642	IO_MUT_GROUPS
C001643	IO_OS_MONTHS_START_OF_IO
C001644	IO_PDL1_TESTED
C001645	IO_PFS_MONTHS_START_OF_IO_TO_POD
C001646	IO_PFS_STATUS
C001647	IO_REGIMEN_MONOTHERAPY_VS_COMBINATION
C001648	IO_RESPONSE
C001649	IPI
C001650	IPILIMUMAB_DOSE_MG_PER_KG
C001651	IPSS_SCORE
C001652	IRB
C001653	ISCN
C001654	ISHAK_FIBROSIS_SCORE
C001655	ISOPURE_PURITY
C001656	IS_FFPE
C001657	I_131_RADIATION_FIRST_TX_DOSE
C001658	I_131_RADIATION_FIRST_TX_METHOD
C001659	I_131_RADIATION_SUBSEQUENT_TX
C001660	I_131_RADIATION_TX_CUMULATIVE_DOSE
C001661	JAK2_NEGATIVE
C001662	JAK2_POSITIVE
C001663	JAUNDICE
C001664	JEWISH_RELIGION_HERITAGE_INDICATOR
C001665	KAPPA_OR_LAMBDA
C001666	KARNOFSKY_PERFORMANCE_SCORE
C001667	KARYOTYPE
C001668	KATABI_PATH
C001669	KBASE_ID
C001670	KDM6A_MUTATION
C001671	KERATINIZATION_SQUAMOUS_CELL
C001672	KITI_AGENT
C001673	KIT_INHIBITOR
C001674	KIT_LEVEL_2A
C001675	KIT_NEGATIVE
C001676	KIT_POSITIVE
C001677	KI_67
C001678	KMT2A_MUTATION
C001679	KMT2B_MUTATION_STATUS
C001680	KMT2C_MUT
C001681	KMT2D_MUTATION
C001682	KNOWN_EXPOSURES
C001683	KNOWN_MOLECULAR_CLASSIFIER
C001684	KNOWN_MOLECULAR_CLASSIFIER_FINAL
C001685	KNOWN_MOLECULAR_CLASSIFIER_PRIMARY
C001686	KRAS_CELLULARITY
C001687	KRAS_GENE_ANALYSIS_INDICATOR
C001688	KRAS_MUTATION
C001689	KRAS_MUTATION_IDENTIFIED_TYPE
C001690	KRAS_PROTEIN_CODING
C001691	KSHV_HHV8_TEST
C001692	LARGEST_METASTATIC_BURDEN
C001693	LARGEST_SIZE
C001694	LARGE_DELETION_NUM
C001695	LAST_CONTACT_DAYS_TO
C001696	LAST_FOLLOWUP_FUDR_START
C001697	LAST_FOLLOWUP_STATUS
C001698	LAST_FOLLOWUP_YEAR
C001699	LAST_STATUS
C001700	LAST_TREATMENT_REGIMEN
C001701	LATERALITY
C001702	LATERALITY_OF_SECOND_PRIMARY_TUMOR
C001703	LATERALITY_OF_UNDESCENT
C001704	LAUREN_CLASS
C001705	LDH_LEVEL
C001706	LDH_NORM_RANGE_UPPER
C001707	LDH_U_L
C001708	LDH_YEAR
C001709	LEIOMYOSARCOMA_HISTOLOGIC_SUBTYPE
C001710	LEIOMYOSARCOMA_UTERINE_INVOLVEMENT
C001711	LEIOMYO_MAJOR_VESSEL_INVOLVEMENT
C001712	LEUKEMIA_TYPE
C001713	LEUKOCYTE_FRACTION
C001714	LEUKOCYTE_INDEX_METHYLATION
C001715	LEVEL_OF_NON_DESCENT
C001716	LIGHT_CHAIN
C001717	LINES_OF_TX
C001718	LINES_OF_TX_PRIOR_IMPACT
C001719	LIVER_FIBROSIS
C001720	LIVER_INVOLVEMENT
C001721	LIVER_PROGRESSION
C001722	LNCLIN_STS_DES
C001723	LNDSCT_CMP_DES
C001724	LNDSCT_YEAR
C001725	LNEXTNODST_DES
C001726	LNI
C001727	LNIHC_DESC
C001728	LNIMMHMB45_DES
C001729	LNIMM_MELA_DES
C001730	LNINTRMETS_DES
C001731	LNMATTED_DESC
C001732	LNPROLYSCT_DES
C001733	LNPROSUCC_DESC
C001734	LNSENTINBX_DES
C001735	LNSENTINBX_YEA
C001736	LNSIZE
C001737	LNSIZE_UNK_DES
C001738	LNSLNLARG_SIZE
C001739	LN_METASTASIS_2CAT
C001740	LN_METS
C001741	LOCALIZED_VS_METS_AT_DX
C001742	LOCAL_DESC
C001743	LOCAL_RECCURENCE_OR_DISTANT_MET
C001744	LOCAL_RECURRENCE
C001745	LOCAL_RECURRENCE_MONTHS
C001746	LOCAL_RECURRENCE_NUM
C001747	LOCAL_RECURRENCE_PRIOR_TO_DISTANT
C001748	LOCAL_RECURRENCE_YEAR
C001749	LOCAL_REGIONAL_DISEASE_AT_DIAGNOSIS
C001750	LOCAL_REGIONAL_RECURENCE
C001751	LOCAL_REGIONAL_RECURRENCE
C001752	LOCAL_RFS_MONTHS
C001753	LOCAL_TEST
C001754	LOCATION
C001755	LOCATION_LUNG_PARENCHYMA
C001756	LOCOREGIONAL_RECURRENCE_INDICATOR
C001757	LOCO_REG_MONTHS
C001758	LOCO_REG_STATUS
C001759	LONGEST_DIMENSION
C001760	LOSS_OF_HER2
C001761	LOST_TO_FOLLOWUP
C001762	LOWPASS
C001763	LOW_GRADE_HISTORY
C001764	LST
C001765	LVI
C001766	LYMPHOCYTE_INFILTRATION
C001767	LYMPHOVASCULAR_INVASION_INDICATOR
C001768	LYMPHOVASCULAR_INVASION_PRESENT
C001769	LYMPHOVASCULAR_INVOLVEMENT
C001770	LYMPH_NODES
C001771	LYMPH_NODES_AORTIC_EXAMINED_COUNT
C001772	LYMPH_NODES_AORTIC_POS_BY_HE
C001773	LYMPH_NODES_AORTIC_POS_BY_IHC
C001774	LYMPH_NODES_AORTIC_POS_TOTAL
C001775	LYMPH_NODES_EXAMINED
C001776	LYMPH_NODES_EXAMINED_HE_COUNT
C001777	LYMPH_NODES_EXAMINED_IHC_COUNT
C001778	LYMPH_NODES_EXAMINED_NEGATIVE
C001779	LYMPH_NODES_EXAMINED_POSITIVE
C001780	LYMPH_NODES_PELVIC_EXAMINED_COUNT
C001781	LYMPH_NODES_PELVIC_POS_BY_IHC
C001782	LYMPH_NODES_PELVIC_POS_TOTAL
C001783	LYMPH_NODES_PELVIC_POS__BY_HE
C001784	LYMPH_NODES_PREOP_IMAGING
C001785	LYMPH_NODES_PREOP_IMAGING_TYPE
C001786	LYMPH_NODES_SUPRACLAVICULAR
C001787	LYMPH_NODE_DISSECTION_METHOD
C001788	LYMPH_NODE_EXAMINED_COUNT
C001789	LYMPH_NODE_INVOLVEMENT
C001790	LYMPH_NODE_INVOLVEMENT_SITE
C001791	LYMPH_NODE_METASTASIS
C001792	LYMPH_NODE_NECK_DISSECTION_INDICATOR
C001793	LYMPH_NODE_SPRD_RADIOGRAPH_EVIDENCE
C001794	LYMPH_NODE_STATUS
C001795	LYNCH
C001796	LYNCH_SYNDROME
C001797	M1_STATUS
C001798	MACIS_SCORE
C001799	MACROPHAGES_M0
C001800	MACROPHAGES_M1
C001801	MACROPHAGES_M2
C001802	MAF_DATA
C001803	MAINT_THERAPY_COURSE_COMPLETE
C001804	MAIN_VS_BRANCH_DUCT
C001805	MAJOR_ANATOMIC_SITE
C001806	MAPK_PATHWAY_ALTERATION
C001807	MARGINS_INVOLVED_HYSTERECTOMY
C001808	MARGIN_CODE
C001809	MARGIN_STATUS
C001810	MARGIN_STATUS_REEXCISION
C001811	MAST_CELLS_ACTIVATED
C001812	MAST_CELLS_RESTING
C001813	MATCHED_GERMLINE_DNA
C001814	MATCHED_GE_ACGH
C001815	MATCHED_NORMAL_ID
C001816	MATCHED_NORMAL_TISSUE
C001817	MATCHED_PRE_POST
C001818	MATCHED_STATUS
C001819	MATCH_STATUS
C001820	MAXIMUM_TUMOR_BULK_ANATOMIC_SITE
C001821	MAX_GERMLINE
C001822	MB_COV
C001823	MC2_VARIANT_CALLS
C001824	MCRC_MSS_SAMPLES
C001825	MCRC_MSS_SAMPLES_RVSL
C001826	MCRC_TYPE
C001827	MDR
C001828	MEAN_COVERAGE
C001829	MEAN_PLODY
C001830	MEAN_TARGET_COVERAGE_NORMAL
C001831	MEAN_TARGET_COVERAGE_TUMOR
C001832	MED12_MUTATION
C001833	MEDIA
C001834	MEDIAN_COVERAGE
C001835	MEDICATION
C001836	MEDR_PRIMARY_SITE
C001837	MEGF
C001838	MEGF1
C001839	MEGF2
C001840	MELF
C001841	MENOPAUSAL_STATUS_AT_DIAGNOSIS
C001842	MENOPAUSE_STATUS
C001843	MENOPAUSE_STATUS_AT_DIAGNOSIS
C001844	MENTAL_STATUS_CHANGES
C001845	MERKEL_CELL
C001846	MESOTHELIOMA_DETECTION_METHOD
C001847	METANEPHRINE
C001848	METASTASECTOMY
C001849	METASTASECTOMY_SITE
C001850	METASTASES_SITE_FIRST_BONE
C001851	METASTASES_SITE_FIRST_BRAIN
C001852	METASTASES_SITE_FIRST_GYN
C001853	METASTASES_SITE_FIRST_LIVER
C001854	METASTASES_SITE_FIRST_LN
C001855	METASTASES_SITE_FIRST_LUNG
C001856	METASTASES_SITE_FIRST_PELVIS
C001857	METASTASES_SITE_FIRST_PERITONEUM_OMENTUM_ABDOMEN
C001858	METASTASES_SITE_FIRST_PLEURA
C001859	METASTASIS
C001860	METASTASIS_BONE
C001861	METASTASIS_CODED
C001862	METASTASIS_EXAMINED
C001863	METASTASIS_LIVER
C001864	METASTASIS_LUNG
C001865	METASTASIS_OVARY
C001866	METASTASIS_PERITONEUM
C001867	METASTASIS_TESTED
C001868	METASTATIC_BIOPSY_SITE
C001869	METASTATIC_BX_MSKCC
C001870	METASTATIC_CRC
C001871	METASTATIC_DISEASE
C001872	METASTATIC_DISEASE_CONFIRMED
C001873	METASTATIC_DX
C001874	METASTATIC_DX_CONFIRMED_BY
C001875	METASTATIC_DX_CONFIRMED_BY_OTHER
C001876	METASTATIC_RESECTION
C001877	METASTATIC_SITE
C001878	METASTATIC_SITE_OTHER
C001879	METASTATIC_STAGE
C001880	RESCINDED_URI_PREVIOUSLY_USED_FOR_METASTATIC_STAGE
C001881	METASTATIC_TUMOR_INDICATOR
C001882	METFORMIN_USE
C001883	METHOD_NUCLEIC_ACID_DELIVERY
C001884	METHOD_OF_DIAGNOSIS
C001885	METHOD_OF_INITIAL_PATH_DIAGNOSIS
C001886	METHOD_OF_INITIAL_PATH_DIAGNOSIS_OTHER
C001887	METHOD_OF_INITIAL_SAMPLE_PROCUREMENT
C001888	METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER
C001889	METHOD_OF_SAMPLE_PROCUREMENT
C001890	METHOD_OF_SAMPLE_PROCUREMENT_OTHER
C001891	METHOD_PURITY
C001892	METHOXYTYRAMINE
C001893	METHYL
C001894	METHYLATION450
C001895	METHYLATION_CLASS
C001896	METHYLATION_CLUSTER
C001897	METHYLATION_CLUSTER_K3
C001898	METHYLATION_DATA
C001899	METHYLATION_ID
C001900	METHYLATION_STATUS
C001901	METHYLATION_SUBTYPE
C001902	METS_DISEASE_DATE_INT
C001903	METS_FREE_TIME_MONTHS
C001904	METS_SITES_AT_DX
C001905	METS_SITES_AT_IMPACT_SAMPLE_COLLECTION
C001906	METS_SITES_AT_LAST_FOLLOWUP
C001907	METS_SITES_AT_METS_ABST_ADRENAL_GLAND
C001908	METS_SITES_AT_METS_ABST_ASCITES
C001909	METS_SITES_AT_METS_ABST_BONE
C001910	METS_SITES_AT_METS_ABST_BRAIN_CNS
C001911	METS_SITES_AT_METS_ABST_CHEST_WALL
C001912	METS_SITES_AT_METS_ABST_DIST_LYMPH
C001913	METS_SITES_AT_METS_ABST_INTRA_ABDOMINAL
C001914	METS_SITES_AT_METS_ABST_LIVER
C001915	METS_SITES_AT_METS_ABST_LUNG
C001916	METS_SITES_AT_METS_ABST_OVARY
C001917	METS_SITES_AT_METS_ABST_PLEURAL_EFFUSION
C001918	METS_SITES_AT_METS_ABST_REG_LYMPH
C001919	METS_SITES_AT_METS_ABST_SKIN
C001920	METS_SITES_AT_METS_ABST_SOFT_TISSUE
C001921	METS_SITES_AT_METS_ABST_UNKNOWN
C001922	METS_SITES_AT_METS_DX_ADRENAL_GLAND
C001923	METS_SITES_AT_METS_DX_ASCITES
C001924	METS_SITES_AT_METS_DX_BONE
C001925	METS_SITES_AT_METS_DX_BRAIN_CNS
C001926	METS_SITES_AT_METS_DX_CHEST_WALL
C001927	METS_SITES_AT_METS_DX_DIST_LYMPH
C001928	METS_SITES_AT_METS_DX_INTRA_ABDOMINAL
C001929	METS_SITES_AT_METS_DX_LIVER
C001930	METS_SITES_AT_METS_DX_LUNG
C001931	METS_SITES_AT_METS_DX_OVARY
C001932	METS_SITES_AT_METS_DX_PLEURAL_EFFUSION
C001933	METS_SITES_AT_METS_DX_REG_LYMPH
C001934	METS_SITES_AT_METS_DX_SKIN
C001935	METS_SITES_AT_METS_DX_SOFT_TISSUE
C001936	METS_SITES_AT_METS_DX_UNKNOWN
C001937	MET_BONE
C001938	MET_BRAIN
C001939	MET_IMPACT_ADRENAL
C001940	MET_IMPACT_BONE
C001941	MET_IMPACT_LIVER
C001942	MET_IMPACT_LN
C001943	MET_IMPACT_LUNG
C001944	MET_IMPACT_PLEURA
C001945	MET_LAST_FUP_ADRENAL
C001946	MET_LAST_FUP_BONE
C001947	MET_LAST_FUP_BRAIN
C001948	MET_LAST_FUP_LIVER
C001949	MET_LAST_FUP_LN
C001950	MET_LAST_FUP_LUNG
C001951	MET_LAST_FUP_PLEURA
C001952	MET_LAST_LMD
C001953	MET_LAST_PERITONEUM
C001954	MET_LAST_SUBCUTANEOUS
C001955	MET_LIVER
C001956	MET_LUNG
C001957	MET_PERITONEUM
C001958	MET_SITE_OTHER_DMT
C001959	MET_SKIPPED_EXONS_18_AND_19
C001960	MET_SKIPPED_EXON_2
C001961	MFGF
C001962	MFGF1
C001963	MFGF2
C001964	MGMT_PROMOTER_STATUS
C001965	MGMT_RESULT_SURGERY_1
C001966	MGMT_STATUS
C001967	MHGF
C001968	MHGF2
C001969	MIBC_OR_NON_MIBC
C001970	MIBC_PROGRESSIVE
C001971	MIBC_RECURRENCE
C001972	MIB_1_POSITIVE_PERCENT_RANGE
C001973	MICROMET_DETECTION_BY_IHC
C001974	MICRORNA_EXPRESSION_CLUSTER
C001975	MICROVASCULAR_DENSITY_MVD
C001976	MICRO_RNA_CLUSTER
C001977	MICRO_RNA_SCORE
C001978	MINUS_X
C001979	MINUS_Y
C001980	MIRNASEQ
C001981	MIRNA_CLUSTER
C001982	MIRNA_CLUSTER_K3
C001983	MIRNA_CLUSTER_K6
C001984	MIRNA_EXPRESSION_CLUSTER_EC
C001985	MIRNA_EXPRESSION_CLUSTER_GEA
C001986	MIRNA_EXPRESSION_CLUSTER_GEA_CIN
C001987	MIRNA_EXPRESSION_CLUSTER_SCC
C001988	MISSENSE_MUTATIONS
C001989	MITO
C001990	MITOSES_PER_10_HPF
C001991	MITOSES_PER_50_HPF
C001992	MITOTIC_ACTIVITY
C001993	MITOTIC_COUNT
C001994	MITOTIC_INDEX
C001995	MITOTIC_RATE
C001996	MITOTIC_SCORE
C001997	MKI
C001998	MLH1_METHYLATION
C001999	MLH1_SILENCING
C002000	MLH1_STATUS
C002001	MLL
C002002	MLL_FUSION
C002003	MLL_MULTIPLE_COPIES
C002004	MLL_STATUS
C002005	MODIFIED_CAPRA_S_SCORE_WITHOUT_INCLUDING_SURGICAL_MARGINS
C002006	MOLD_OR_DUST_ALLERGY_HISTORY
C002007	MOLECULAR_SMOKING_SIGNATURE
C002008	MOLECULAR_STUDIES_OTHERS_PERFORMED
C002009	MOLECULAR_SUBTYPE
C002010	MOLECULAR_TEST_RESULT
C002011	MONOCYTES
C002012	MONOSOMY_5
C002013	MONOSOMY_7
C002014	MONTHS_ON_STUDY
C002015	MONTHS_ON_TREATMENT
C002016	MONTHS_TO_DISTANT_RECURRENCE
C002017	MONTHS_TO_LOCAL_RECURRENCE
C002018	MONTH_ADDED
C002019	MORE_2SNV_CFDNA
C002020	MORPHOLOGICAL_ARCHITECTURE
C002021	MORPHOLOGY
C002022	MORPHOLOGY_OTHER_FEATURES
C002023	MORPHOLOGY_SUBTYPE
C002024	MOTOR_MOVEMENT_CHANGES
C002025	MOUSE_STRAIN
C002026	MPL_EVIDENCE
C002027	MPNST_NF1_GENETIC_TESTING_INDICATOR
C002028	MPNST_NF1_MUTATIONS_IDENTIFIED
C002029	MPNST_NF_FAMILIAL_OR_SPORADIC
C002030	MPNST_NF_INDICATOR
C002031	MPNST_PLEXIFORM_NEUROFIBROMA_SITE
C002032	MRD_AT_END_OF_COURSE_1
C002033	MRD_AT_END_OF_COURSE_2
C002034	MRD_END_CONSOLIDATION
C002035	MRD_END_CONSOLIDATION_SENSITIVITY
C002036	MRD_PERCENTAGE_AT_END_OF_COURSE_1
C002037	MRD_PERCENTAGE_AT_END_OF_COURSE_2
C002038	MRD_PERCENT_DAY_29
C002039	MRD_PERCENT_DAY_29_SENSITIVITY
C002040	MRD_PERCENT_DAY_43
C002041	MRD_PERCENT_DAY_43_SENSITIVITY
C002042	MRD_PERCENT_DAY_8
C002043	MRD_PERCENT_DAY_8_SENSITIVITY
C002044	MRI
C002045	MRI_RESULTS
C002046	MRNASEQ_DATA
C002047	MRNA_CLUSTER
C002048	MRNA_CLUSTER_K4
C002049	MRNA_DATA
C002050	MRNA_EXPRESSION_CLUSTER
C002051	MRNA_EXPRESSION_CLUSTER_EC
C002052	MRNA_EXPRESSION_CLUSTER_GEA
C002053	MRNA_EXPRESSION_CLUSTER_SCC
C002054	MRNA_STATUS
C002055	MSH2_STATUS
C002056	MSH6_STATUS
C002057	MSI_COMMENT
C002058	MSI_MMR
C002059	MSI_PREDICTION_SCORE
C002060	MSI_SCORE
C002061	MSI_SENSOR_SCORE
C002062	MSI_STATUS
C002063	MSI_STATUS_5_MARKER_CALL
C002064	MSI_STATUS_7_MARKER_CALL
C002065	MSI_TYPE
C002066	MSKCC_CATEGORY
C002067	MSK_DEPT
C002068	MSK_NOMOGRAM
C002069	MSK_REVIEW_DES
C002070	MSK_THERAPEUTIC_CLINICAL_TRIAL
C002071	MSK_VISITS
C002072	MSS_RL_ALL
C002073	MSS_RL_EARLY_STAGE
C002074	MSS_RL_MCRC
C002075	MSS_SAMPLES
C002076	MTOR_MUTATION_STATUS
C002077	MUCOID_STOOL_WEEKS
C002078	MULTICENTRICITY
C002079	MULTIFOCAL
C002080	MULTIPLE_BREAST_PRIMARIES
C002081	RESCINDED_URI_PREVIOUSLY_USED_FOR_MULTIPLE_BREAST_PRIMARIES
C002082	MULTIPLE_BREAST_PRIMARIES_SEQUENCE
C002083	MULTIPLE_HN_CSCC
C002084	MULTIPLE_TUMORS
C002085	MULTI_ERBB2
C002086	MUM1_STATUS
C002087	MUTATIONAL_SIGNATURES
C002088	MUTATIONAL_SIGNATURES_PVAL
C002089	MUTATIONA_SIGNATURES_PROPORTIONS
C002090	MUTATIONS
C002091	MUTATIONS_PER_MEGABASE
C002092	MUTATION_BURDEN
C002093	MUTATION_COUNT
C002094	MUTATION_FEATURE
C002095	MUTATION_LOAD
C002096	MUTATION_RATE
C002097	MUTATION_RATE_CLUSTER
C002098	MUTATION_STATUS
C002099	MUTATION_TYPE
C002100	MUTIPLE_NODULES
C002101	MUTSIG_RATENON_PERMB
C002102	MUTSIG_RATESIL_PERMB
C002103	MUTSIG_RATETOT_PERMB
C002104	MUT_CANCER_GENE_CENSUS_PROTEIN_CHANGE
C002105	MUT_CLINDX_TX_GENE_PROTEIN_CHANGE
C002106	MUT_DNAREPAIR_GENE_PROTEIN_CHANGE
C002107	MUT_DRIVER_PROTEIN_CHANGE
C002108	MUT_EPIGENETIC_PROTEIN_CHANGE
C002109	MUT_OTHER_PROTEIN_CHANGE
C002110	MUT_RARE_DRIVER_PROTEIN_CHANGE
C002111	MUT_TUMORPORTAL_GENE_PROTEIN_CHANGE
C002112	MVEGF
C002113	MVEGF1
C002114	MVEGF2
C002115	MYB_ABNORMALITY
C002116	MYB_ACTIVATION
C002117	MYB_FISH
C002118	MYB_IHC
C002119	MYB_MYBL1_FUSION
C002120	MYB_MYBL1_FUSION_METHOD
C002121	MYB_MYBL1_REARRANGEMENT
C002122	MYB_NFIB_CNA
C002123	MYB_NFIB_FISH
C002124	MYB_NFIB_NONSYNONYMOUS_COUNT
C002125	MYB_NFIB_REARRANGEMENT
C002126	MYB_NFIB_TRANSCRIPT
C002127	MYB_NFIB_TRANSLOCATION
C002128	MYB_VALIDATION
C002129	MYCN
C002130	MYCN_AMP
C002131	MYCN_FISH
C002132	MYCOPLASMA_TESTED
C002133	MYC_BA
C002134	MYC_REAR
C002135	M_SCORE
C002136	M_STAGE
C002137	NAACCR_ETHNICITY
C002138	NAACCR_RACE
C002139	NADIR_CD4_COUNTS
C002140	NASH
C002141	NCNNCT_OTHMETHONSP
C002142	NECK_DISSECTION_TYPE
C002143	NECK_RECURRENCE
C002144	NECK_RFS_MONTHS
C002145	NECROSIS
C002146	NEOADJUVANT_CHEMO
C002147	NEOADJUVANT_CHEMOTHERAPY_RESPONDER
C002148	NEOADJUVANT_OR_ADJUVANT
C002149	NEOADJUVANT_SYSTEMIC_CHEMO
C002150	NEOADJUVANT_TX
C002151	NEOADJ_CHEMO
C002152	NEOADJ_TX_BEFORE_FIRST_SURGERY
C002153	NEOAGCNT
C002154	NEOANTIGEN_BURDEN
C002155	NEOCRX
C002156	NEORX
C002157	NEPC_SCORE
C002158	NEUROENDOCRINE_CARCINOMA
C002159	NEUROENDOCRINE_FEATURES
C002160	NEUTROPHILS
C002161	NEW_NEOPLASM_EVENT_OCCURRENCE_ANATOMIC_SITE
C002162	NEW_NEOPLASM_EVENT_TYPE
C002163	NEW_NEOPLASM_EVENT_TYPE_1
C002164	NEW_PRIMARY_TESTIS_TUMOR
C002165	NEW_TUMOR
C002166	NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT
C002167	NEW_TUMOR_EVENT_DX_INDICATOR
C002168	NEW_TUMOR_EVENT_MELANOMA_COUNT
C002169	NEW_TUMOR_EVENT_OTHER_SITE
C002170	NEW_TUMOR_EVENT_PRIOR_TO_BCR_TUMOR
C002171	NEW_TUMOR_EVENT_SITE
C002172	NEW_TUMOR_EVENT_TYPE
C002173	NF1_GERMLINE
C002174	NF1_MUTATION
C002175	NF1_SOMATIC
C002176	NF2_FISH
C002177	NF2_FUSION
C002178	NF2_STATUS_ARRAY
C002179	NFIB_FISH
C002180	NFIB_FUSION_OTHER
C002181	NGS_TEST
C002182	NI
C002183	NK_CELLS_ACTIVATED
C002184	NK_CELLS_RESTING
C002185	NODAL_DESC
C002186	NODAL_STAGE
C002187	NODAL_STATUS
C002188	NODES
C002189	NODES_DETAILS
C002190	NODES_EX
C002191	NODE_CODED
C002192	NODULE_NUMBER
C002193	NODULE_SIZE
C002194	NONINVASIVE_BLADDER_CA_TX_TYPE
C002195	NONINVASIVE_BLADDER_HISTORY
C002196	NONSENSE_MUTATION
C002197	NONSILENT_DENSITY_AGE_FIT
C002198	NONSILENT_MUTATION_DENSITY
C002199	NONSILENT_PER_MB
C002200	NONSILENT_RATE
C002201	NONSTOP_MUTATION
C002202	NONSYNONYMOUS_MUTATION_BURDEN
C002203	NONSYNONYMOUS_MUTATION_RATE
C002204	NON_SILENT_MUTATION
C002205	NON_SILENT_MUT_TP53_ATRX_CIC_FUBP1
C002206	NON_SILENT_SNV
C002207	NON_STANDARD_ADJUVANT
C002208	NOREPINEPHRINE
C002209	NORMAL
C002210	NORMAL_EPITHELIUM_PERCENTAGE
C002211	NORMAL_EXOME_DEPTH
C002212	NORMAL_GENOME_COVERAGE
C002213	NORMAL_GENOME_LIBRARY
C002214	NORMAL_SITE
C002215	NORMETANEPHRINE
C002216	NOSYSTXT
C002217	NOTE
C002218	NO_CHEMO_PROGRESSIVE
C002219	NO_CHEMO_PROGRESSIVE_PRIOR_BCG
C002220	NPI
C002221	NPM1_NEGATIVE
C002222	NPM1_POSITIVE
C002223	NPM_MUTATION
C002224	NRAS_MUTATION
C002225	NRAS_STATUS
C002226	NSAID_USE
C002227	NTAI
C002228	NTE_AFTER_INITIAL_TREATMENT
C002229	NTE_CENT17_HER2_OTHER_SCALE
C002230	NTE_CENT_17_HER2_RATIO
C002231	NTE_CENT_17_SIGNAL_NUMBER
C002232	NTE_ER_IHC_INTENSITY_SCORE
C002233	NTE_ER_POSITIVITY_DEFINE_METHOD
C002234	NTE_ER_POSITIVITY_OTHER_SCALE
C002235	NTE_ER_STATUS
C002236	NTE_ER_STATUS_IHC__POSITIVE
C002237	NTE_HER2_FISH_DEFINE_METHOD
C002238	NTE_HER2_FISH_STATUS
C002239	NTE_HER2_POSITIVITY_IHC_SCORE
C002240	NTE_HER2_POSITIVITY_METHOD
C002241	NTE_HER2_POSITIVITY_OTHER_SCALE
C002242	NTE_HER2_SIGNAL_NUMBER
C002243	NTE_HER2_STATUS
C002244	NTE_HER2_STATUS_IHC__POSITIVE
C002245	NTE_LESION_PATHOLOGIC_DEPTH
C002246	NTE_LESION_PATHOLOGIC_LENGTH
C002247	NTE_LESION_PATHOLOGIC_WIDTH
C002248	NTE_LESION_RADIOLOGIC_DEPTH
C002249	NTE_LESION_RADIOLOGIC_LENGTH
C002250	NTE_LESION_RADIOLOGIC_WIDTH
C002251	NTE_PR_IHC_INTENSITY_SCORE
C002252	NTE_PR_POSITIVITY_DEFINE_METHOD
C002253	NTE_PR_POSITIVITY_OTHER_SCALE
C002254	NTE_PR_STATUS_BY_IHC
C002255	NTE_PR_STATUS_IHC__POSITIVE
C002256	NUCLEAR_GRADE
C002257	NUCLEAR_GRADE_III_IV
C002258	NUMBER_DOSES_IT_THERAPY
C002259	NUMBER_OF_LINES_OF_TREATMENT_FOR_MET_DISEASE
C002260	NUMBER_OF_LINES_POST_IMPACT
C002261	NUMBER_OF_LYMPHNODES_POSITIVE
C002262	NUMBER_OF_LYMPHNODES_POSITIVE_BY_HE
C002263	NUMBER_OF_LYMPHNODES_POSITIVE_BY_IHC
C002264	NUMBER_OF_ONCOGENIC_MUTATIONS
C002265	NUMBER_OF_PRIMARY_SITES
C002266	NUMBER_OF_RELATIVES_DIAGNOSED
C002267	NUMBER_OF_RELATIVES_WITH_STOMACH_CANCER
C002268	NUMBER_OF_SITES
C002269	NUMBER_OF_TARGET_THERAPIES_RECEIVED
C002270	NUMBER_OF_TUMORS
C002271	NUMBER_OF_VIAL
C002272	NUMBER_PRIOR_THEARPY_REGIMENS
C002273	NUMBER_VIAL
C002274	NUM_EXTRANODAL_SITES
C002275	NUM_GENOME_WIDE_SOMATIC_MUTATIONS
C002276	NUM_MUT_APOBEC
C002277	NUM_MUT_CPGT
C002278	NUM_MUT_DBSNP
C002279	NUM_NONSILENT_MUTATION
C002280	NUM_PRIOR_THERAPIES
C002281	NUM_SAMPLES_CAPTURE_MULTIPLEX
C002282	NUM_SILENT_MUTATION
C002283	NUM_SNV_WITHOUT_SNP
C002284	NUM_SOMATIC_MUTATION
C002285	NUP98_NSD1
C002286	N_POS_N_NEG
C002287	N_SCORE
C002288	N_STAGE
C002289	N_STAGE_REPORTED
C002290	OBSTRUCTION_WEEKS
C002291	OCCUPATION_CURRENT
C002292	OCCUPATION_PRIMARY
C002293	OCCUPATION_PRIMARY_CHEMICAL_EXPOSURE
C002294	OCCUPATION_PRIMARY_INDUSTRY
C002295	OCCUPATION_PRIMARY_OTHER
C002296	OCCUPATION_PRIMARY_YEARS_WORKED
C002297	OCT_EMBEDDED
C002298	OFFICIAL_PATH
C002299	OLAPARIB_DOSAGE
C002300	OLIGOPROGRESSION
C002301	ONCOGENIC_ALTERATIONS
C002302	ONCOKB_LEVELS
C002303	ONCOPANEL_STATUS
C002304	ONCOPANEL_TUMOR_TYPE
C002305	ONCOPRINT
C002306	ONCOSIGN_CLUSTER
C002307	ONCOSIGN_CLUSTER_2
C002308	ONCOTREE_CODE
C002309	ONCOTREE_PRIMARY_NODE
C002310	ONCOTREE_SECONDARY_NODE
C002311	ONCOTYPE_OR_MAMAPRINT
C002312	ONGOING_TREATMENT
C002313	ORAL_CONTRACEPTION
C002314	ORAL_CONTRACEPTION_YEARS
C002315	ORIGINAL_SUBTYPE
C002316	OR_PERCENT
C002317	OR_TIME
C002318	OS_DAYS
C002319	OS_EVENT
C002320	OS_MONTHS
C002321	OS_MONTHS_ADDITIONAL
C002322	OS_MONTHS_ADVANCED_DISEASE
C002323	OS_MONTHS_DATE_DX
C002324	OS_MONTHS_DMT
C002325	OS_MONTHS_METS
C002326	OS_MONTHS_PRIMARY
C002327	OS_MONTHS_RECURRENCE
C002328	OS_MONTHS_SEQUENCED
C002329	OS_MONTHS_STAGE_IV
C002330	OS_STATUS
C002331	OS_STATUS_DMT
C002332	OTHER_CANCER_TYPE
C002333	OTHER_CHEMO
C002334	OTHER_DISEASES
C002335	OTHER_DNP
C002336	OTHER_HEPATO_CARCINOMA_RISK_FACTORS
C002337	OTHER_HYSTERECTOMY_TYPE
C002338	OTHER_IMMUNOSUPPRESSIVE_DISEASE
C002339	OTHER_INVOLVED_MARGINS
C002340	OTHER_METHOD_OF_SAMPLE_PROCUREMENT
C002341	OTHER_MLL
C002342	OTHER_PATIENT_ID
C002343	OTHER_POS_NODE_LOCATION
C002344	OTHER_SAMPLE_ID
C002345	OTHER_SITES_OF_METS
C002346	OTHER_SITE_OF_RELAPSE
C002347	OTHER_SKIN_TUMORS
C002348	OTHER_SPECIFY_SECTION
C002349	OTHER_SYMPTOM_DETAILS
C002350	OTHER_SYMPTOM_DURATION
C002351	OTHER_TREATMENT_RESPONSE
C002352	OUTSIDE_INSTITUTE
C002353	OUTSIDE_SURGICAL_PROCEDURES
C002354	OVERALL_METASTATIC_BURDEN
C002355	OVERALL_PATIENT_HISTOLOGY
C002356	OVERALL_RESPONSE
C002357	OVERALL_STAGE
C002358	P4EBP1_STATUS
C002359	P53
C002360	P53_GENE_ANALYSIS
C002361	P53_GERMLINE
C002362	P53_MUTATION
C002363	PAM50_SUBTYPE
C002364	PAN_GLIOMA_DNA_METHYLATION_CLUSTER
C002365	PAN_GLIOMA_RNA_EXPRESSION_CLUSTER
C002366	PAPILLARY_FLAT
C002367	PARADIGM_CLUSTER_NUMERIC_VALUE
C002368	PARADIGM_CLUSTER_K4
C002369	PARANEOPLASTIC_SYNDROME
C002370	PARITY
C002371	PAROTID_LN
C002372	PARTA_CONSENTED_12_245
C002373	PARTC_CONSENTED_12_245
C002374	PASSAGE_NUMBER
C002375	PATHFINDNUMNODESREMD
C002376	PATHFINDPOSNODES
C002377	PATHLOCATION
C002378	PATHMARGIN
C002379	PATHOLOGICAL_DIAGNOSIS
C002380	PATHOLOGIC_DISTANT_SPREAD
C002381	PATHOLOGIC_PRIMARY_TUMOR_STAGE
C002382	PATHOLOGIC_RESPONSE
C002383	PATHOLOGIC_SPREAD_INCIDENTAL_PROSTATE_CANCER
C002384	PATHOLOGIC_VASCULAR_INVASION
C002385	PATHOLOGY_CLASSIFICATION
C002386	PATHOLOGY_COMMENT
C002387	PATHOLOGY_LAUREN
C002388	PATHOLOGY_REPORT_FILE_NAME
C002389	PATHOLOGY_REPORT_UUID
C002390	PATHPERINEURALINV
C002391	PATHSTAGEDISEASE
C002392	PATHSTAGEGROUP
C002393	PATHSTAGEM
C002394	PATHSTAGEN
C002395	PATHSTAGET
C002396	PATHTUMORMAXDIM
C002397	PATHVASCULARINV
C002398	PATH_CANCER_MAX_DIM_CM
C002399	PATH_CAPSULE_INV
C002400	PATH_CODE
C002401	PATH_EXTRAHEPATIC_TISSUE_TYPE
C002402	PATH_GLEASON_SCORE
C002403	PATH_GLEASON_SCORE_1
C002404	PATH_GLEASON_SCORE_2
C002405	PATH_GRADE
C002406	PATH_INVASION_DEPTH
C002407	PATH_INV_HST
C002408	PATH_LVI_LV
C002409	PATH_LVI_SV
C002410	PATH_MARGIN
C002411	PATH_MASS_FORMING
C002412	PATH_MULTIFOCAL
C002413	PATH_M_STAGE
C002414	PATH_N_STAGE
C002415	PATH_N_STATUS
C002416	PATH_PERIDUCTAL_INFIL
C002417	PATH_RELAPSE
C002418	PATH_REPORT_UUID
C002419	PATH_SATELLITE_NODULES
C002420	PATH_SOLITARY_MASS
C002421	PATH_STEATOSIS
C002422	PATH_T_STAGE
C002423	PATH_WHO_TYPE
C002424	PATH_WHO_TYPE_2
C002425	PATIENTS_WITH_MULTIPLE_SAMPLES
C002426	PATIENT_DEATH_REASON
C002427	PATIENT_DISPLAY_NAME
C002428	PATIENT_GRADE
C002429	PATIENT_HARVEST_YEAR
C002430	PATIENT_ID
C002431	PATIENT_ID_LEGACY
C002432	PATIENT_NOTE
C002433	PATIENT_NOTES
C002434	PATIENT_STUDY_ID
C002435	PATIENT_TO_UNDERGO_SURGERY
C002436	PAX8
C002437	PAX_FUSION
C002438	PBRM1_LOSS
C002439	PB_BLAST_PERCENTAGE
C002440	PCLTPS
C002441	PCR_PRIMER_PAIRS
C002442	PCR_PRIMER_PAIRS_OTHER
C002443	PC_RPLND
C002444	PC_RPLND_STATUS
C002445	PDL1_EXPRESSION
C002446	PDL1_POS_OUTOFTUMORCELLS
C002447	PDL1_POS_OUTOF_CD45POS
C002448	PDL1_SCORE
C002449	PDTC_DEFINITION
C002450	PDX_GENERATION_NUMBER
C002451	PDX_MEDIAN_SURVIVAL
C002452	PDX_PARENT
C002453	PDX_SURVIVAL_RANGE
C002454	PDX_TREATMENT
C002455	PEDIATRIC_SAMPLE
C002456	PEDS_CANCER_TYPE_DETAILED
C002457	PED_AGE
C002458	PED_DISEASE_CATEGORY
C002459	PED_DRIVER_MUTATION
C002460	PED_IND
C002461	PED_NCCN_LEVEL
C002462	PED_PRIMARY_SITE
C002463	PED_SEX
C002464	PED_SPECIMEN_TYPE
C002465	PED_STAGE
C002466	PEG10_MUTATION
C002467	PELLET_STOOL_WEEKS
C002468	PELVIC_EXTENSION_COMMENT
C002469	PERCENTAGE_NECROSIS
C002470	PERCENTAGE_OF_TARGET_EXONS_IN_TUMORS_COVERED
C002471	PERCENTAGE_TUMOR_PURITY
C002472	PERCENT_ANEUPLOIDY
C002473	PERCENT_CHANGE
C002474	PERCENT_GLEASON_PATTERN_4_OR_5
C002475	PERCENT_LYMPHOCYTE_INFILTRATION
C002476	PERCENT_TUMOR_CELLS
C002477	PERCENT_TUMOR_CELLS_RELAPSE
C002478	PERCENT_TUMOR_NUCLEI
C002479	PERCENT_TUMOR_VS_STROMA
C002480	PERFORMANCE_STATUS
C002481	PERFORMANCE_STATUS_DAYS_TO
C002482	PERFORMANCE_STATUS_OTHER_TIMING
C002483	PERFORMANCE_STATUS_SCALE_TIMING
C002484	PERFORMANCE_STATUS_TIMING
C002485	PERINEURAL_INVASION
C002486	PERIPHERAL_BLASTS_PERCENTAGE
C002487	PERITONEAL_WASHING
C002488	PERI_OP_CHEMO
C002489	PERSISTANT_DISEASE_TUMOR_STUDIED
C002490	PERSONAL_HISTORY
C002491	PERSON_NEOPLASM_CANCER_STATUS
C002492	PET_CT_STANDARDIZED_VALUES
C002493	PET_SCAN
C002494	PET_TBR
C002495	PFS_DAYS
C002496	PFS_EVENT
C002497	PFS_INTERVAL_GROUP
C002498	PFS_MONTHS
C002499	PFS_STATUS
C002500	PFS_YEARS
C002501	PF_MONTHS
C002502	PF_STATUS
C002503	PHARMACEUTICAL_TX_ADJUVANT
C002504	PHARM_REGIMEN
C002505	PHARM_REGIMEN_OTHER
C002506	PHARM_TX_MITOTANE_ADJUVANT
C002507	PHARM_TX_MITOTANE_FOR_MACRO_DISEASE
C002508	PHARM_TX_MITOTANE_INDICATOR
C002509	PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG
C002510	PHARM_TX_MITOTANE_THERAPUTIC_AT_REC
C002511	PHARM_TX_MITOTANE_THERAPUTIC_LEVELS
C002512	PHARM_TX_MITOTANE_THERAPUTIC_MACRO
C002513	PHENOTYPE
C002514	PHYSICIAN
C002515	PI3K_MTOR_STATUS
C002516	PI3K_MUTATION
C002517	PIK3CA_MUTATION
C002518	PIK3CA_PROTEIN_CODING
C002519	PIK3R1_MUTATION_STATUS
C002520	PIK3R2_MUTATION_STATUS
C002521	PIPELINE_VER
C002522	PIPELINE_VERSION
C002523	PI_REVIEWED
C002524	PLASMA_CELLS
C002525	PLASMA_SERIES_VALUE
C002526	PLATELET_COUNT
C002527	PLATELET_COUNT_PRERESECTION
C002528	PLATELET_NORMAL_RANGE_LOWER
C002529	PLATELET_NORMAL_RANGE_UPPER
C002530	PLATELET_NORM_RANGE_LOWER
C002531	PLATELET_NORM_RANGE_UPPER
C002532	PLATFORM
C002533	PLATINUM_BEST_RESPONSE
C002534	PLATINUM_DOUBLET
C002535	PLATINUM_GERMLINE_TESTED
C002536	PLATINUM_HRD_MUTATION
C002537	PLATINUM_LST_SCORE
C002538	PLATINUM_OS_MONTHS
C002539	PLATINUM_OS_STATUS
C002540	PLATINUM_PFS_MONTHS
C002541	PLATINUM_PFS_STATUS
C002542	PLATINUM_STATUS
C002543	PLEOMORPHISM_SCORE
C002544	PLEURAL_INVASION
C002545	PLEURA_STATUS
C002546	PLEURODESIS_PERFORMED_90_DAYS
C002547	PLEURODESIS_PERFORMED_PRIOR
C002548	PLOCATION
C002549	PLOIDY
C002550	PLOIDY_PREDICTION_SCORE
C002551	PLT_COUNT
C002552	PM
C002553	PMS2_STATUS
C002554	PN
C002555	PNI
C002556	POD_AT_BLOOD_DRAW
C002557	POLE_MUTATION_STATUS
C002558	POOL
C002559	PORTAL_VEIN_INVASION
C002560	POSSIBLE_DNA_CONTANMINATION
C002561	POSSIBLE_HPYLORI_INFECTION
C002562	POSTOPERATIVE_RX_TX
C002563	POSTOPERATIVE_TX
C002564	POSTTREATMENT_STAGE
C002565	POST_OP_RADIATION
C002566	POST_ORCHI_AFP
C002567	POST_ORCHI_HCG
C002568	POST_ORCHI_LDH
C002569	POST_ORCHI_LH
C002570	POST_ORCHI_LYMPH_NODE_DISSECTION
C002571	POST_ORCHI_TESTOSTERONE
C002572	POST_SCT_RELAPSE
C002573	POST_SURGERY_PREVENTATIVE_THERAPY
C002574	POST_TX_OVERALL_STAGE
C002575	POST_TX_TNM_STAGE
C002576	POS_LYMPH_NODE_LOCATION
C002577	PPP2R1A_MUTATION
C002578	PRD_DIAGNOSIS_LOC
C002579	PRD_EVER_LOCATION
C002580	PRD_LOCATION_AT_ENROLLMENT
C002581	PRD_OTHER_CANCER
C002582	PRD_OTHER_CANCER_LIST
C002583	PRD_OTHER_CANCER_RADIATION
C002584	PRD_RADIATION
C002585	PRD_RADIATION_SURGERY
C002586	PRD_SURGERY
C002587	PRD_SURGERY_CLEAN_MARGINS
C002588	PRD_TREATED_AT_ENROLLMENT
C002589	PREGNANCIES_COUNT_ECTOPIC
C002590	PREGNANCIES_COUNT_INDUCED_ABORTION
C002591	PREGNANCIES_COUNT_LIVE_BIRTH
C002592	PREGNANCIES_COUNT_MISCARRIAGE
C002593	PREGNANCIES_COUNT_STILLBIRTH
C002594	PREGNANCIES_COUNT_TOTAL
C002595	PREGNANCIES_FULL_TERM_COUNT
C002596	PREGNANT_AT_DIAGNOSIS
C002597	PRENEOPLASTIC_CHANGE
C002598	PREOPERATIVE_ANTISEIZURE_MED
C002599	PREOPERATIVE_CORTICOSTEROIDS
C002600	PREOPERATIVE_PSA
C002601	PREOPERATIVE_TREATMENT
C002602	PREOP_CT
C002603	PREOP_PRETREAT_CEA_LEVEL
C002604	PREOP_RT_BEFORE_FIRST_SURGERY
C002605	PRERESECTION_CREATININE_LEVEL
C002606	PRERESECTION_SERUM_ALBUMIN
C002607	PRESENTATION
C002608	PRES_STG_YEAR
C002609	PRETREATED_TISSUE
C002610	PRETREATMENT_HISTORY
C002611	PRETREATMENT_IMAGING
C002612	PRETREATMENT_STAGE
C002613	PREVIOUS_MAPKI
C002614	PREVIOUS_MDS_MPN_AML_REGIMEN
C002615	PREVIOUS_TREATMENT
C002616	PRE_EXISTING_POLYP
C002617	PRE_ORCHI_AFP
C002618	PRE_ORCHI_HCG
C002619	PRE_ORCHI_LDH
C002620	PRE_ORCHI_LH
C002621	PRE_ORCHI_TESTOSTERONE
C002622	PRE_OR_POST_TX
C002623	PRE_POST_CHEMO
C002624	PRE_POST_TX
C002625	PRE_RC_SYSTEMICCHEMO
C002626	PRIMARY_AT_DX_COUNT
C002627	PRIMARY_CYTOGENETIC_CODE
C002628	PRIMARY_DEPTH
C002629	PRIMARY_DIAGNOSIS
C002630	PRIMARY_EXOME
C002631	PRIMARY_HISTOLOGY
C002632	PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT
C002633	PRIMARY_MELANOMA_KNOWN_DX
C002634	PRIMARY_MELANOMA_MITOTIC_RATE
C002635	PRIMARY_MELANOMA_SKIN_TYPE
C002636	PRIMARY_MELANOMA_TUMOR_ULCERATION
C002637	PRIMARY_METS_HER2_DISCONCORDANT
C002638	PRIMARY_METS_HR_DISCONCORDANT
C002639	PRIMARY_MITOSES
C002640	PRIMARY_MITOTIC_RATE_50_HPF
C002641	PRIMARY_MULTIPLE_AT_DX
C002642	PRIMARY_PHARMA_THERAPY
C002643	PRIMARY_RACE
C002644	PRIMARY_RADIATION_THERAPY
C002645	PRIMARY_RESECTION
C002646	PRIMARY_RPLND
C002647	PRIMARY_SITE
C002648	PRIMARY_SITE_NOTES
C002649	PRIMARY_SITE_OTHER
C002650	PRIMARY_SITE_PROGRESSION
C002651	PRIMARY_SURGICAL_THERAPY
C002652	PRIMARY_THERAPY_OUTCOME_SUCCESS
C002653	PRIMARY_THYROID_NEOPLASM_SITE
C002654	PRIMARY_TISSUE
C002655	PRIMARY_TUMOR_GRADE
C002656	PRIMARY_TUMOR_LOCALIZATION_TYPE
C002657	PRIMARY_TUMOR_LOCATION
C002658	PRIMARY_TUMOR_LOCATION_LEFT
C002659	PRIMARY_TUMOR_LOCATION_RECTUM
C002660	PRIMARY_TUMOR_PATHOLOGIC_SPREAD
C002661	PRIMARY_TUMOR_SIZE
C002662	PRIMARY_TX_MODALITY
C002663	PRIMARY_VS_SECONDARY
C002664	PRIM_SEQ
C002665	PRINCIPAL_SAMPLE
C002666	PRIORCHEMOFOROTHERCANCER
C002667	PRIORRADIATIONFOROTHERCANCER
C002668	PRIOR_AI
C002669	PRIOR_AIDS_CONDITIONS
C002670	PRIOR_ANTIRETROVIRAL_THERAPY
C002671	PRIOR_ANTI_EGFR
C002672	PRIOR_ANTI_VEGF
C002673	PRIOR_BCG
C002674	PRIOR_CANCER
C002675	PRIOR_CHEMO
C002676	PRIOR_DIAGNOSIS
C002677	PRIOR_DX
C002678	PRIOR_DXYN
C002679	PRIOR_FLUOROPYRIMIDINE
C002680	PRIOR_FULVESTRANT
C002681	PRIOR_GLIOMA
C002682	PRIOR_HAI
C002683	PRIOR_HERCEPTIN
C002684	PRIOR_INTRAVESICAL_CHEMO
C002685	PRIOR_INTRAVESICAL_CHEMOTHERAPY
C002686	PRIOR_IP
C002687	PRIOR_IRINOTECAN
C002688	PRIOR_LAPATINIB
C002689	PRIOR_LOCAL_THERAPY
C002690	PRIOR_MDS_AML_TREATMENT
C002691	PRIOR_MGUS
C002692	PRIOR_OS_MONTHS
C002693	PRIOR_OXALIPLATIN
C002694	PRIOR_PERI_OPERATIVE_CHEMO
C002695	PRIOR_PERTUZUMAB
C002696	PRIOR_RADIATION_THERAPY
C002697	PRIOR_RT
C002698	PRIOR_RT_OF_SEQUENCED_SITE
C002699	PRIOR_SURGERY_YEAR
C002700	PRIOR_SURGICAL_RESECTION
C002701	PRIOR_SYSTEMIC_CHEMO
C002702	PRIOR_TAMOXIFEN
C002703	PRIOR_TDM1
C002704	PRIOR_THYROID_CANCER
C002705	PRIOR_TREATMENT
C002706	PRIOR_TREATMENT_OF_CYTOTOXIC_CHEMOTHERAPY
C002707	PRIOR_TUMOR
C002708	PRIOR_TX_TO_IMPACT_SAMPLE
C002709	PRIOR_VITAL_STATUS
C002710	PROCEDURE_COMPLETE_RESECTION
C002711	PROCEDURE_DATE
C002712	PROCEDURE_LOCATION
C002713	PROCEDURE_LOCATION_SPECIFY
C002714	PROCEDURE_YEAR
C002715	PROCINTENT
C002716	PROCSUBSITE
C002717	PROGRESSION_DETERMINED_BY
C002718	PROGRESSION_OF_DISEASE
C002719	PROJECT_CODE
C002720	PROSPECTIVE_COLLECTION
C002721	PROTEIN_CODING_RHOA
C002722	PROTEIN_EXPRESSION_CLUSTER
C002723	PROTHROMBIN_TIME_INR_AT_PROCUREMENT
C002724	PROTHROMBIN_TIME_NORMAL_RANGE_UPPER
C002725	PROTHROMBIN_TIME_NORM_RANGE_UPPER
C002726	PROTHROM_TIME_INR_NORMAL_RANGE_LOWER
C002727	PROTHROM_TIME_INR_NORM_RANGE_LOWER
C002728	PROTOCOL
C002729	PROTOCOL_NUM
C002730	PRRT_THERAPY
C002731	PR_EXPR
C002732	PR_POSITIVITY_DEFINE_METHOD
C002733	PR_POSITIVITY_IHC_INTENSITY_SCORE
C002734	PR_POSITIVITY_SCALE_OTHER
C002735	PR_POSITIVITY_SCALE_USED
C002736	PR_STATUS
C002737	PR_STATUS_BY_IHC
C002738	PR_STATUS_IHC_PERCENT_POSITIVE
C002739	PR_STATUS_METASTASIS
C002740	PR_STATUS_PRIMARY
C002741	PSA
C002742	PSAT_IMPACT_ORDER
C002743	PSA_MOST_RECENT_RESULTS
C002744	PSEUDO_ADJ_IMATINIB
C002745	PTCH1_MUTATION
C002746	PTEN_CNA
C002747	PTEN_DELETION
C002748	PTEN_FISH
C002749	PTEN_MUTATION
C002750	PTPN11_MUTATION
C002751	PT_SIZE_CATEGORY
C002752	PUBMED_ID
C002753	PULMONARY_FUNCTION_TEST_INDICATOR
C002754	PUMA_COHORT
C002755	PURITY
C002756	PURITY_ABSOLUTE
C002757	PURITY_ASSESSMENT
C002758	PURITY_PREDICTION_SCORE
C002759	P_VALUE
C002760	QS_DATE
C002761	QUALIFYING_MUT
C002762	R0_SURGERY
C002763	RACE
C002764	RACE_AMERICAN_INDIAN_OR_NATIVE_AMERICAN
C002765	RACE_BLACK_OR_AFRICAN_AMERICAN
C002766	RACE_CATEGORIZED
C002767	RACE_CHINESE
C002768	RACE_JAPANESE
C002769	RACE_NATIVE_HAWAIIAN_OR_OTHER_PACIFIC_ISLANDER
C002770	RACE_OTHER
C002771	RACE_OTHER_EAST_ASIAN
C002772	RACE_PREFER_NOT_TO_ANSWER
C002773	RACE_SOUTH_EAST_ASIAN_OR_INDIAN
C002774	RACE_WHITE
C002775	RAD51C_CNA
C002776	RADADJUVANT
C002777	RADIATION_HISTORY
C002778	RADIATION_OR_CHEMOTHERAPY
C002779	RADIATION_THERAPY
C002780	RADIATION_THERAPY_DOSE_PARAAORTIC_NODES
C002781	RADIATION_THERAPY_XRT_DOSE
C002782	RADIATION_THERAPY_XRT_METHOD_PREP
C002783	RADIATION_THERAPY_XRT_SENSITIZERS
C002784	RADIATION_THERAPY_XRT_TYPE
C002785	RADIATION_TREATMENT_ADJUVANT
C002786	RADIATION_TREATMENT_NEOADJUVANT
C002787	RADIATION_TYPE_OTHER
C002788	RADICALITY
C002789	RADICAL_SURGERY
C002790	RADIO_THERAPY
C002791	RADNEOADJUVANT
C002792	RAF1_FUSION
C002793	RAFI_AGENT
C002794	RAF_INHIBITOR
C002795	RAF_RAS_STATUS
C002796	RAI
C002797	RAI_AVID
C002798	RAI_UPTAKE
C002799	RANDOM_FOREST_STURM_CLUSTER
C002800	RAS_MUTATION_RESULT
C002801	RATIO_OF_INDEL_TO_SUBSTITUTIONS
C002802	RB1_CNA
C002803	RB1_MUT
C002804	RC_GRADE
C002805	RC_YEAR
C002806	REARRANGEMENT_11Q23
C002807	REARRANGEMENT_14Q32
C002808	REARRANGEMENT_2P23
C002809	REARRANGEMENT_3P27
C002810	REASON_FOR_TX_DISCONTINUATION
C002811	REASON_WHY_NOT_RECEIVE_MT
C002812	REC
C002813	RECEIVED_IO_AFTER_1ST_LINE
C002814	RECIST_BURDEN_OF_DISEASE
C002815	RECIST_RESPONSE
C002816	RECORD_ID
C002817	RECUR
C002818	RECUR1
C002819	RECURRED_ON_ADJ_OR_PSEUDO_ADJ_TREATMENT
C002820	RECURRENCE
C002821	RECURRENCE_AT_DIAGNOSIS
C002822	RECURRENCE_HISTOLOGY
C002823	RECURRENCE_METHOD
C002824	RECURRENCE_OR_DEATH
C002825	RECURRENCE_STATUS_INTERVAL_YEARS
C002826	RECURRENT_DISEASE
C002827	RECURRENT_DISEASE_TUMOR_STUDIED
C002828	RECURRENT_FREE_INTERVAL_MONTHS
C002829	RECURRENT_METASTATIC_DISEASE
C002830	RECUR_NDSZ_DES
C002831	RECUR_NODAL_NO
C002832	RECUR_TO_IMPACT_EXTENT_MONTHS
C002833	REFLUX_HISTORY
C002834	REF_COUNT
C002835	REGIONAL_LYMPH_NODE
C002836	REGIONAL_LYMPH_NODES
C002837	REGIONAL_NODES_PATHOLOGIC_SPREAD
C002838	REGRESSION_DES
C002839	RELAPSE
C002840	RELAPSE_INTERVAL_IN_DAYS
C002841	RELAPSE_PERCENT_NECROSIS
C002842	RELAPSE_PERCENT_STROMA
C002843	RELAPSE_SEROSA
C002844	RELAPSE_TYPE
C002845	RELAPSE_YEAR
C002846	RELATED_SYMPTOM_FIRST_PRESENT
C002847	RELATED_TUMORS_OUTSIDE_ADRENAL_GLANDS
C002848	RELATION_TESTICULAR_CANCER
C002849	RELATIVE_FAMILY_CANCER_HX_TEXT
C002850	RELEVANT_MEDICAL_HISTORY
C002851	RELIGION
C002852	REPORT_YEAR
C002853	RESEARCH_NUM
C002854	RESECTION_AT_MSKC
C002855	RESECTION_AT_MSKCC
C002856	RESECTION_TIMING
C002857	RESIDUAL_SIGNATURE_NON_NORMALIZED
C002858	RESIDUAL_SIGNATURE_NORMALIZED
C002859	RESIDUAL_TUMOR
C002860	RESOURCE
C002861	RESOURCE_TYPE
C002862	RESPONSE_DAYS
C002863	RESPONSE_DURATION
C002864	RESPONSE_DURATION_MONTHS
C002865	RESPONSE_GRADE
C002866	RESPONSE_TO_FRONT_LINE_THERAPY
C002867	RESPONSE_TO_SMO_INHIBITION
C002868	RESPONSE_TO_TARGET_THERAPY
C002869	RET
C002870	RETROSPECTIVE_COLLECTION
C002871	RETROSPECTIVE_OR_PROSPECTIVE
C002872	RET_GERMLINE
C002873	RET_PTC_REARRANGEMENT_RESULT
C002874	RET_SOMATIC
C002875	REVIEWED_GLEASON
C002876	REVIEWED_GLEASON_CATEGORY
C002877	REVIEWED_GLEASON_SUM
C002878	RFS_MONTHS
C002879	RFS_STATUS
C002880	RHABDOID
C002881	RHOA_MUTATION
C002882	RHOA_PROTEIN_CODING
C002883	RICTOR_MUTATION_STATUS
C002884	RISK_CYTO
C002885	RISK_GROUP
C002886	RISK_MOLECULAR
C002887	RISK_STRATIFICATION
C002888	RMSE
C002889	RNASEQ_CLUSTER
C002890	RNASEQ_DATA
C002891	RNASEQ_PASSAGE
C002892	RNASEQ_SAMPLE_NUMBER
C002893	RNA_ID
C002894	RPA
C002895	RPLND_PATH
C002896	RPPA
C002897	RPPA_CLUSTER
C002898	RPPA_CLUSTERS_K3
C002899	RPPA_CLUSTERS_K4
C002900	RPPA_CLUSTER_EC
C002901	RPPA_CLUSTER_GEA
C002902	RPPA_CLUSTER_GEA_CIN
C002903	RPPA_CLUSTER_SCC
C002904	RPPA_DATA
C002905	RPS15_MUTATION
C002906	RSITE
C002907	RSITE1
C002908	RT_MAX_DOSE_CGY
C002909	RT_TX_REASON_NOT_COMPLETED
C002910	RT_TX_REASON_NOT_COMPLETED_OTHER
C002911	RT_TX_TOTAL_DOSE_TO_PELVIS
C002912	RUN
C002913	RX
C002914	RX_ADJ
C002915	RX_NEO_IH_CHEMO
C002916	RX_NEO_SYS_CHEMO
C002917	RX_RADS
C002918	SALVAGE_CHEMO
C002919	SALVAGE_CYSTECTOMY
C002920	SALVAGE_HAIP
C002921	SAMPLE_ACCESSION_NUMBER
C002922	SAMPLE_CATEGORY
C002923	SAMPLE_CLASS
C002924	SAMPLE_COLLECTION_METHOD
C002925	SAMPLE_COLLECTION_SOURCE
C002926	SAMPLE_COVERAGE
C002927	SAMPLE_DETAILED_SUBHISTOLOGIES
C002928	SAMPLE_DISPLAY_NAME
C002929	SAMPLE_ID
C002930	SAMPLE_ID_LEGACY
C002931	SAMPLE_INITIAL_WEIGHT
C002932	SAMPLE_MAIN_HISTOLOGY
C002933	SAMPLE_METH_ID
C002934	SAMPLE_NAME
C002935	SAMPLE_NOTES
C002936	SAMPLE_ORIGIN
C002937	SAMPLE_PRE_CHEMO
C002938	SAMPLE_PRE_LUNG_THERAPY
C002939	SAMPLE_PRE_POST_IMMUNE
C002940	SAMPLE_RNA_ID
C002941	SAMPLE_SITE
C002942	SAMPLE_SITE_SOURCE
C002943	SAMPLE_STATUS
C002944	SAMPLE_TESTED_CATEGORY
C002945	SAMPLE_TIMEPOINT
C002946	RESCINDED_URI_PREVIOUSLY_USED_FOR_SAMPLE_TIMEPOINT
C002947	SAMPLE_TREATMENT
C002948	SAMPLE_TYPE
C002949	SAMPLE_TYPE_DETAIL
C002950	SAMPLE_TYPE_ID
C002951	SAMPLE_TYPE_ID_NUMBER
C002952	SARCOMATOID_COMPONENT
C002953	SARCOMATOID_FEATURES
C002954	SARCOMATOID_PERCENT_OF_TUMOR
C002955	SATELLITES_DES
C002956	SCA_TYPE
C002957	SCC
C002958	SCCA_TUMOR_MARKER
C002959	SCCSMG
C002960	SCC_CLUSTER_ICLUSTER_AND_SMARCA4
C002961	SCENS
C002962	SCNA_ANALYSIS
C002963	SCNA_CLUSTER
C002964	SCNA_CLUSTER_EC
C002965	SCNA_CLUSTER_GEA
C002966	SCNA_CLUSTER_GEA_CIN
C002967	SCNA_CLUSTER_SCC
C002968	SCT_IN_FIRST_CR
C002969	SDHA
C002970	SDHAF2_SDH5
C002971	SDHB
C002972	SDHB_GERMLINE
C002973	SDHC
C002974	SDHD
C002975	SDHD_GERMLINE
C002976	SDH_STATUS
C002977	SECONDARY_ALTERATIONS
C002978	SECONDARY_HISTOLOGY
C002979	SECONDARY_PLATFORM
C002980	SECONDARY_RACE
C002981	SECONDARY_THERAPY
C002982	SECOND_PRIMARY_CANCER
C002983	SEIZURE_HISTORY
C002984	SEMINAL_VESICLE_INVASION
C002985	SENSORY_CHANGES
C002986	SEQCAP_EZ_EXOME_VERSION
C002987	SEQUENCED
C002988	SEQUENCED_SAMPLE
C002989	SEQUENCE_REPORT_DATE_INT_STATIC
C002990	SEQUENCING_TYPE
C002991	SEQUENOM
C002992	SEQUENOME_MUTATIONS_FUSIONS
C002993	SEQ_ASSAY_ID
C002994	SEQ_DATE
C002995	SERUM_ALBUMIN_NORMAL_RANGE_LOWER
C002996	SERUM_ALBUMIN_NORMAL_RANGE_UPPER
C002997	SERUM_ALBUMIN_NORM_RANGE_LOWER
C002998	SERUM_ALBUMIN_NORM_RANGE_UPPER
C002999	SERUM_ALBUMIN_PRERESECTION
C003000	SERUM_ALPHA_FOETO_PROTEIN
C003001	SERUM_CALCIUM_LEVEL
C003002	SERUM_LACTATE_DEHYDROGENASE
C003003	SERUM_MARKERS
C003004	SERUM_MESOTHELIN_LOWER_LIMIT
C003005	SERUM_MESOTHELIN_PRIOR_TX
C003006	SERUM_MESOTHELIN_UPPER_LIMIT
C003007	SERUM_PSA
C003008	SETD2_MUTATION
C003009	SETD2_SOMATIC
C003010	SEX
C003011	SEX_DMT
C003012	SEX_NAACCR
C003013	SHH_AMPLIFICATION
C003014	SHORTEST_DIMENSION
C003015	SHORT_HISTOLOGY
C003016	SIDE_SURGERY
C003017	SIEWERT1
C003018	SIGCLUST_INTRINSIC_MRNA
C003019	SIGCLUST_UNSUPERVISED_MRNA
C003020	SIGNATUREA
C003021	SIGNATUREB
C003022	SIGNATUREC
C003023	SIGNATURED
C003024	SIGNATUREE
C003025	SIGNATUREF
C003026	SIGNATURE_A
C003027	SIGNATURE_B
C003028	SIGNATURE_C
C003029	SIGNET_RING
C003030	SIGNIFICANT_COMORBIDITIES
C003031	SILENT_MUTATION
C003032	SILENT_PER_MB
C003033	SILENT_RATE
C003034	SILENT_SNV
C003035	SIMPLIFIED_TUMOR_SITE
C003036	SINUSOID_INVASION
C003037	SITE
C003038	SITES_IN_COLON
C003039	SITES_OF_METASTATIC_DISEASE
C003040	SITE_FIRST_RECURRENCE
C003041	SITE_ID
C003042	SITE_OF_DM
C003043	SITE_OF_INITIAL_RELAPSE
C003044	SITE_OF_RADIATION_THERAPY
C003045	SITE_OF_RECURRENCE
C003046	SITE_OF_TISSUE_BIOPSY
C003047	SITE_OF_TISSUE_SOURCE
C003048	SITE_OF_TUMOR_TISSUE
C003049	SITE_SEQUENCED
C003050	SITE_SIMPLIFIED
C003051	SKMEL_ID
C003052	SMAD4_STATUS
C003053	SMALL_EXONIC_SOMATIC_INDELS
C003054	SMOKER
C003055	SMOKER_YEARS
C003056	SMOKING
C003057	SMOKING_AGE_START_YEARS
C003058	SMOKING_HISTORY
C003059	SMOKING_PACK_PER_DAY
C003060	SMOKING_PACK_YEARS
C003061	SMOKING_QUESTIONNAIRE
C003062	SMOKING_YEARS_QUIT
C003063	SMOKING_YEAR_STARTED
C003064	SMOKING_YEAR_STOPPED
C003065	SMO_MUTATION
C003066	SMS
C003067	SNAPSHOT_MUTATIONS
C003068	SNOMED
C003069	SNP
C003070	SNP6
C003071	SOCIAL_HISTORY
C003072	SOMATIC_BRCA_WT_STATUS
C003073	SOMATIC_STATUS
C003074	SOMATOSTATIN_ANALOG_THERAPY
C003075	SORT_FILE_NUMBER
C003076	SOURCE
C003077	SOURCE_LAB
C003078	SOURCE_OF_RECURRENCE_TISSUE
C003079	SOURCE_PATHOLOGY
C003080	SOURCE_TYPE
C003081	SO_COMMENTS
C003082	SPECIAL_HISTOLOGY
C003083	SPECIMEN
C003084	SPECIMEN_CHEMOTHERAPY_STATUS
C003085	SPECIMEN_CODE
C003086	SPECIMEN_COLLECTION_PRE_OR_POST_CHEMO
C003087	SPECIMEN_CURRENT_WEIGHT
C003088	SPECIMEN_FREEZING_METHOD
C003089	SPECIMEN_PRESERVATION_TYPE
C003090	SPECIMEN_REFERENCE_NUMBER
C003091	SPECIMEN_SECOND_LONGEST_DIMENSION
C003092	SPECIMEN_SITE
C003093	SPECIMEN_TYPE
C003094	SPINK1_HIGH
C003095	SPLICE_SITE
C003096	SPLICE_SITE_INSERTION
C003097	SPLICE_SITE_SNP
C003098	SPOPL_CNA
C003099	SPOP_MUTATION
C003100	STAGE
C003101	STAGE_AT_DIAGNOSIS
C003102	STAGE_AT_FIRST_RECURRENCE
C003103	STAGE_AT_PRESENTATION
C003104	STAGE_AT_PRESENTATION_OR_RELAPSE
C003105	STAGE_AT_TESTING
C003106	STAGE_CODE
C003107	STAGE_M
C003108	STAGE_OTHER
C003109	STAGE_YEAR
C003110	STAGING_SYSTEM
C003111	STAGING_SYSTEM_OTHER
C003112	STAIN_34BE12CK
C003113	STANDARDIZED_CELL_NAME
C003114	STANDARDIZED_PARENT_CELL_NAME
C003115	START_DATE
C003116	START_DATE_BIRTH_DATE
C003117	STATE_PROVINCE_COUNTRY_OF_PROCUREMENT
C003118	STATIN_USE
C003119	STATUS
C003120	STATUS1
C003121	STATUSDATE
C003122	STATUS_10P
C003123	STATUS_10Q
C003124	STATUS_11P
C003125	STATUS_11Q
C003126	STATUS_12P
C003127	STATUS_12Q
C003128	STATUS_13_13Q
C003129	STATUS_14_14Q
C003130	STATUS_15_15Q
C003131	STATUS_16P
C003132	STATUS_16Q
C003133	STATUS_17P
C003134	STATUS_17Q
C003135	STATUS_18P
C003136	STATUS_18Q
C003137	STATUS_19P
C003138	STATUS_19Q
C003139	STATUS_1P
C003140	STATUS_1P_19Q
C003141	STATUS_1Q
C003142	STATUS_20P
C003143	STATUS_20Q
C003144	STATUS_21_21Q
C003145	STATUS_22_22Q
C003146	STATUS_2P
C003147	STATUS_2Q
C003148	STATUS_3P
C003149	STATUS_3Q
C003150	STATUS_4P
C003151	STATUS_4Q
C003152	STATUS_5P
C003153	STATUS_5Q
C003154	STATUS_6P
C003155	STATUS_6Q
C003156	STATUS_7P
C003157	STATUS_7Q
C003158	STATUS_8P
C003159	STATUS_8Q
C003160	STATUS_9P
C003161	STATUS_9Q
C003162	STEAP
C003163	STEPHANSON_5YR_NOMOGRAM
C003164	STES_CIN_GS
C003165	STES_UNIQUE_ANATOMIC_SITE
C003166	STES_UNIQUE_ANATOMIC_SITE_GEACIN_SAMPLES_NUMERIC_CODING
C003167	STES_UNIQUE_ANATOMIC_SITE_NUMERIC_CODING
C003168	STG_GRP_NAME
C003169	STIME
C003170	STOOL_BLOOD_MONTHS
C003171	STOOL_IN_BLOOD
C003172	STOP_DATE
C003173	STOP_DATE_BIRTH_DATE
C003174	STRAIN
C003175	STROMAL_SCORE
C003176	STROMA_PERCENTAGE
C003177	STRUCTURAL_VARIANTS
C003178	STR_STATUS
C003179	STR_TESTED
C003180	STS_SRCE_DESC
C003181	STUDY
C003182	STUDY_ARM
C003183	STUDY_ID
C003184	SU2C_SAMPLE_ID
C003185	SUBCLONAL_GENOMIC_FRACTION
C003186	SUBGROUP
C003187	SUBMITTED_TUMOR_DX_DAYS_TO
C003188	SUBSEQUENT_CANCERS
C003189	SUBSEQUENT_RX
C003190	SUBSTITUTION
C003191	SUBTYPE
C003192	SUBTYPE_DETAILS
C003193	SUB_CLONES
C003194	SUB_SITE
C003195	SUFU_MUTATION
C003196	SUN_EXPOSURE
C003197	SUPERFICIAL_DX_HISTORY
C003198	SUPERVISED_DNA_METHYLATION_CLUSTER
C003199	SUPRATENTORIAL_LOCALIZATION
C003200	SURGERY
C003201	SURGERY_AT_DX
C003202	SURGERY_AT_MSKCC
C003203	SURGERY_DETAILS
C003204	SURGERY_FOR_POSITIVE_MARGINS
C003205	SURGERY_FOR_POSITIVE_MARGINS_OTHER
C003206	SURGERY_HISTORY
C003207	SURGERY_MET
C003208	SURGERY_PROCEDURE
C003209	SURGERY_SITE
C003210	SURGICAL_APPROACH_AT_DIAGNOSIS
C003211	SURGICAL_MARGIN
C003212	SURGICAL_PROCEDURE_FIRST
C003213	SURGICAL_PROCEDURE_OTHER
C003214	SURVIVAL_AFTER_BIOPSY_MONTHS
C003215	SURVIVAL_DATA_FORM
C003216	SURVIVAL_FROM_FIRST_CHEMOTHERAPY
C003217	SURVIVAL_FROM_FIRST_HORMONE_THERAPY
C003218	SUSPECTED_PRIMARY
C003219	SUV_OF_PLEURA_MAX
C003220	SVEGF
C003221	SVEGFMED
C003222	SVI
C003223	SVMEDBASE
C003224	SYMP_CHANGES_MENTAL_STATUS
C003225	SYMP_CHANGES_MOTOR_MOVEMENT
C003226	SYMP_CHANGES_SENSORY
C003227	SYMP_CHANGES_VISUAL
C003228	SYNCHRONOUS_COLON_CANCER_PRESENT
C003229	SYNCHRONOUS_DISEASE
C003230	SYNCHRONOUS_TUMOR_HISTOLOGY_PCT
C003231	SYNONYMS
C003232	SYNOVIAL_SS18SSX_FUSION_STATUS
C003233	SYNOVIAL_SS18SSX_TESTING_METHOD
C003234	SYN_IHC
C003235	SYSTEMIC_DISEASE_STATUS
C003236	SYSTEMIC_THERAPY
C003237	SYSTEMIC_TREATMENT
C003238	SYSTEMIC_TREATMENTS_OTHER
C003239	SYSTEM_VERSION
C003240	SYS_DESC
C003241	S_100_STAIN
C003242	S_STAGE
C003243	TARGETED_MOLECULAR_THERAPY
C003244	TARGETED_SEQ
C003245	TARGET_ID
C003246	TARGET_THERAPY
C003247	TARGET_THERAPY_NAME
C003248	TCF3_PBX1_STATUS
C003249	TCGA_SMOKING_CATEGORY
C003250	TCR_GAMMA_BETA
C003251	TCR_GENE_REARRANGEMENT
C003252	TELOMERE_LENGTH_ESTIMATE_IN_BLOOD_NORMAL_KB
C003253	TELOMERE_LENGTH_ESTIMATE_IN_TUMOR_KB
C003254	TELOMERE_MAINTENANCE
C003255	TEL_STATUS
C003256	TEMOZOLOMIDE_CONCURRENT_WITH_XRT
C003257	TEMOZOLOMIDE_TREATMENT
C003258	TENESMUS_WEEKS
C003259	TERTIARY_PATTERN
C003260	TERTIARY_RACE
C003261	TERT_EXPRESSION_LOG2
C003262	TERT_EXPRESSION_STATUS
C003263	TERT_MUTATION
C003264	TERT_PROMOTER_STATUS
C003265	TESTES_SITE_OF_RELAPSE
C003266	TESTICULAR_INVOLVEMENT
C003267	TESTIS_TUMOR_MACROEXTENT
C003268	TESTIS_TUMOR_MACROEXTENT_OTHER
C003269	TESTIS_TUMOR_MICROEXTENT
C003270	TEST_ALK_FISH
C003271	TEST_FGFR1_FISH
C003272	TEST_MET_FISH
C003273	TEST_MGMT_IHC
C003274	TEST_PTEN_IHC
C003275	TG_STAIN
C003276	THERAPIES_2YRS_LIST
C003277	THERAPIES_XRC_LIST
C003278	THERAPY
C003279	THREEGENE
C003280	THYROID_RELATED_DEATH
C003281	TIMEPOINT
C003282	TIMEPOINT_AFATINIB
C003283	TIMEPOINT_TRASTUZUMAB
C003284	TIME_BETWEEN_BLOOD_DRAW_AND_BIOPSY
C003285	TIME_BETWEEN_CLAMPING_AND_FREEZING
C003286	TIME_BETWEEN_EXCISION_AND_FREEZING
C003287	TIME_BETWEEN_HEALER_AND_PHYSICIAN
C003288	TIME_FROM_DX_TO_IMPACT_TESTING_MONTHS
C003289	TIME_FROM_MET_DX_SEQUENCING
C003290	TIME_FROM_OBTAINING_SAMPLE_TO_RUNNING_IMPACT_MONTHS
C003291	TIME_FROM_SURGERY_TO_CHEMOTHERAPY
C003292	TIME_FROM_SURGERY_TO_DEATH
C003293	TIME_FROM_SURGERY_TO_POD
C003294	TIME_POINT
C003295	TIME_POST_START_OF_AFATINIB_WEEKS
C003296	TIME_TO_COMPLETE_RESPONSE
C003297	TIME_TO_DEATH_MONTHS
C003298	TIME_TO_DIAGNOSIS_WITH_ADVANCED_DISEASE
C003299	TIME_TO_DISTANT_RECURRENCE
C003300	TIME_TO_FIRST_EVENT_OR_EVENT_FREE_SURVIAL
C003301	TIME_TO_FIRST_RECURRENCE
C003302	TIME_TO_LAST_FOLLOWUP
C003303	TIME_TO_LOCAL_RECURRENCE
C003304	TIME_TO_LOCAL_RECURRENCE_STATUS
C003305	TIME_TO_METASTASIS_MONTHS
C003306	TIME_TO_MET_MONTHS
C003307	TIME_TO_PATH_MONTHS
C003308	TIME_TO_PROGRESSION_OF_DISEASE
C003309	TIME_TO_PROGRESSION_OF_DISEASE_DAYS
C003310	TIME_TO_PROGRESSION_ON_FOLFOX_AND_REGORAFENIB
C003311	TIME_TO_RECURRENCE_AFTER_COMPLERE_RESECTION_OF_METS_MONTHS
C003312	TIME_TO_RECURRENCE_MONTHS
C003313	TIME_TO_RECURRENCE_OR_DEATH_MONTHS
C003314	TIME_TO_RECURRENCE_OR_MET
C003315	TIME_TO_RELAPSE
C003316	TIME_TO_RELAPSE_PROTOCOL_ENROLLMENT
C003317	TIME_TO_RESECTION
C003318	TIME_TO_SURGERY
C003319	TIME_TO_TREATMENT
C003320	TIME_TO_UNRESECTABLE_OR_METASTATIC_DISEASE_MONTHS
C003321	TIMING_OF_IMPACT
C003322	TIMING_OF_IMPACT_RELATIVE_TO_DISEASE
C003323	TISSUE_ANALYZED
C003324	TISSUE_BANK_AVAIL
C003325	TISSUE_COLLECTION_MONTHS
C003326	TISSUE_DIAGNOSIS
C003327	TISSUE_LEVEL_ANATOMIC_SITE
C003328	TISSUE_PROSPECTIVE_COLLECTION_INDICATOR
C003329	TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR
C003330	TISSUE_SEQUENCED
C003331	TISSUE_SITE
C003332	TISSUE_SITE_MET_BURDEN
C003333	TISSUE_SOURCE_SITE
C003334	TISSUE_TYPE
C003335	TMEM127
C003336	TMEM127_GERMLINE
C003337	TMPRSS2_ERG_FUSION_STATUS
C003338	TNM
C003339	TNMSTAGE
C003340	TOBACCO_SMOKING_HISTORY_INDICATOR
C003341	TOBACCO_TYPE
C003342	TOTAL
C003343	TOTAL_BILIRUBIN
C003344	TOTAL_CELL_NUMBERS
C003345	TOTAL_CNA
C003346	TOTAL_EXONIC_MUTATION_BURDEN
C003347	TOTAL_MITOSES
C003348	TOTAL_MUTATIONS
C003349	TOTAL_NUMBER_OF_SAMPLES_PER_PATIENT
C003350	TOTAL_PER_MB
C003351	TOTAL_POST_INDUCTION_REGIMENS
C003352	TOTAL_REARRANGEMENT
C003353	TOTAL_SNV
C003354	TOTAL_TIME_ON_AFATINIB_WEEKS
C003355	TOTAL_TIME_PERIOD_MONTHS
C003356	TP53_CNA
C003357	TP53_DELETION
C003358	TP53_MUTATION
C003359	TP53_PROTEIN_CODING
C003360	TP53_SOMATIC
C003361	TPS
C003362	TRADITIONAL_HEALER_HISTORY
C003363	TRANSCRIPTOME_SUBTYPE
C003364	TRANSFORMATION
C003365	TRANSFORMED_LYMPHOMA_DAYS
C003366	TRANSLOCATIONS
C003367	TRANSLOCATION_16
C003368	TRANSLOCATION_DEL_CHR_11
C003369	TRANSPLANT_TYPE
C003370	TREATED_OR_UNTREATED_AT_TIME_OF_INITIAL_VISIT
C003371	TREATED_OR_UNTREATED_AT_TIME_OF_INITIAL_VISIT_SAMPLE
C003372	TREATMENT
C003373	TREATMENT_ARM
C003374	TREATMENT_AT_MSK
C003375	TREATMENT_BEFORE_PDX
C003376	TREATMENT_BEST_RESPONSE
C003377	TREATMENT_CHEMOTHERAPY
C003378	TREATMENT_DETAILS
C003379	TREATMENT_EFFECT
C003380	TREATMENT_EXPOSED_VS_NAIVE
C003381	TREATMENT_FOR_MTS_DISEASE_BEFORE_MTS_SAMPLING
C003382	TREATMENT_HORMONE_THERAPY
C003383	TREATMENT_INTERVENTION
C003384	TREATMENT_OUTCOME_AT_TCGA_FOLLOWUP
C003385	TREATMENT_OUTCOME_FIRST_COURSE
C003386	TREATMENT_PALLIATIVE_RADIATION
C003387	TREATMENT_PRIOR_TO_RESECTION
C003388	TREATMENT_PRIOR_TO_SURGERY_INDICATOR
C003389	TREATMENT_PROSTATECTOMY
C003390	TREATMENT_RADIATION
C003391	TREATMENT_RESPONSE
C003392	TREATMENT_SCHEDULE
C003393	TREATMENT_STATUS
C003394	TREATMENT_TYPE
C003395	TRIPLE_NEG_STATUS
C003396	TRISOMY_10_11_P11_2_Q23
C003397	TRISOMY_11
C003398	TRISOMY_11_19_Q23_P13_1
C003399	TRISOMY_12
C003400	TRISOMY_21
C003401	TRISOMY_3
C003402	TRISOMY_3_5_Q25_Q34
C003403	TRISOMY_4_10
C003404	TRISOMY_4_10_17
C003405	TRISOMY_6_11_Q27_Q23
C003406	TRISOMY_6_9
C003407	TRISOMY_8
C003408	TRISOMY_8_21
C003409	TRISOMY_9
C003410	TRISOMY_9_11_P22_Q23
C003411	TSC1_MUTATION_STATUS
C003412	TSC2_MUTATION_STATUS
C003413	TSS_NAME
C003414	TTF1_STAIN
C003415	TUBE_ID
C003416	TUBULE_SCORE
C003417	TUMOR
C003418	TUMOR_BASAL_DIAMETER
C003419	TUMOR_BASAL_DIAMETER_MX
C003420	TUMOR_BORDER
C003421	TUMOR_BURDEN_PATHOLOGIC
C003422	TUMOR_BURDEN_RADIOLOGIC
C003423	TUMOR_CELLULARITY_DOMINANT_CLONE_VAF
C003424	TUMOR_CELLULARITY_PATHOLOGY_REVIEW
C003425	TUMOR_CHANGE
C003426	TUMOR_CONTENT
C003427	TUMOR_DIFFERENTIATION
C003428	TUMOR_EXOME_DEPTH
C003429	TUMOR_EXTENT
C003430	TUMOR_FOCALITY
C003431	TUMOR_GENOME_COVERAGE
C003432	TUMOR_GENOME_LIBRARY
C003433	TUMOR_GRADE
C003434	TUMOR_INFILTRATING_LYMPHOCYTES
C003435	TUMOR_INFILTRATING_MACROPHAGES
C003436	TUMOR_INVASION_PERCENT
C003437	TUMOR_LARGER_THAN_FOUR_CM
C003438	TUMOR_LEVEL
C003439	TUMOR_LOCATION
C003440	TUMOR_LOCATION_DETAILED
C003441	TUMOR_MORPHOLOGY
C003442	TUMOR_MORPHOLOGY_PERCENTAGE
C003443	TUMOR_MSK_IMPACT
C003444	TUMOR_PLOIDY
C003445	TUMOR_PURITY
C003446	TUMOR_REGION
C003447	TUMOR_RESECTED_MAX_DIMENSION
C003448	TUMOR_RESIDUAL_DISEASE
C003449	TUMOR_RESPONSE
C003450	TUMOR_SAMPLE_HISTOLOGY
C003451	TUMOR_SAMPLE_PROCUREMENT_COUNTRY
C003452	TUMOR_SHAPE_PATHOLOGIC_CLINICAL
C003453	TUMOR_SIDE
C003454	TUMOR_SITE
C003455	TUMOR_SIZE
C003456	TUMOR_SIZE_WIDTH
C003457	TUMOR_STAGE
C003458	TUMOR_STAGE_2009
C003459	TUMOR_STAGE_MPUC_DX
C003460	TUMOR_STATUS
C003461	TUMOR_SUBTYPE
C003462	TUMOR_T1_CODED
C003463	TUMOR_THICKNESS
C003464	TUMOR_THICKNESS_MEASUREMENT
C003465	TUMOR_TISSUE_SITE
C003466	TUMOR_TISSUE_SITE_OTHER
C003467	TUMOR_TOTAL_DEPTH
C003468	TUMOR_TOTAL_NECROSIS
C003469	TUMOR_TREATED
C003470	TUMOR_TYPE
C003471	TUMOR_VOLUME
C003472	TURIN
C003473	TX_90DAYS_POST_RESECTION
C003474	TX_CLASS
C003475	TX_COMPLETE_RESPONSE
C003476	TX_INDUCTION_COURSES_INDICATOR
C003477	TX_MAINTENANCE_COURSES_INDICATOR
C003478	TX_REG
C003479	TYPE
C003480	TYPE_OF_CLINICAL_VARIANT
C003481	TYPE_OF_PRIOR_LOCAL_THERAPY
C003482	TYPE_OF_SURGERY
C003483	TYPE_OF_SURGERY_2
C003484	TYPE_OF_TREATMENT_BEFORE_SAMPLING
C003485	T_10_11_P11_2_Q23
C003486	T_10_19
C003487	T_11Q23
C003488	T_11_14
C003489	T_11_17
C003490	T_11_18
C003491	T_11_19_Q23_P13_1
C003492	T_11_23
C003493	T_12_2
C003494	T_14_16
C003495	T_14_18
C003496	T_15_17
C003497	T_1_19
C003498	T_1_22
C003499	T_3Q27
C003500	T_3_5_Q25_Q34
C003501	T_4_11
C003502	T_4_14
C003503	T_5_12
C003504	T_5_14
C003505	T_6_11_Q27_Q23
C003506	T_6_14
C003507	T_6_9
C003508	T_8_14
C003509	T_8_21
C003510	T_9_11
C003511	T_9_11_P22_Q23
C003512	T_9_14
C003513	T_9_22
C003514	T_CELLS_CD4_MEMORY_ACTIVATED
C003515	T_CELLS_CD4_MEMORY_RESTING
C003516	T_CELLS_CD4_NAIVE
C003517	T_CELLS_CD8
C003518	T_CELLS_FOLLICULAR_HELPER
C003519	T_CELLS_GAMMA_DELTA
C003520	T_CELLS_REGULATORY_TREGS
C003521	T_SCORE
C003522	T_STAGE
C003523	T_STAGE_REPORTED
C003524	U133A
C003525	UBIQUITOUS_ASSAY_PANEL
C003526	UICC_TUMOR_STAGE
C003527	ULTRASOUND
C003528	UNDESCENDED_TESTIS_CORRECTED
C003529	UNDESCENDED_TESTIS_CORRECTED_AGE
C003530	UNDESCENDED_TESTIS_METHOD_LEFT
C003531	UNDESCENDED_TESTIS_METHOD_RIGHT
C003532	UNIQUE_PAPER_SAMPLES
C003533	UNIT
C003534	UPD
C003535	UROTHELIAL_PRIMARY
C003536	USAGE
C003537	UTERINE_WEIGHT
C003538	V
C003539	V1
C003540	V2
C003541	V3
C003542	VALIDATION_STATUS
C003543	VARIANT_HISTOLOGY
C003544	VARIANT_HISTOLOGY_SUBTYPE
C003545	VAR_10Q_NEG
C003546	VAR_10_005
C003547	VAR_11Q_NEG
C003548	VAR_11_NEG
C003549	VAR_11_POS
C003550	VAR_12P_POS
C003551	VAR_12_245
C003552	VAR_13P_NEG
C003553	VAR_13_NEG
C003554	VAR_14Q_NEG
C003555	VAR_15Q_POS
C003556	VAR_16Q_NEG
C003557	VAR_17P_NEG
C003558	VAR_17Q_POS
C003559	VAR_18_NEG
C003560	VAR_19P_NEG
C003561	VAR_19Q_POS
C003562	VAR_1P_NEG
C003563	VAR_1Q_POS
C003564	VAR_20Q_POS
C003565	VAR_22_NEG
C003566	VAR_2P_NEG
C003567	VAR_2P_POS
C003568	VAR_3P_NEG
C003569	VAR_3Q_NEG
C003570	VAR_3Q_POS
C003571	VAR_4P_NEG
C003572	VAR_4_NEG
C003573	VAR_6P_POS
C003574	VAR_6Q_NEG
C003575	VAR_7Q_POS
C003576	VAR_9P_NEG
C003577	VAR_9_NEG
C003578	VASCULAR_INVASION
C003579	VASCULAR_INVASION_INDICATOR
C003580	VEGF1
C003581	VEGF2
C003582	VHL
C003583	VHL_GERMLINE
C003584	VHL_MUTATION_AA
C003585	VHL_MUTATION_CODON
C003586	VHL_SOMATIC
C003587	VI
C003588	VIAL_NUMBER
C003589	VISCERAL_METS
C003590	VISMO_STATUS
C003591	VISUAL_CHANGES
C003592	VITAL_STATUS
C003593	VITAL_STATUS_INTERVAL_YEARS
C003594	WASHING
C003595	WATERFALL_GROUP
C003596	WBC
C003597	WBC_X_10_3_PER_MICROLITER
C003598	WEEK_ADDED
C003599	WEIGHT
C003600	WEIGHT_LOSS
C003601	WEIGHT_LOSS_AMOUNT_KG
C003602	WEIGHT_LOSS_WEEKS
C003603	WEISS_SCORE_OVERALL
C003604	WEISS_VENOUS_INVASION
C003605	WELL_DIFF_LIPOSARC_PRIOR_DX_DAYS_TO
C003606	WELL_DIFF_LIPOSARC_PRIOR_DX_INDICATOR
C003607	WELL_DIFF_LIPOSARC_RESECTION_DAYS_TO
C003608	WGD
C003609	WGS_BASED_PURITY_ESTIMATION
C003610	WGS_STATUS
C003611	WHOLE_EXOME_SEQUENCING
C003612	WHOLE_GENOME_SEQUENCING
C003613	WHO_CLASS
C003614	WHO_GRADE
C003615	WITHDRAWAL_OF_CONSENT
C003616	WT1_MUTATION
C003617	XENOGRAFT_INFORMATION
C003618	XTANDI
C003619	XTANDI_EXPOSED_BEFORE_BX
C003620	X_SOURCEINFO
C003621	YEAR
C003622	YEARS_TO_LAST_KNOWN_ALIVE
C003623	YEARS_TO_NEW_TUMOR
C003624	YEAR_MET_DISEASE_IDENTIFIED
C003625	YEAR_OF_COLLECTION
C003626	YEAR_OF_DIAGNOSIS
C003627	YEAR_OF_INITIAL_PATHOLOGIC_DIAGNOSIS
C003628	YEAR_OF_RC
C003629	YEAR_OF_SPECIMEN
C003630	YEAR_OF_SURGERY
C003631	ZAP70_TEST
C003632	ZMYM3_MUT
C003633	ZYTIGA
C003634	ZYTIGA_EXPOSED_BEFORE_BX
C003635	PDX_SAMPLE_STATUS
C003636	MUTATION_NUMBER
C003637	CNA_NUMBER
C003638	RNA_SEQUENCED
C003639	PDX_NOTES
C003640	IN_PANCANPATHWAYS_FREEZE
C003641	TEXTURE
C003642	HGP_SCORE
C003643	STEATOFFIBROSISSCORE
C003644	ADJUVANTCREASY_PATIENTS
C003645	PRESENCE_OF_ADENOMA
C003646	PRESENCE_OF_EXOCRINE_COMPONENT
C003647	REGIONAL_VS_PRIMARY
C003648	UV_SIGNATURE
C003649	UV_RATE
C003650	AGE_AT_TCGA_SPECIMEN
C003651	SITE_OF_PRIMARY_TUMOR_KNOWN_PRIMARY_ONLY
C003652	SITE_OF_PRIMARY_TUMOR_INCLUDING_UNKNOWN
C003653	BRESLOW
C003654	ULCERATION
C003655	T_STAGE_AT_DIAGNOSIS_COMPLEX
C003656	T_STAGE_AT_DIAGNOSIS_SIMPLE
C003657	N_STAGE_AT_DIAGNOSIS_COMPLEX
C003658	N_STAGE_AT_DIAGNOSIS_SIMPLE
C003659	M_STAGE_AT_DIAGNOSIS_COMPLEX
C003660	M_STAGE_AT_DIAGNOSIS_SIMPLE
C003661	PATHOLOGIC_STAGE_AJCC7_AT_DIAGNOSIS_COMPLEX
C003662	PATHOLOGIC_STAGE_AJCC7_AT_DIAGNOSIS_SIMPLE
C003663	TCGA_SPECIMEN_SITE
C003664	DISTANT_ANATOMIC_SITE
C003665	TCGA_DAYS_TO_DEATH_OR_LAST_FU
C003666	TCGA_SPECIMEN_DISTANT
C003667	STAGE_HCC_SYSTEMIC
C003668	INTRAHEPATIC_DISEASE
C003669	GROSS_VASCULAR_INVOLVEMENT
C003670	PRIOR_TRANSPLANT
C003671	PRIOR_RESECTION
C003672	PRIOR_REGIONAL_TREATMENT
C003673	SORAFENIB_TREATMENT
C003674	MUTATION_CLASS
C003675	FIG2_ORDER
C003676	PRIOR_TAXANE
C003677	PRIOR_ABI_OR_ENZ
C003678	NON_VIRAL
C003679	PDX_CASE_ID
C003680	TREATMENT_BEFORE_COLLECTION
C003681	IMPACT_PDX_PASSAGE
C003682	IMPACT_NUMBER
C003683	RNASEQ_NUMBER
C003684	PDX_LIB_NUMBER
C003685	ANATOMY
C003686	PLANNED_DOSE
C003687	DELIVERED_DOSE
C003688	PLANNED_FRACTIONS
C003689	DELIVERED_FRACTIONS
C003690	REF_POINT_SITE
C003691	INDUCTION_CHEMO
C003692	INDUCTION_XRT
C003693	PATHOLOGIC_STAGE_AJCC8
C003694	PATHOLOGIC_STAGE_AJCC8_COLLAPSE
C003695	PATHOLOGIC_STAGE_AJCC8_CODE
C003696	RESECTION
C003697	POST_OP_RECUR
C003698	MONTHS_FROM_SURGERY_TO_RECURRENCE
C003699	POST_OP_RECUR_FIRST_SITE_TYPE
C003700	BRAIN_RECUR_STATUS
C003701	BRAIN_RECUR_MONTHS
C003702	BONE_RECUR_STATUS
C003703	DFS_BONE_RECUR_MONTHS
C003704	INITIAL_SAMPLE_WEIGHT_GRAMS
C003705	X2YR_AIS
C003706	X2YR_TAMOXIFEN
C003707	X2YR_ANTIHER2
C003708	X2YR_FULVESTRANT
C003709	X2YR_CAPECITABINE
C003710	X2YR_VEGF_INHIBITOR
C003711	X2YR_ANTHRACYCLINE
C003712	X2YR_ALKYLATING_AGENT
C003713	X2YR_CDK46
C003714	X2YR_TAXANE
C003715	PATIENT_TREATMENT_MODE
C003716	REGIMEN
C003717	RELAPSE_SEQUENCED
C003718	ETS_FUSION_DETAILS
C003719	RAF1_BRAF_STATUS
C003720	TMB_COHORT
C003721	TMB_COHORT_PERCENTILE
C003722	TMB_TT_COHORT
C003723	TMB_TT_COHORT_PERCENTILE
C003724	TMB_SCORE
C003725	POLYA_ARV7_SRPM
C003726	CAPTURE_ARV7_SRPM
C003727	AR_POLYA_SCORE
C003728	AR_CAPTURE_SCORE
C003729	NEPC_CAPTURE_SCORE
C003730	NEPC_POLYA_SCORE
C003731	CVR_TMB_COHORT
C003732	CVR_TMB_COHORT_PERCENTILE
C003733	CVR_TMB_TT_COHORT
C003734	CVR_TMB_TT_COHORT_PERCENTILE
C003735	CVR_TMB_SCORE
C003736	PASSAGE_ID
C003737	PROCEDURE_TYPE
C003738	PRETREATED
C003739	TREATED
C003740	STAGE_AT_HCC_DIAGNOSIS
C003741	EARLY_RESISTANCE
C003742	AGE_AT_SEQ_REPORTED_YEARS
C003743	SEQ_YEAR
C003744	CANCER_STUDY_ID
C003745	NONSYNONYMOUS_MUTATION_COUNT
C003746	EXOME_COVERAGE
C003747	EGFR_POSITIVE
C003748	ALK_NEGATIVE
C003749	KRAS_NEGATIVE
C003750	OTHER_CONCURRENT_THERAPY
C003751	DRUG_TYPE
C003752	RECIST
C003753	VA_RESPONSE
C003754	ROH_RESPONSE
C003755	P16_ISH
C003756	AGE_START_IO
C003757	METASTATIC_SITE_PATIENT
C003758	PRIMARY_SITE_PATIENT
C003759	TUMOR_TISSUE_SITE_PATIENT
C003760	PLATINUM_RESISTANT
C003761	PLATINUM_SENSITIVE
C003762	GRADE_1
C003763	GRADE_2
C003764	GRADE_3
C003765	RETINOBLASTOMA
C003766	ALK_POSITIVE
C003767	AR_NEGATIVE
C003768	AR_POSITIVE
C003769	BRCA1_NEGATIVE
C003770	BRCA1_POSITIVE
C003771	BRCA2_NEGATIVE
C003772	BRCA2_POSITIVE
C003773	BREAST_IMPLANTS
C003774	C_MYC_NEGATIVE
C003775	C_MYC_POSITIVE
C003776	CROHN_DISEASE
C003777	DESTINATION_STUDY_ID
C003778	EGFR_NEGATIVE
C003779	ER_NEGATIVE
C003780	ER_POSITIVE
C003781	HER2_NEGATIVE
C003782	HER2_POSITIVE
C003783	HPV_NEGATIVE
C003784	HPV_POSITIVE
C003785	IDH1_POSITIVE
C003786	IDH2_NEGATIVE
C003787	IDH2_POSITIVE
C003788	KRAS_POSITIVE
C003789	P16_NEGATIVE
C003790	P16_POSITIVE
C003791	PDX_ID
C003792	PR_NEGATIVE
C003793	PR_POSITIVE
C003794	RESPONSE
C003795	TIME_TO_RECURRENCE
C003796	ULCERATIVE_COLITIS
C003797	UV_EXPOSURE
C003798	IDH1_NEGATIVE
C003799	GBC_ABC_STATUS
C003800	IHC_DOUBLE_EXPRESSOR
C003801	BCL2_STATUS
C003802	BCL2_FISH_STATUS
C003803	BCL6_FISH_STATUS
C003804	MYC_FISH
C003805	FISH_DOUBLE_HIT
C003806	TIMING_OF_SEQUENCING
C003807	BIOPSY_FROM_RELAPSE
C003808	DISEASE_RELAPSED
C003809	TRANSFORMED_DZ_ORIGINAL_TO_TX
C003810	TRANSFORMATION_DATE
C003811	CNS_PPX
C003812	MAINTENANCE
C003813	SCT
C003814	RADIO_IMMUNO_TREATMENT
C003815	MDS_RISK_FACTOR
C003816	BRCA
C003817	DENOVO_MBC
C003818	HER2_FISH_RATIO
C003819	HR_STATUS_SAMPLE
C003820	PR_PCT_PRIMARY
C003821	ER_PCT_PRIMARY
C003822	RECEPTOR_STATUS_PRIMARY
C003823	RECEPTOR_STATUS_PATIENT
C003824	N_STAGE_SAMPLE
C003825	M_STAGE_SAMPLE
C003826	PRIOR_BREAST_PRIMARY
C003827	INVASIVE_CARCINOMA_DX_TIME
C003828	NGS_SAMPLE_COLLECTION_TIME
C003829	PRIOR_LOCAL_RECURRENCE
C003830	INVASIVE_CARCINOMA_DX_AGE
C003831	PDX_RELATED
C003832	TREATMENT_DETAIL_BEFORE_PDX
C003833	SPECIMEN_DEFINITION
C003834	PDX_MUTATION_FEATURE
C003835	PDX_DEL_FEATURE
C003836	PDX_AMP_FEATURE
C003837	PDX_IMPACT_PASSAGE
C003838	PDX_IMPACT_NUMBER
C003839	PDX_RNA_SEQUENCED
C003840	PDX_RNASEQ_PASSAGE
C003841	PDX_RNASEQ_NUMBER
C003842	PDX_MRI
C003843	HETEROGENEITY
C003844	ARCHITECTURAL_PATTERN_GREATER_THAN_50_PERCENT
C003845	ARCHITECTURAL_PATTERN_GREATER_THAN_70_PERCENT
C003846	NUCLEUS_SCORE
C003847	CYTOPLASM_VARIABILITY
C003848	CLEAR_CELL_COMPONENT
C003849	PERIDUCTAL_INFILTRATION
C003850	AJCC_SUMMARY_STAGE
C003851	UNCOMMON_MUTATION_PROFILE
C003852	PATIENT_SURGERY_NUMBER
C003853	ENHANCING
C003854	ACQUIRED_AFTER_RADIOTHERAPY
C003855	ACQUIRED_AFTER_ALKYLATOR_TREATMENT
C003856	ACQUIRED_AFTER_ANY_SYSTEMIC_TREATMENT
C003857	TMZ_HYPERMUTATED
C003858	OVERALL_SURVIVAL_STATUS_FROM_SURGERY
C003859	OVERALL_SURVIVAL_MONTHS_FROM_SURGERY
C003860	PROGRESSION_FREE_SURVIVAL_STATUS
C003861	PROGRESSION_FREE_SURVIVAL_MONTHS_FROM_SURGERY
C003862	PATH_GRADE_DX_TUMOR
C003863	PFS_MONTHS_FIRST_LINE_TX
C003864	PROGRESSION_STATUS
C003865	MMRD_IHC
C003866	IHC_DETAIL
C003867	POLE_IMPACT
C003868	COO_BY_GEP
C003869	COO_LYMPH2CX
C003870	ANY_COO
C003871	CCC
C003872	PLOIDY_ABSOLUTE
C003873	MUTATION_DENSITY
C003874	SILENT_MUTATION_DENSITY
C003875	NUM_DBSNP_MUTATIONS
C003876	DBSNP_MUTATION_DENSITY
C003877	NUM_DRIVER_SCNA
C003878	NUM_DRIVER_SV
C003879	DRIVER_MUTATION_DENSITY
C003880	TUMOR_IN_NORMAL_ESTIMATE
C003881	CLUSTER
C003882	IPI_AGE
C003883	IPI_LDH
C003884	IPI_ECOG
C003885	IPI_STAGE
C003886	IPI_EXBM
C003887	CNS_INVOLVEMENT
C003888	R_CHOP_LIKE_CHEMO
C003889	B_SYMPTOMS_AT_DIAGNOSIS
C003890	CNS_RELAPSE
C003891	IPI_ANNARBOR_STAGE
C003892	IPI_EXTRANODAL_SITES
C003893	PROGNOSTIC_MODEL
C003894	SECONDARY_PATHOLOGICAL_REVIEW
C003895	TMB
C003896	PRD_HISPANIC
C003897	TUMOR_NUMBER
C003898	POPULATION
C003899	MATCHED_CONTROL
C003900	RNA
C003901	AGE_RESECTED
C003902	HISTOPATOLOGY_PRIMARY_TUMOR
C003903	HIGHEST_RECORDED_CLINICAL_TNM_STAGE
C003904	BODY_SITE
C003905	STATUS_LFU
C003906	TTIHR
C003907	FIRST_RECURLIVER_YN
C003908	FIRST_RECUREHD_YN
C003909	LIVERRECUR_YN
C003910	STATUS_RFS
C003911	CYCLESCOMPLETE_TOTAL
C003912	CYCLESCOMPLETE_RECUR
C003913	POSTPUMPCHEMO_YN
C003914	POST_AVAS
C003915	POST_CETUX
C003916	POST_PANIT
C003917	POST_FUONLY
C003918	POST_FOLFIRI
C003919	POST_FOLFOX
C003920	POST_FOLFIRINOX
C003921	TTFD
C003922	DOSE_FUDR1
C003923	ABLATION_YN
C003924	COMP_YN
C003925	MAJCOMP_YN
C003926	INFECTCOMP_YN
C003927	LIVERCOMP_YN
C003928	HAIPCOMP_YN
C003929	HAIP_6MO_CEA
C003930	PATH_LRXMARGIN
C003931	CRLMPROC_LNDX
C003932	CRLMPROC_TYPE
C003933	AGE_HAIP_PLACEMENT
C003934	AGE_CRLM_DX
C003935	PRE_PUMP_CHEMO
C003936	TIME_LATE_CHEMO_WEEKS
C003937	PRE_AVAS
C003938	PRE_CETUX
C003939	PRE_PANIT
C003940	PRE_FU_ONLY
C003941	PRE_FOLFIRI
C003942	PRE_FOLFOX
C003943	PRE_FOLFIRINOX
C003944	CRS
C003945	CRS_DFI
C003946	LATERALITY_CRC
C003947	CRC_PRIMARY_T_STAGE
C003948	CRC_PRIMARY_NODE_STATUS
C003949	CRS_CEA
C003950	CRS_LARGEST_MET
C003951	CRS_NUMBER_METS
C003952	STAGE_4_DX
C003953	POD_FIRST_LINE
C003954	FACETS_VERSION
C003955	FACETS_SNP_NBHD
C003956	FACETS_NDEPTH
C003957	FACETS_PURITY_CVAL
C003958	FACETS_CVAL
C003959	FACETS_MIN_NHET
C003960	FACETS_GENOME
C003961	FACETS_DIPLOGR
C003962	FACETS_LOGLIK
C003963	FACETS_FLAGS
C003964	FACETS_WGD
C003965	GGS
C003966	TAXANE_EXPOSURE_STATUS
C003967	OS_ARSI_START
C003968	BAP1_ALTERATION
C003969	CN_CLUSTER_K6
C003970	MIRNA_CLUSTER_K5
C003971	NCRNA_CLUSTER_K4
C003972	RPPA_CLUSTERS_K5
C003973	PARADIGM_CLUSTER
C003974	ICLUSTER_K4_5TYPES
C003975	OFF_ARSI
C003976	TIME_ON_FIRST_LINE_ARSI
C003977	BRAF_CLASS
C003978	DMT_PRIMARY_SITE
C003979	COMP_PATH_WSV_URL
C003980	SIMPLIFIED_METASTATIC_SITE
C003981	SURVIVAL_STATUS
C003982	DAYS_FROM_DX_TO_DEATH_OR_LAST_FOLLOW_UP
C003983	NEED_2ND_LINE_TREATMENT_VIA_IMPACT
C003984	MATCHED_2ND_LINE_TREATMENT_VIA_IMPACT
C003985	IN_TREATED_GROUP
C003986	IMMUNE_TX_FAIL
C003987	TFFS_MONTH
C003988	SURVIVAL_STATUS_PD1
C003989	OS_MONTH_PD1
C003990	AJCC_STAGE_PD1
C003991	CANCER_SUBTYPE_CURATED
C003992	MDSMPN_DIAGNOSIS_AT_ACQUISITION
C003993	NON_AML_MDSMPN_DIAGNOSIS_AT_ACQUISITION
C003994	PRIOR_MDS
C003995	PRIOR_MDSMPN
C003996	MDS_TWO_MONTHS_PRIOR_AML
C003997	MDSMPN_TWO_MONTHS_PRIOR_AML
C003998	PRIOR_MPN
C003999	MPN_TWO_MONTHS_PRIOR_AML
C004000	DIAGNOSIS_AT_INCLUSION
C004001	SPECIFIC_DIAGNOSIS_AT_INCLUSION
C004002	ELN_2017
C004003	ELN_2008
C004004	SPECIFIC_DIAGNOSIS_AT_ACQUISITION
C004005	EX_VIVO_DRUG_TESTING
C004006	RNA_SEQ_ANALYSIS
C004007	EXOME_SEQ_ANALYSIS
C004008	DRUG_TESTING_IN_ANALYSIS
C004009	TREATMENT_TYPE_COUNT
C004010	TREATMENT_REGIMEN_COUNT
C004011	TREATMENT_REGIMENS
C004012	TREATMENT_STAGE_COUNT
C004013	TREATMENT_STAGES
C004014	INDUCTION_RESPONSE
C004015	TYPE_INDUCTION_TREATMENT
C004016	DURATION_OF_INDUCTION_TREATMENT
C004017	MOST_RECENT_TREATMENT_TYPE
C004018	CURRENT_REGIMEN
C004019	CURRENT_STAGE
C004020	MOST_RECENT_TREATMENT_DURATION
C004021	KARYOTYPE_SAMPLE_ACQUISITION_INTERVAL_DIFFERENCE
C004022	PB_BASOPHILS_PERCENTAGE
C004023	CEBPA_BIALLELIC_MUTATION
C004024	PB_EOSINOPHILS_PERCENTAGE
C004025	PB_IMMATURE_GRANULOCYTES_PERCENTAGE
C004026	PB_LYMPHOCYTES_PERCENTAGE
C004027	PB_MONOCYTES_PERCENTAGE
C004028	PB_NEUTROPHILS_PERCENTAGE
C004029	PB_NUCLEATED_RBC_PERCENTAGE
C004030	PB_ALT_LEVEL
C004031	PB_AST_LEVEL
C004032	PB_ALBUMIN_LEVEL
C004033	HEMATOCRIT_LEVEL
C004034	MEAN_CORPUSCULAR_VOLUME
C004035	SURFACE_ANTIGENS
C004036	TOTAL_PROTEIN_LEVEL
C004037	FLT3_ITD_CONSENSUS_CALL
C004038	NPM1_CONSENSUS_CALL
C004039	DNMT3A_MUTATION
C004040	CYTOGENETICS_OTHER
C004041	MSK_SLIDE_ID
C004042	MUTATIONAL_SIGNATURES_MEANS
C004043	MUTATIONAL_SIGNATURES_CONFIDENCE
C004044	PATIENT_ASSAYS
C004045	NERVOUS_SYSTEM_INVOLVEMENT
C004046	INTERFERON_ALPHA
C004047	KINASE_INHIBITOR
C004048	PRIOR_SYSTEMIC_THERAPIES
C004049	DOR_MONTHS
C004050	DOR_STATUS
C004051	DOSE_REDUCTION
C004052	EVALUABLE_FOR_PET
C004053	PERCENT_CHANGE_BY_PET
C004054	PET_BEST_RESPONSE
C004055	TIME_TO_FIRST_PET_RESPONSE
C004056	TIME_TO_BEST_PET_RESPONSE
C004057	EVALUABLE_FOR_RECIST
C004058	PERCENT_CHANGE_BY_RECIST
C004059	ON_STUDY
C004060	OFF_STUDY_REASON
C004061	ON_TREATMENT
C004062	DOT_MONTHS
C004063	PATH_SLIDE_EXISTS
C004064	PDX_TREATED
C004065	CDK4_STATUS
C004066	DBM_MONTHS
C004067	PDX_CASE_PER_PATIENT
C004068	RIGHT_LEFT_RECTUM
C004069	MICROSATELLITE_STABLE
C004070	DOWNSTAGING_CALC_OF_T_STAGE
C004071	POST_CRT_TNM_DISEASE_STAGE
C004072	POST_CRT_PATHOLOGIC_T_STAGE
C004073	PRE_CRT_TNM_DISEASE_STAGE
C004074	PRE_CRT_PATHOLOGIC_T_STAGE
C004075	MMR_IHC
C004076	MMR_STATUS
C004077	DISPLAY_SAMPLE_NAME
C004078	RESPONSE_PT2N0
C004079	RESPONSE_PT0N0
C004080	RESPONSE_RATE_PT0N0_VS_LESS_PT2N0_GREATER_PT2N0
C004081	PHEOCHROMOCYTOMA_OR_PARAGANGLIOMA
C004082	SPECIFIC_TUMOR_LOCATION
C004083	VIRUS
C004084	HPV
C004085	HHV
C004086	MCPYV
C004087	HADV
C004088	GAMMAPAPILLOMAVIRUS_16
C004089	HUMAN_PAPILLOMAVIRUS_FA75_KI88_03
C004090	GAMMAPAPILLOMAVIRUS_18
C004091	ALPHA_HERPESVIRUS
C004092	BETA_HERPESVIRUS
C004093	JC_POLYOMAVIRUS_TYPE_3
C004094	ALPHAPAPILLOMAVIRUS_2
C004095	HUMAN_POLYOMAVIRUS_6
C004096	GAMMAPAPILLOMAVIRUS_10
C004097	GAMMAPAPILLOMAVIRUS_3
C004098	HUMAN_PAPILLOMAVIRUS_UNIDENTIFIED_TYPE_RTRX6
C004099	ALPHAPAPILLOMAVIRUS_5
C004100	GAMMAPAPILLOMAVIRUS_8
C004101	ALPHAPAPILLOMAVIRUS_7
C004102	DYOXIPAPILLOMAVIRUS
C004103	ALPHAPAPILLOMAVIRUS_6
C004104	BETAPAPILLOMAVIRUS_3
C004105	ALPHAPAPILLOMAVIRUS_3
C004106	BETAPAPILLOMAVIRUS_2
C004107	ALPHAPAPILLOMAVIRUS_9
C004108	BETAPAPILLOMAVIRUS_1
C004109	GAMMAPAPILLOMAVIRUS_15
C004110	GAMMAPAPILLOMAVIRUS_20
C004111	MUPAPILLOMAVIRUS_1
C004112	GAMMA_HERPESVIRUS
C004113	HUMAN_ADENOVIRUS
C004114	GAMMAPAPILLOMAVIRUS_1
C004115	ALPHAPAPILLOMAVIRUS_10
C004116	HUMAN_POLYOMAVIRUS_7
C004117	BETAPAPILLOMAVIRUS_4
C004118	TRICHODYSPLASIA_SPINULOSA_ASSOCIATED_POLYOMAVIRUS
C004119	BK_POLYOMAVIRUS_MM
C004120	BETAPAPILLOMAVIRUS_5
C004121	MERKEL_CELL_POLYOMAVIRUS
C004122	HUMAN_PAPILLOMAVIRUS_TYPE_XS2
C004123	GAMMAPAPILLOMAVIRUS_7
C004124	ALPHAPAPILLOMAVIRUS_4
C004125	ALPHAPAPILLOMAVIRUS_1
C004126	CLINICALLY_AGGRESSIVE
C004127	CLINICALLY_AGRESSIVE_AND_OR_METASTATIC
C004128	DAYS_TO_EVENT_AGGRESSIVE_DISEASE
C004129	DAYS_TO_EVENT_DISTANT_METASTASIS
C004130	PT_BIRTH_YEAR
C004131	PT_DEATH_AGE
C004132	PLA_LAST_ACTV_AGE
C004133	HAS_METASTASIS_DX
C004134	HAS_METASTASIS
C004135	HAS_RECURRENCE
C004136	PNI_PRESENT
C004137	PNI_EXTENSIVE
C004138	PNI_FOCAL
C004139	MET_CASE_CLASS
C004140	CC
C004141	HIPPO
C004142	MYC
C004143	NOTCH
C004144	NRF2
C004145	PI3K
C004146	TGFB
C004147	RTKRAS
C004148	TP53
C004149	WNT
C004150	NUM_ICDO_LOCAL
C004151	NUM_ICDO_REGIONAL
C004152	NUM_ICDO_DISTANT
C004153	CNA_FACETS
C004154	FACETS_FIT_TIMESTAMP
C004155	IS_MAPPED_TO_CANCER_TYPE
C004156	DAYS_FROM_DX_TO_FIRST_RECUR
C004157	DAYS_FROM_FIRST_DX_TO_FIRST_DISTANT_MET
C004158	DAYS_FROM_FIRST_RECUR_TO_FIRST_DISTANT_MET
C004159	DAYS_FROM_DX_TO_IMPACTED_SAMPLE
C004160	STAGE_AT_PRIMARY_DX
C004161	STAGE_AT_MET
C004162	LOW_TUMOR_CONTENT_OR_TEST_FAILURE
C004163	V600EKR
C004164	KIT_DETAILS
C004165	CHANGED_DX_TO_MEL
C004166	BRAIN_METS_EVER
C004167	RT
C004168	IMPACT_DIRECTED_CLIN_TRIAL
C004169	AGE_AT_PD1
C004170	IMMUNE_TX_NON_ADJUVANT
C004171	AGE_FIRST_IMMUNE_THERAPY
C004172	TARGETED_TX
C004173	OTHER_SITES_OF_METS_IMPACT
C004174	OTHER_SITES_OF_MET_EVER
C004175	MULTIPLE_PRIMARY
C004176	CLINICAL_STAGE_AT_IMPACT
C004177	LPI_RESISTANT
C004178	PD1_RESISTANT
C004179	INTERVAL_MONTHS
C004180	PRIOR_THERAPY
C004181	OTHER_CANCER_HISTORY
C004182	BIOPSY_SITE
C004183	STROMA_SCORE
C004184	MIMM_SCORE
C004185	IMMUNE_CLUSTER
C004186	APC_CLUSTER
C004187	T_CELL_CLUSTER
C004188	INFILTRATION_NOMINATION
C004189	NUM_TCRB_TEMPLATE
C004190	NUM_TCRB_CLONES
C004191	CANCER_TYPE_OTHER
C004192	BUFFA_HYPOXIA_SCORE
C004193	WINTER_HYPOXIA_SCORE
C004194	RAGNUM_HYPOXIA_SCORE
C004195	HAS_MET
C004196	HAS_MET_DX
C004197	NUM_MET_SITES
C004198	NUM_METS
C004199	ADRENAL_GLAND_MET
C004200	ADRENAL_GLAND_MET_COUNT
C004201	BILIARY_TRACT_MET
C004202	BILIARY_TRACT_MET_COUNT
C004203	BLADDER_OR_URINARY_TRACT_MET
C004204	BLADDER_OR_URINARY_TRACT_MET_COUNT
C004205	BONE_MET
C004206	BONE_MET_COUNT
C004207	BOWEL_MET
C004208	BOWEL_MET_COUNT
C004209	BREAST_MET
C004210	BREAST_MET_COUNT
C004211	CNS_BRAIN_MET
C004212	CNS_BRAIN_MET_COUNT
C004213	GENITAL_NON_SPECIFIC_MET
C004214	GENITAL_NON_SPECIFIC_MET_COUNT
C004215	HEAD_AND_NECK_MET
C004216	HEAD_AND_NECK_MET_COUNT
C004217	KIDNEY_MET
C004218	KIDNEY_MET_COUNT
C004219	LIVER_MET
C004220	LIVER_MET_COUNT
C004221	LUNG_MET
C004222	LUNG_MET_COUNT
C004223	LYMPH_MET_ICD9_10
C004224	LYMPH_MET_ICD9_10_COUNT
C004225	LYMPH_MET_REGIONAL_ICD0
C004226	LYMPH_MET_REGIONAL_ICD0_COUNT
C004227	MEDIASTINUM_MET
C004228	MEDIASTINUM_MET_COUNT
C004229	OVARY_OR_FALLOPIAN_TUBE_MET
C004230	OVARY_OR_FALLOPIAN_TUBE_MET_COUNT
C004231	PERIPHERAL_NERVOUS_SYSTEM_MET
C004232	PERIPHERAL_NERVOUS_SYSTEM_MET_COUNT
C004233	PERITONEUM_MET
C004234	PERITONEUM_MET_COUNT
C004235	PLEURA_MET
C004236	PLEURA_MET_COUNT
C004237	SKIN_MET
C004238	SKIN_MET_COUNT
C004239	OTHER_MET
C004240	OTHER_MET_COUNT
C004241	OTHER_NON_SPECIFIC_MET
C004242	OTHER_NON_SPECIFIC_MET_COUNT
C004243	NUM_TOTAL_DX
C004244	TREATMENT_BIOLOGIC
C004245	TREATMENT_DURATION_BIOLOGIC
C004246	TREATMENT_DURATION_CHEMOTHERAPY
C004247	TREATMENT_HORMONE
C004248	TREATMENT_DURATION_HORMONE
C004249	TREATMENT_IMMUNOTHERAPY
C004250	TREATMENT_DURATION_IMMUNOTHERAPY
C004251	TREATMENT_TARGETED
C004252	TREATMENT_DURATION_TARGETED
C004253	TREATMENT_UNKNOWN_SUBSTANCE
C004254	TREATMENT_DURATION_UNKNOWN_SUBSTANCE
C004255	TREATMENT_DURATION_RADIATION
C004256	TIME_FROM_SURGERY_TO_RECURRENCE_OR_FUP
C004257	MEDICASTINUM_MET_COUNT
C004258	CANCER_REG_CLINICAL_EDITION
C004259	CANCER_REG_CT_STAGE
C004260	CANCER_REG_CN_STAGE
C004261	CANCER_REG_CM_STAGE
C004262	MSK_EXTRACT_AGE_AT_PROCEDURE
C004263	MSK_EXTRACT_PAJCC_EDITION
C004264	MSK_EXTRACT_PT_STAGE
C004265	MSK_EXTRACT_PN_STAGE
C004266	MSK_EXTRACT_PM_STAGE
C004267	FINAL_BMI_CLASS
C004268	BMI_CLASS
C004269	DISTAL_RECURRENCE
C004270	INITIAL_BMI_NUMBER
C004271	FINAL_BMI_NUMBER
C004272	BMI_DELTA
C004273	DISTANCE_CLASS
C004274	DISTANCE_FROM_ANAL_VERGE_CM
C004275	DEPMAPID
C004276	NAME
C004277	SITE_SUBTYPE1
C004278	SITE_SUBTYPE2
C004279	SITE_SUBTYPE3
C004280	HIST_SUBTYPE1
C004281	HIST_SUBTYPE2
C004282	HIST_SUBTYPE3
C004283	LIFE_STAGE
C004284	SITE_OF_FINDING
C004285	ANNOTATION_SOURCE
C004286	CHARACTERISTICS
C004287	GROWTH_MEDIUM
C004288	SUPPLEMENTS
C004289	FREEZING_MEDIUM
C004290	DOUBLING_TIME_FROM_VENDOR
C004291	TYPE_REFINED
C004292	PRE_TREATMENT_PET_SUV
C004293	SIEWART
C004294	TRG_SCORE
C004295	RESIDUAL_NODAL_DISEASE
C004296	PSADXCAT
C004297	RXPRIM_OTHER
C004298	EXT_PROS
C004299	EXT_LNDIS
C004300	EXT_BONE
C004301	EXT_VIS
C004302	BONEVOL
C004303	CNTADT
C004304	DZVOL
C004305	DENOVOM
C004306	HIST_ADENO
C004307	HIST_NEURO
C004308	HIST_SMALL
C004309	HIST_DUCT
C004310	IS_CRPC
C004311	ADT_OS_MOS
C004312	CRPC_OS_MOS
C004313	SMP_OS_MOS
C004314	ALL_MUTS
C004315	ALL_SYNS
C004316	FRAMESHIFT_INDELS
C004317	MUTS_CLONAL
C004318	MUTS_SUBCLONAL
C004319	MUTS_UNEVAL
C004320	NONSYNS_CLONAL
C004321	NONSYNS_SUBCLONAL
C004322	NONSYNS_UNEVAL
C004323	DRUG
C004324	TREATMENT_GROUP
C004325	MAX_TUMOR_CHANGE
C004326	OS_CENSOR
C004327	PFS_CENSOR
C004328	CELL_MEMBRANE_PDL1_0PERCENT
C004329	CELL_MEMBRANE_PDL1_1PLUS_PERCENT
C004330	CELL_MEMBRANE_PDL1_2PLUS_PERCENT
C004331	CELL_MEMBRANE_PDL1_3PLUS_PERCENT
C004332	PDL1_POSITIVE_1PERCENT
C004333	PDL1_POSITIVE_5PERCENT
C004334	HIGHEST_ONCOKB_LEVEL
C004335	WHO_CLASSIFICATION_OF_DX_TUMOR
C004336	ACTIONABLE_LESION1
C004337	RECEIVED_TARGETED_TX
C004338	TUMOR_SURGERY_NUMBER
C004339	SURGERY_DATE_RELATIVE_TO_DX_MONTHS
C004340	ACQUIRED_AFTER_ALKALATOR_TREATMENT
C004341	PRIOR_LINES_OF_THERAPY
C004342	ALCOHOL_ABUSE
C004343	ASHKENAZI_JEWISH
C004344	T1_OR_T2_DISEASE_WITHOUT_NODAL_METASTASIS
C004345	T3_DISEASE_OR_ANY_T_STAGE_WITH_NODAL_METASTASIS
C004346	IF_DISEASE_DX_INCIDENTALLY
C004347	IMPACT_ON_UNTREATED
C004348	FIRST_RECURRENCE_SITE
C004349	SITE_DISTANT_RECURRENCE
C004350	NEOAD_CHEMO_BASED
C004351	NEOADJ_CHEMO_PLATINUM
C004352	ADJ_THERAPY
C004353	ADJ_RADIATION
C004354	NEOADJ_THERAPY
C004355	GREATER_THAN_PT2
C004356	SURVIVAL_STATUS_ORIGINAL
C004357	ANY_ADJUVANT
C004358	ECOG
C004359	LDH
C004360	LDH_RATIO
C004361	LDH_ABNL
C004362	NLR
C004363	NLR_GREATER_THAN_4_DOT_73
C004364	AMC_GREATER_THAN_0_DOT_8
C004365	EOS_GREATER_THAN_1_DOT_1
C004366	BASO_GREATER_THAN_0_DOT_6
C004367	REC_GREATER_THAN_1_DOT_5
C004368	RLC_GREATER_THAN_17_DOT_5
C004369	LUNG
C004370	CNS
C004371	BONE
C004372	LIVER_METS
C004373	AJCC_7
C004374	AJCC_8
C004375	THREE_PLUS_MET_SITES
C004376	ANY_PTEN_IF_V600
C004377	ANY_PI3K_IF_V600
C004378	ANY_B2M
C004379	ANY_JAK1_SLASH_2
C004380	CTNNB1
C004381	ANY_PTEN
C004382	DMT_PRIMARY_SITE_CLASSIFIED
C004383	DRIVER_CLASS
C004384	SITE_METS_PD1_FIRS
C004385	AGE_AT_MENOPAUSE
C004386	RECURRENCE_SITE
C004387	RECURRENCE_DATE
C004388	DEATH_DATE
C004389	LAST_CONTACT_DATE
C004390	CURRENT_STATUS_DATE
C004391	CURRENT_STATUS
C004392	CHEMO_PLUS_XRT
C004393	PROGESTINS
C004394	OTHER_ADJUV_THERAPY
C004395	CHEMO_TYPE
C004396	OTHER_CHEMO_TYPE
C004397	NO_FURTHER_TREATMENT
C004398	PELVIC_XRT
C004399	WAR
C004400	EXTENDED_FIELD_XRT
C004401	BRACHYTHERAPY
C004402	CVA
C004403	KIDNEY_DISEASE
C004404	MYOCARDIAL_INFARCTION
C004405	PREVIOUS_CANCER
C004406	CAD
C004407	DVT_PE
C004408	YEARS_OF_TAMOXIFEN
C004409	SLEEP_APNEA
C004410	ORTHO_DISEASE
C004411	PREVIOUS_SURGERY
C004412	NUMBER_OF_PRIOR_SURGERIES
C004413	OPEN_ABDOM_SURG
C004414	NO_OPEN_ABDOM_SURG
C004415	LAPAR_SURG
C004416	NO_LAPAR_SURG
C004417	FAM_HX_BREAST_CA
C004418	NO_RELATIVES_BREAST_CA
C004419	FAM_HX_UTERINE_CA
C004420	NO_RELATIVES_UTERINE_CA
C004421	FAM_HX_OVARIAN_CA
C004422	NO_RELATIVES_OVARIAN_CA
C004423	FAM_HX_COLON_CA
C004424	NO_RELATIVES_COLON_CA
C004425	FAM_HX_OTHER_CA
C004426	NO_RELATIVES_OTHER_CA
C004427	SURGERY_DATE
C004428	OTHER_PROC_HERNIA_REPAIR
C004429	OTHER_PROC_ENTEROLYSIS
C004430	OTHER_PROC_URETEROLYSIS
C004431	OTHER_PROC_OTHER
C004432	OTHER_PROC_MINILAP_REMOVE_UTERUS
C004433	OVARIES
C004434	INTRA_OP_NODE_ASSESS
C004435	INTRA_OP_MYOINVASION
C004436	METHOD_MYOINVASION_ASSESS
C004437	GROSS_PERITONEAL_DISEASE
C004438	FIGO_GRADE
C004439	FINAL_DIAGNOSIS
C004440	SECOND_PATH_REVIEW_NOTES
C004441	FINAL_PATH_MIXED
C004442	MIXED_PHENOTYPES
C004443	MLH1
C004444	MSH2
C004445	MSH6
C004446	PMS2
C004447	MYOINVASION_DEPTH
C004448	LUS_INVOLVEMENT
C004449	LVSI_INVOLVEMENT
C004450	VAGINAL_INVOLVEMENT
C004451	BOWEL_BLADDER_INVOLVEMENT
C004452	ADNEXAL_INVOLVEMENT
C004453	ENDO_CX_INVOLVEMENT
C004454	STROMA_CX_INVOLVEMENT
C004455	POSITIVE_WASHINGS
C004456	CONFINED_POLYP
C004457	RESIDUAL_UTERINE_DS
C004458	POSITIVE_PELVIC_NODES
C004459	POSITIVE_PARA_AORTIC_NODES
C004460	ANY_NODE_POSITIVE
C004461	SYNCH_OVARIAN_MALIG
C004462	ASTHMA
C004463	ARTHRITIS
C004464	CHRONIC_BACK_PAIN
C004465	CONGESTIVE_HEART_FAILURE
C004466	CHRONIC_LUNG_DISEASE
C004467	PRIMARY_SURGICAL_MANAGEMENT
C004468	PRE_OP_HISTOLOGY
C004469	IF_MIXED_LIST_SUBTYPE
C004470	PRE_OP_CA125
C004471	GRAVIDA
C004472	PTEN_GENETIC_STATUS
C004473	PTEN_LOH
C004474	PTEN_IHC_SCORE_EPITHELIUM
C004475	PTEN_IHC_SCORE_STROMA
C004476	HLA_A1_ALLELE
C004477	HLA_A2_ALLELES
C004478	HLA_B1_ALLELES
C004479	HLA_B2_ALLELES
C004480	HLA_C1_ALLELES
C004481	HLA_C2_ALLELES
C004482	SMOKING_STATUS
C004483	BEST_OVERALL_RESPONSE
C004484	ECOG_PERFORMANCE_STATUS
C004485	PREDICTED_NEOANTIGEN_BURDEN
C004486	AGE_YRS
C004487	EXCLUDE_CLINICAL_OUTCOMES
C004488	IMPACT_MATCHED_NORMAL_COLON
C004489	IMPACT_MATCHED_NORMAL_BLOOD
C004490	CRT_CHEMO_AGENT
C004491	NEOADJ_CHEMO_AGENT
C004492	NEOADJUVANT_TREATMENT_DETAILS
C004493	RADIATION_DOSE
C004494	PCR
C004495	CCR
C004496	PATHOLOGICAL_TUMOR_RESPONSE
C004497	TRG_AJCC
C004498	CLINICAL_LN_POSITIVE
C004499	POSTCRT_PATHOLOGICAL_LN
C004500	PRECRT_AJCC_CLASSIFICATION
C004501	POSTCRT_TNM_STAGE_YP_TNM
C004502	PRECRT_CLINICAL_T_STAGE
C004503	POSTCRT_PATHOLOGIC_TSTAGE_YP_T
C004504	TUMOR_SIZE_CM
C004505	IGO_PROJECT
C004506	MUTATION_COUNT_341
C004507	MUTATION_RATE_ALL
C004508	MUTATION_RATE_341
C004509	MSI_EVIDENCE
C004510	FRACTION_GENOME_ALTERED_REPORTED
C004511	BMI_DELTA_DAYS
C004512	DISTANCE_FROM_AV_CM
C004513	RECTAL_LOCATION
C004514	ADJUVANT_CHEMO_REGIMEN
C004515	ADJUVANT_CYCLES_NUM
C004516	TOTAL_CYCLES_NUM_NEOADJUVANT_ADJUVANT
C004517	DFS_DAYS
C004518	IMAGE_SCAN_SITE
C004519	IMAGE_CA
C004520	INST_SCAN_PERF
C004521	INST_SCAN_INT
C004522	IMAGE_OVERALL
C004523	IMAGE_CANCER_SITE1
C004524	IMAGE_CANCER_SITE2
C004525	IMAGE_CANCER_SITE3
C004526	IMAGE_CANCER_SITE4
C004527	IMAGE_CANCER_SITE5
C004528	IMAGE_CANCER_SITE6
C004529	IMAGE_CANCER_SITE7
C004530	DRUGS_CT_YN
C004531	DRUGS_INST
C004532	DRUGS_DC_YNU
C004533	DRUGS_NUM
C004534	PATH_TYPE
C004535	PATH_REP_INST
C004536	PATH_PROC_INST
C004537	PATH_NUM_SPEC
C004538	PATH_SITE_1
C004539	PATH_INSITU1
C004540	PATH_CA1
C004541	PATH_CA_TYPE1
C004542	PATH_CA_HIST1
C004543	PATH_SITE2
C004544	PATH_INSITU2
C004545	PATH_CA2
C004546	PATH_CA_TYPE2
C004547	PATH_CA_HIST2
C004548	LAB_TEST
C004549	PDL1_TEST
C004550	PDL1_SUM
C004551	PDL1_YN_2
C004552	MSI_YN
C004553	MMR_YN
C004554	FACETS_SUITE_VERSION
C004555	FACETS_REVIEW
C004556	FRACTION_LOH
C004557	NTELOMERIC_AI
C004558	PDX_SAMPLE_DAYS_FROM_DIAGNOSIS
C004559	TMB_NONSYNONYMOUS
C004560	ASCN_PLOIDY
C004561	ASCN_PURITY
C004562	ASCN_VERSION
C004563	ASCN_WGD
C004564	CMO_TMB_SCORE
C004565	IGO_ID
C004566	PIPELINE
C004567	PROJECT_ID
C004568	PROJECT_PI
C004569	REQUEST_ID
C004570	REQUEST_PI
C004571	ANCESTRY_LABEL
C004572	ADMIXTURE_LABEL
C004573	ASJ
C004574	AFR
C004575	EAS
C004576	EUR
C004577	NAM
C004578	SAS
C004579	NUM_NONREF_ASJ_MARKERS
C004580 DISEASE_TYPE
